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In the Netherlands, 27% of the population is currently smoking. Nicotine is 
among the most addictive substances of abuse. Thirty-two percent of the people 
who tried smoking develop nicotine dependence within ten year. This percentage 
is higher for nicotine than for other substances of abuse (e.g., 23 for heroin: 
Anthony, et al. 1994). Eighty percent of the smokers intend to quit smoking in the 
future while only 25% actually attempt to quit every year. Most of these quit 
attempts fail as 88-95% of the quitters smoke again in the year following the quit 
attempt (International Tobacco Control Policy Evaluation Project 2011). Although 
smoking rates are decreasing since 1970, the decline in smoking rates is less 
distinct in populations with a lower social economic status. Youngsters with lower 
educational levels start smoking more often and it could be that those with lower 
social economic status have more difficulties giving up smoking. Nicotine 
dependence is currently included in the Diagnostic and Statistical Manual of 
Mental Disorders fourth edition (DSM-IV-TR) as a ‘substance use disorder’. 
Examples of diagnostic criteria are tolerance, withdrawal, smoking more than 
one intended, and the continuation of smoking despite knowledge of adverse 
consequences. Although nicotine dependence is included in the DSM-IV, nicotine 
dependence is rarely diagnosed. In addition, many smokers do not meet the 
diagnostic criteria, although they do experience problems giving up smoking 
(Schmitz, et al. 2003) and have increased risks for serious health problems. All 
these characteristics of smoking imply that smoking is a serious and chronic 
condition that occurs in a substantial part of the population.
Neurocognitive processes in smokers
Several theories of addiction suggest an imbalance in cognitive processing in 
addicted individuals (Field, et al. 2008; Franken 2003; Goldstein, et al. 2011; 
Volkow, et al. 2004; Wiers, et al. 2007). These models explain substance 
dependence as a consequence of an overactive motivational brain circuit in 
combination with insufficient control due to an ineffective cognitive control 
circuit. This ineffective cognitive control circuit may be one of the reasons why 
addicted individuals are characterized by the inability to adequately control 
behavior related to substance use such as abstaining from substances of abuse. 
Adequate cognitive control is of key importance when habitual and rigid 
behavioral patterns should be changed. The ability to guide our behavior 
according to our long-term goals, such as giving up smoking, requires the 
inhibition of automatic behavior and the monitoring of ongoing behavior, with 
both these functions being implemented by cognitive control circuits in our brain. 
Inhibitory control and error-processing are two core components of cognitive 
control (Ridderinkhof, et al. 2004a) that are associated with addictive behaviors. 
Inhibitory control refers to the ability to suppress behaviors (such as smoking) 
that are automatic, inappropriate, unsafe or no longer required (Chambers, et al. 
2007). Error-processing, on the other hand, refers to the monitoring and 
evaluation of ongoing behavior in order to be able to continue and optimize future 
behavior (Ridderinkhof, et al. 2004a). Chapter 2 introduces the concept of 
cognitive control in more detail. The sub-processes inhibitory control and error-
processing are further explained, task paradigms to measure these cognitive 
processes are described, and the neural networks and event-related potentials 
associated with these processes are explained. Chapter 2 also includes an 
overview of the studies investigating cognitive control in addiction. At the moment 
this thesis project was started (2008), studies in opiate and cocaine dependent 
patients showed reduced inhibitory control and error-processing and associated 
hypoactivation in prefrontal regions such as the anterior cingulate cortex and 
dorsolateral prefrontal cortex (Franken, et al. 2007; Fu, et al. 2008; Hester, et al. 
2004b; Kaufman, et al. 2003). However, it was unclear whether smokers are also 
characterized by reduced inhibitory control and error-processing. Another 
ongoing scientific endeavor with regard to inhibitory control is the underlying 
pharmacology. Recent studies in humans have shown that inhibitory control may 
be modulated by dopamine levels (Nandam, et al. 2011), although these studies 
are still scarce. It is important to gain more knowledge on how dopamine affects 
neural networks underlying inhibitory control to better understand disorders 
such as addiction, known to be characterized by dysfunctional dopamine systems 
(Balfour 2009; Berkman, et al. 2011; Diekhof, et al. 2008; Franken, et al. 2005; 
Koob, et al. 1997; Volkow, et al. 2009). Possibly, the alterations in dopaminergic 
functioning in addiction may lie at the basis of observed deficits in inhibitory 
control as well as hypoactivation in associated prefrontal regions.
 Addicted individuals are also characterized by an overactive motivational 
and reward related network (i.e., the mesocorticolimbic system) when they are 
confronted with substance-related cues (Kuhn, et al. 2011). It has been suggested 
that enhanced attention allocation to substance-related cues is one of the 
cognitive processes that may contribute to the overactive motivational brain 
system in addicted individuals (Franken 2003; Robinson, et al. 2003). This 
attention allocation to substance-related cues is also referred to as attentional 
bias and is defined as the tendency of addicted individuals to automatically and 
involuntarily turn their attention to and maintain their focus on conditioned 
substance-related cues. Attentional bias has consistently been found in various 
types of addiction (Field, et al. 2008; Franken 2003; Robbins, et al. 2004) utilizing 
a wide range of experimental paradigms including attentional tasks such as the 
emotional Stroop and visual probe task. Smokers, for example, are slower in 
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naming the color of smoking-related words when compared to neutral words 
during the smoking Stroop tasks (Munafo, et al. 2003), and they are faster in 
responding to probes replacing smoking pictures than to probes replacing non-
smoking pictures (Bradley, et al. 2004; Ehrman, et al. 2002; Mogg, et al. 2005) 
during the visual probe task. Eye-tracking studies (Field, et al. 2004; Mogg, et al. 
2003) have also indicated enhanced attentional processing of drug cues in 
smokers. As predicted by theoretical models, attentional bias is associated with 
current craving, the strong subjective urge to consume a substance of abuse 
(Field, et al. 2009; Franken 2003). Recently, attentional bias has been associated 
with clinically relevant aspects such as the temptation to use substances (Waters, 
et al. 2012), treatment outcome (Carpenter, et al. 2006; Cox, et al. 2002) and 
relapse rates (Marissen, et al. 2006; Waters, et al. 2003). Further, preliminary 
evidence has suggested that attentional bias extinction training reduces 
conditioned cigarette craving in smoking males (Attwood, et al. 2008) and 
drinking behavior in alcohol dependent patients (Fadardi, et al. 2009; 
Schoenmakers, et al. 2010). However, research into attentional bias extinction 
training is still in its infancy and it seems that a single training session is not 
sufficient to reduce smoking behavior (Attwood, et al. 2008; Field, et al. 2009; 
McHugh, et al. 2010b). Theoretical models further suggest that attentional bias is 
a consequence of a dopamine signal that triggers attention to substance-related 
cues whenever they are encountered by substance dependent patients (Franken 
2003; Robinson, et al. 2003). There is general consensus that the dopaminergic 
system, with projections from the ventral tegmental area (VTA) to the striatum, 
the anterior cingulate cortex (ACC) and other prefrontal brain regions, is 
responsible for reinforcement learning and experiencing reward (Schultz, et al. 
1997). After repeated drug intake, substance-related cues become conditioned 
cues and elicit dopaminergic activity (Volkow, et al. 2006; Wong, et al. 2006; 
Zijlstra, et al. 2008) thereby signaling the expectation of a future reward (i.e., the 
intake of the substance of abuse). Gradually, the dopaminergic system becomes 
sensitized to substance-related cues so that they become extremely salient, the 
focus of attention, and elicit behaviors like drug seeking and consumption 
(Phillips, et al. 2003; Robinson, et al. 2008). Although attentional bias theories 
(Franken 2003; Robinson, et al. 1993) explain attentional bias in terms of 
neurobiological processes, neuroimaging studies in humans investigating the 
neurobiology of attentional bias are scarce. Two event-related potentials (ERPs), 
the P300 and Late Positive Potential (LPP), measured using 
electroencephalography (EEG), represent the allocation of enhanced attentional 
resources to motivationally relevant stimuli. A recent meta-analysis showed that 
both the P300 and LPP are consistently enhanced in addicted individuals for 
substance-related cues (Littel, et al. in press) indicating increased neural 
processing of these cues. However, due to limited spatial resolution, ERP studies 
cannot provide information concerning the role of specific brain regions in 
attentional bias. Functional magnetic resonance imaging (fMRI) can provide this 
information; however, fMRI studies using attentional bias paradigms in addicted 
individuals are rare, therefore empirical evidence concerning the role of specific 
brain regions in attentional bias is as yet lacking.
Research objectives and relevance
The main objective of this thesis is to gain more knowledge about the 
neurocognitive processes involved in smoking behavior. This is achieved by 
investigating brain functions associated with cognitive control and attentional 
bias in smokers and healthy controls. Greater insight into the malfunction of 
neural networks associated with cognitive control and attentional bias in smokers 
could provide valuable information to understand the low success rates for giving 
up smoking. In addition, it can eventually contribute to the development of new 
strategies to support quit attempts in smokers. At the start of the current PhD 
project it was not yet clear whether smokers are characterized by reduced 
inhibitory control and ineffective prefrontal brain activation. At that moment, a 
few studies investigated inhibitory control in smokers by means of behavioral 
paradigms, without measuring accompanied brain activation. Results of these 
studies in smokers were inconsistent. That is, some studies have found response 
inhibition to be impaired in smokers relative to controls (e.g., Spinella 2002) 
whereas other studies could not confirm this (Dinn, et al. 2004; Monterosso, et al. 
2005; Reynolds, et al. 2007). Therefore, the aim of the current thesis was to 
investigate inhibitory control and associated brain activation in smokers. An 
additional aim was to gather more detailed information concerning the underlying 
mechanisms for problems with inhibitory control in addiction. Addiction models 
suggest that problems with inhibitory control arise when rewarding stimuli, such 
as substance-related cues or stimuli associated with immediate reward, are to be 
suppressed (Dawe, et al. 2004a; Goldstein, et al. 2002; Jentsch, et al. 1999). This 
is, however, not explicitly tested in studies manipulating the type of stimuli to be 
suppressed. Therefore, we examined whether the presence of smoking-related 
cues could hamper inhibitory control and whether inhibitory control in smokers is 
impaired when previously rewarding stimuli need to be inhibited in order to 
obtain a larger delayed reward. Furthermore, the pharmacology of inhibitory 
control is largely unknown so our aim was to clarify the role of dopamine in 
inhibitory control, as more knowledge concerning the pharmacology of inhibitory 
control could eventually contribute to the development of pharmacotherapy for 
addiction. Error-processing, the ability to detect and monitor performance errors 
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in order to continue ongoing behavior (Ridderinkhof, et al. 2004a), is also critically 
depending on optimal activation in the prefrontal cognitive control system, 
especially the ACC. In the last few years, error-processing is emerging as an 
important concept in addiction. Therefore, it was evaluated whether smokers 
sufficiently process and monitor their errors in ongoing behavior. 
 A second major objective of this thesis was to investigate the motivational 
brain system in smokers by elucidating the neural mechanisms associated with 
attentional bias. More specifically, we wanted provide empirical evidence for 
theoretical models stating that attentional bias is the result of enhanced brain 
activation when smokers are confronted with smoking-related cues due to 
dopaminergic activity evoked by these cues. Consequently, both the 
neuroanatomical substrate of attentional bias in smokers was investigated, as 
well as the effect of a dopaminergic challenge on brain activation associated with 
attentional bias. Understanding the neuroanatomical correlates of attentional 
bias as well as the pharmacology of attentional bias could provide vital information 
for future research with the aim to reduce attentional bias in smokers.
 
Neuroimaging techniques
In order to investigate the neural correlates of cognitive processing in smokers 
we need neuroimaging techniques to measure ongoing brain activation. Technical 
advances in the past decades have made it possible to study brain activation in a 
non-invasive way. Brain activation associated with cognitive processes (e.g., 
inhibitory control, error-processing or attentional bias) is evoked by specific task 
paradigms that evoke brain activation associated with the cognitive process 
under investigation. Neuroimaging methods used in this thesis are event-related 
potentials (ERPs) and functional magnetic resonance imaging (fMRI). In addition, 
a pharmacological challenge is used in combination with fMRI to clarify the role 
of dopamine in inhibitory control and attentional bias.
 For the studies described in chapter 3 and chapter 4 we have used ERPs 
to measure brain activation. ERPs are acquired by means of the recording 
electroencephalographic (EEG) activity. EEG is the electrical activity along the 
scalp reflecting the summation of the synchronous activity of thousands or 
millions of neurons that have similar spatial orientation (Fabiani, et al. 2000). 
ERPs are electrical brain potentials that are averaged and time-locked to the 
occurrence of specific events such as the onset of a particular stimulus in a 
cognitive task. ERPs provide sensitive indices of the temporal aspects of neural 
processes representing cognitive functions evoked by the cognitive task. This is 
because ERPs have temporal resolution in the order of milliseconds and because 
previous ERP research has shown that each ERP indexes a specific cognitive 
process. For example, for error-processing two ERP components have been 
identified. The error-related negativity (ERN) and the error-positivity (Pe) and it is 
known that the ERN is associated with fast initial error detection while the Pe is 
associated with the more conscious evaluation of an error (Overbeek, et al. 
2005). 
 For the studies described in chapter 5, 6, 7, and 8 we have used fMRI to 
measure brain activation. FMRI has a high spatial resolution and is therefore 
suitable to detect brain activation in specific brain regions that are involved in the 
cognitive process under investigation. fMRI does not provide an absolute 
measure of brain activation, but provides a reliable measure of changes in brain 
activation depending on the supply of oxygen to an active region. The so-called 
Blood Oxygenation Level-Dependent (BOLD) contrast is the most commonly 
measured contrast for fMRI. A wealth of research has provided evidence that the 
BOLD response is tightly linked to neuronal activity (Logothetis, et al. 2001). 
Changes in BOLD signal that are correlated in time with the cognitive performance 
on the task paradigm are interpreted as an indication that this specific brain 
region is activated due to task performance. Cognitive paradigms developed for 
fMRI research usually involve an experimental and a control condition. Brain 
activation associated with the control condition is used to isolate the activation 
associated with the cognitive process under investigation. fMRI can also be used 
in combination with a pharmacological challenge. It is then referred to as 
pharmacological fMRI (phMRI). As phMRI can also be applied to cognitive task 
paradigms, it is a very suitable method to measure the effects of a pharmacological 
challenge on cognitive processes (Honey, et al. 2004; Stein 2001). To elucidate 
the effects of the pharmacological challenge, task related brain activation after 
the pharmacological challenge must be compared to a measurement of baseline 
task related activation obtained after administration of placebo. To answer the 
research questions concerning the role of dopamine in inhibitory control and 
attentional bias the dopamine system was challenged using a single administration 
of a dopamine antagonist combined with phMRI measurements.
 The above-mentioned characteristics make ERP and fMRI techniques 
very suitable to study neurobiological correlates of cognitive dysfunctions 
present in substance dependence. A combined evaluation of ERP and fMRI 
research may provide valuable and complementary insights in both the temporal 
and spatial properties of the neural substrate of the cognitive processes involved 
in nicotine dependence.
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Outline of the current thesis
This thesis describes a series of seven studies (chapter 2 to 8). In six of these 
studies smokers were compared to matched non-smoking controls while brain 
activation was measured and a cognitive task paradigm was developed with 
the aim to measure the cognitive process under consideration. Chapter 2 is an 
introductory chapter in which the concept of cognitive control is explained in 
more detail. The sub-processes inhibitory control and error-processing are 
defined, task paradigms to measure these cognitive processes are described 
and the neural networks and event-related potentials associated with these 
processes are explained. Most importantly, this chapter provides an overview 
of the neuroimaging research in substance dependent individuals. Similarities 
and differences between the substances of abuse are described. In light of the 
new update of the DSM-V, which will include a section ‘Substance Use and 
Addictive Disorders’, studies in pathological gamblers and excessive internet 
users are also included in the overview. This chapter also provides treatment 
implications and future research suggestions.
 In the study described in chapter 3, cognitive control in smokers was 
evaluated by focusing on error-processing. Deficits in error-processing in 
smokers were evaluated under challenging conditions, as the Flanker 
paradigm developed for this study included exposure to smoking-related 
cues. It was hypothesized that during smoking cue exposure limited capacity 
may be available to monitor ongoing performance. As a consequence, 
smokers would show reduced error-processing compared to non-smoking 
controls. Additionally, the nature of error-processing deficits was investigated 
in more detail by investigating their associations with trait impulsivity, severity 
of nicotine dependence and cigarette craving. 
 In chapter 4, a study is described in which we investigated whether 
decreased inhibitory control is evident in smokers. In line with theories 
suggesting that inhibitory control is more severely impaired in substance 
dependent individuals in the presence of substance-related cues it was also 
investigated whether deficits in inhibitory control in smokers are more distinct 
during smoking cue exposure. In this study behavioral accuracy on a Go/
NoGo task as well as event-related potentials associated with inhibitory 
control were evaluated in smokers and non-smokers. It was expected that 
smokers showed reduced inhibitory control both on the behavioral and 
electrophysiological level as compared to non-smoking controls. Furthermore, 
it was expected that these effects were more evident during smoking cue 
exposure.
 The study described in chapter 5 investigated the neural basis to inhibit 
an immediately rewarding stimulus in order to obtain a larger delayed reward in 
smokers. It was also investigated whether punishment insensitivity could be 
another factor contributing to inefficient inhibitory control over addictive 
behaviors. To examine the effects of reward and punishment on brain activation 
associated with inhibitory control, a modified version of the Go/NoGo response-
inhibition paradigm was designed that allowed the examination of neural activity 
during inhibitory control over rewarding NoGo stimuli. In the punishment 
condition failure to inhibit resulted in immediate money loss. In line with 
contemporary theories on addiction, we presumed that smokers would have 
significantly more difficulty inhibiting their response to a rewarding stimulus 
when compared to matched control participants. With regard to punishment 
sensitivity, it was expected that smokers are less sensitive to the effects of 
punishment to guide control over rewarding stimuli. More specifically, we 
expected that non-smoking controls would adopt a more cautious responding 
style when failed inhibition resulted in an immediate punishment, while this was 
not expected to influence behavior to the same extent in smokers. 
 
 In the study described in chapter 6, the association between dopamine 
and inhibitory control was examined. Currently, the pharmacology of inhibitory 
control is still largely unknown. Theorists suggest that optimal dopamine levels 
are needed in order to efficiently implement inhibitory control (Cools, et al. 2011). 
This implies that deficiencies in dopaminergic functioning that have been 
observed in substance dependent individuals including smokers may contribute 
to problems in inhibitory control in these populations. A pharmacological fMRI 
study in which dopamine levels were manipulated in smokers and non-smoking 
controls is described in this chapter. Haloperidol (2mg), a selective D2/D3 
dopamine antagonist, or placebo was orally administered our hours before each 
scanning session in a double-blind randomized cross-over design in smokers 
and non-smoking controls. It was assumed that a reduction in dopamine levels 
after the administration of haloperidol reduces inhibitory control and associated 
brain activation. In addition, based on baseline differences in dopaminergic 
functioning between smokers and non-smoking controls it was expected that 
haloperidol will have differential effects on brain activation associated with 
inhibitory control in smokers and non-smokers. 
 In chapter 7 the neural substrate of attentional bias and associated 
subjective craving in smokers was investigated. For this aim a pictorial attentional 
bias task was developed (the attentional bias line counting task) and smokers 
and non-smoking controls performed this task while we measured brain 
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activation using fMRI. It was expected that the dorsal zone of the ACC (dACC) 
would be overactive in smokers during the attentional bias paradigm. This dACC 
activity will contribute to focused attention on the primary task, as smokers will be 
highly distracted by the conditioned smoking cues. In line with other brain regions 
involved in salience attribution and top-down attention, we expected the ventral 
ACC, orbitofrontal cortex, ventral striatum, amygdala, superior parietal and 
dorsolateral frontal cortex to be similarly hyperactive. 
 It has been suggested that attentional bias emerges as a consequence 
of dopaminergic activity evoked by substance-related cues (Franken 2003; 
Robinson, et al. 1993). The pharmacological fMRI study described in chapter 8 
employed a dopaminergic challenge in order to test the hypothesis that brain 
activation associated with attentional bias in smokers can be modulated by a 
dopamine antagonist. To manipulate dopamine levels the same procedures were 
used as in chapter 6. Again, the pictorial attentional bias line counting task was 
used to measure brain activation associated with attentional bias to be able to 
replicate and compare findings to those in chapter 7. It was expected that 
administration of a dopamine antagonist normalized brain activation associated 
with attentional bias in smokers. 
 In chapter 9, our main findings will be summarized and evaluated in 
light of current theories on addiction. Limitations of the current studies are 
discussed. In addition, future research suggestions and clinical implications are 
provided.
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Deficits in cognitive control 
in substance dependence and 
behavioral addictions: 
A systematic review of ERP and 
fMRI studies on inhibitory control 
and error-processing
Maartje Luijten, Marise WJ Machielsen, Dick J Veltman, 
Robert Hester, Lieuwe de Haan, Ingmar HA Franken
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Introduction
Cognitive control has been described as a multifactorial construct that implies 
cognitive operations to allow individuals to optimize goal-directed behavior and 
to adapt behavior accordingly (Botvinick, et al. 2001; Ridderinkhof, et al. 2004a). 
The role of cognitive control in substance dependence is emphasized in several 
contemporary theoretical models of substance dependence (Dawe, et al. 
2004a; Goldstein, et al. 2011; Jentsch, et al. 1999; Lubman, et al. 2004; Verdejo-
Garcia, et al. 2008). Substance dependent individuals are characterized by the 
inability to adequately control behavior related to substance use such as 
abstaining from substances of abuse. In addition, the reduced ability to perform 
goal directed behavior in substance dependent individuals is often accompanied 
by an apparent failure to adaptively learn from previous harmful behavior 
(Franken, et al. 2007). The ability to guide our behavior in accordance with our 
long-term goals requires inhibition of automatic behavior and the monitoring of 
ongoing behavior, with both these functions being implemented by cognitive 
control circuits in our brain. More specifically, inhibitory control and error-
processing are two core components of cognitive control that are associated 
with specific neural networks; the former to implement the inhibition of 
inappropriate behavior and the latter to monitor performance errors in order to 
prevent future mistakes (Ridderinkhof, et al. 2004a). Adequate cognitive control 
is of key importance when habitual and rigid behavioral patterns should be 
changed, such as when substance dependent individuals try to control or 
withhold using the substance of abuse. Given the important role of cognitive 
control in substance dependence, greater insight into the malfunction of neural 
networks in substance dependent individuals could provide valuable information 
for understanding the problems associated with controlling substance use. 
Consequently, a rapidly increasing number of studies have examined inhibitory 
control and error-processing in substance dependent individuals by using 
neuroimaging techniques such as event-related potentials (ERPs) and functional 
magnetic resonance imaging (fMRI). ERPs are electrical brain potentials 
associated with the occurrence of specific events such as the onset of a 
particular stimulus or event in a cognitive task. ERPs are acquired via the 
recording of electroencephalographic (EEG) activity, and provide sensitive 
indices of the temporal aspects of neural processes underlying cognitive 
functions. FMRI, on the other hand, has a high spatial resolution and is suitable 
for localizing activation in the brain. Advances in fMRI technology in the last 
decades have dramatically increased our knowledge of the neurobiological 
basis of cognitive control. By means of advanced experimental designs, 
knowledge has been increased on the contribution of each brain region to 
Abstract
Several theories of addiction stress the role of reduced cognitive control. The 
current review evaluates neural deficits in the domains of inhibitory control and 
error-processing in substance dependent individuals and in individuals showing 
excessive addiction-like behaviors. Event-related potential (ERP) and functional 
magnetic resonance imaging (fMRI) studies were selected based on a Pubmed/
Embase search. The approach in the current review of combined evaluation of 
ERP and fMRI findings offers unique information regarding neural deficits in 
cognitive control in addicted individuals. In line with recent theories, the most 
consistent findings in addicted individuals were reduced N2 and error-related 
negativity amplitudes as well as hypoactivation in the anterior cingulate cortex, 
inferior frontal gyrus and dorsolateral prefrontal cortex. Some differences 
between the major classes of substances of abuse were identified and 
preliminary support for similar neural deficits in excessive addiction-like 
behaviors and substance dependent individuals is provided. Future research 
suggestions include the need for a shift in neuroscience research to clinically 
relevant research. 
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cognitive control. The above-mentioned characteristics make ERP and fMRI 
techniques very suitable to study neurobiological correlates of cognitive 
dysfunctions present in substance dependence. A combined evaluation of ERP 
and fMRI research in this domain may provide valuable and complementary 
insights in both the temporal and spatial properties of the neural substrate of 
cognitive control in substance dependence. Therefore, the main goal of this 
review is to evaluate fMRI and ERP studies in the domains of inhibitory control 
and error-processing in order to evaluate the consistency of the findings across 
neuroimaging studies in the major classes of substance dependent populations.
 A second goal of this review is to contribute to the ongoing discussion 
concerning the differences and similarities between substance dependence 
and other excessive behaviors that have been proposed to have addictive 
characteristics but do not involve the ingestion of substances (Grant, et al. 
2010). For example, pathological gambling is listed as an impulse control 
disorders in the diagnostic and statistical manual of mental disorders (i.e., DSM-
IV TR: American Psychiatric Association 2000) and is characterized by 
unsuccessful efforts to control, cut back or stop gambling, similar to the 
problems with controlling substance related behaviors. Based on these and 
other similarities between substance abuse and gambling (for reviews see: 
Potenza 2006; Van Holst, et al. 2010), pathological gambling may be listed 
under the heading ‘substance use and addictive disorders’ in the upcoming fifth 
edition of the diagnostic and statistical manual of mental disorders (DSM-5). 
Other suggested excessive addiction-like behaviors such as excessive computer 
game playing or internet use (Grant, et al. 2010) are not proposed as diagnostic 
categories in DSM-5 and no clear diagnostic criteria have been formulated. 
Currently individuals showing these excessive addiction-like behaviors are 
identified based on questionnaires examining the compulsivity of the behavior 
under investigation (Beard, et al. 2001; Meerkerk, et al. 2009) or based on the 
amount of time they invest in their excessive addiction-like behaviors. Obviously, 
clear diagnostic criteria for these behaviors will contribute to their identification 
and will improve quality of research into these behaviors. However according to 
the American Psychiatric Association, excessive internet use and gaming will 
not be included in DSM-5 because of a current lack of sufficient scientific 
research to justify their inclusion. Therefore, we will include neuroimaging 
studies that have investigated inhibitory control and error-processing in 
excessive gamers, excessive internet users and pathological gamblers in order 
to compare results to those obtained in substance dependent individuals. 
Throughout the paper, the term ‘addiction’ will refer both to substance 
dependence and the proposed behavioral addictions.
 This review starts with an overview of experimental task paradigms 
that have been employed to measure inhibitory control and error-processing. In 
addition, the neural correlates of inhibitory control and error-processing are 
discussed in order to provide a framework for the evaluation of empirical studies. 
Although most substance users use multiple substances of abuse (Smith, et al. 
2011), many studies have recruited participants based on their primary 
substance of abuse. Consequently, the literature review will be organized 
according to subjects’ primary substance of abuse (i.e., stimulants including 
cocaine and (meth) amphetamine, opioids, cannabis, alcohol, and nicotine). 
Studies that have investigated inhibitory control and error-processing in 
excessive addiction-like behaviors will be discussed separately. This review will 
conclude with a discussion of the findings as well as clinical implications and 
guidance for future research directions. 
 
Experimental measures of inhibitory control
The Go/NoGo and Stop Signal task are the most commonly used paradigms to 
measure inhibitory control (Chambers, et al. 2009; Dalley, et al. 2011; Verbruggen, 
et al. 2008). In the Go/NoGo task, participants respond as quickly as possible to 
frequent ‘Go’ stimuli, and inhibit responses to infrequent ‘NoGo’ stimuli which 
requires inhibitory control in order to overcome execution of an automatic 
response. The proportion of correctly inhibited NoGo trials reflects the ability to 
inhibit automatic behavior. The Stop Signal paradigm (Logan, et al. 1984) 
measures the ability to exert inhibitory control over a response that has already 
been initiated by asking participants to respond as quickly as possible to a 
continuous stream of Go stimuli. In a minority of the trials, a stop signal is 
presented after the onset of the primary stimulus indicating that the response to 
this stimulus should be canceled. The ability to inhibit already initiated behavior 
is indexed by the stop signal reaction time (SSRT), which is the time needed to 
cancel 50% of the Stop trials, relative to mean reaction time for Go stimuli. 
Larger SSRTs represent worse inhibitory control. Most Stop Signal paradigms 
use a staircase method in which that the amount of errors in the task are 
deliberately kept constant. Both the Go/NoGo and the Stop Signal task require 
the activation of a common inhibitory brake. The major difference between 
these tasks being that the Go/NoGo task requires (non) response selection and 
inhibition, whereas the Stop Signal task requires inhibition of an already initiated 
response (Dalley, et al. 2011). In order to place high demand on inhibitory control, 
NoGo and Stop trials should be both infrequent (e.g., 25% or less) and 
unpredictable. Besides the Go/NoGo and Stop Signal task, other cognitive 
paradigms such as the Stroop (Stroop 1992) and Eriksen-Flanker (Eriksen, et al. 
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1974) tasks are argued to measure inhibitory capacities. However, these tasks 
also measure other processes such as conflict resolution, response selection 
and attention (Nigg 2000; Ridderinkhof, et al. 2004b). In order to keep the 
current review focused and to be able to make straightforward comparisons of 
results, only studies utilizing Go/NoGo or Stop Signal paradigms will be included.
ERP measures of inhibitory control
Two major ERP components have been reported to reflect changes in brain 
activity related to inhibitory control (Kok, et al. 2004). The first of these ERP-
components is the N2, which is a negative-going wave emerging approximately 
200-300 ms after stimulus presentation. The neural generators of the N2 
appear to be the anterior cingulate cortex (ACC, Huster, et al. 2010; Kok, et al. 
2004; Nieuwenhuis, et al. 2003) and the right inferior frontal gyrus (IFG, Lavric, 
et al. 2004). The N2 is believed to index a top-down mechanism needed to 
inhibit the automatic tendency to respond (Falkenstein 2006; Kaiser, et al. 2006) 
and corresponds to behavioral outcomes of inhibitory control (Dimoska, et al. 
2006; Falkenstein, et al. 1999; Van Boxtel, et al. 2001). In addition, the N2 
component has been associated with conflict detection during early stages of 
the inhibition process (Falkenstein 2006; Nieuwenhuis, et al. 2003). 
Consequently, the N2 can be interpreted as an index for early cognitive 
processes necessary to implement inhibitory control rather than the actual 
inhibitory brake. The second ERP component that is associated with inhibitory 
control is the P3 (P300), which is a positive-going wave emerging 300-500 ms 
after stimulus onset. Recent research shows that the P3 is associated with the 
efficiency of inhibitory control (Kok, et al. 2004). More specifically, the P3 
appears to represent the urgent inhibitory brake (Dimoska, et al. 2006). The 
source of the P3 has been found to be close to motor and pre-motor cortices 
(Huster, et al. 2010; Kok, et al. 2004; Ramautar, et al. 2006). Hence, P3 
amplitudes appear to reflect a later stage of the inhibitory process that is closely 
related to the actual inhibition of the motor system in the premotor cortex (Band, 
et al. 1999; Dimoska, et al. 2006; Kok, et al. 2004). Together, accumulating 
research shows that the N2 and P3 reflect functionally distinct processes 
associated with inhibitory control. Accordingly, reduced N2 or P3 amplitudes in 
addicted populations can be considered markers for deficits in inhibitory control.
fMRI measures of inhibitory control
Inhibitory control in healthy individuals is associated with a mainly right 
lateralized network including the inferior frontal gyrus (IFG), the ACC/ pre-
supplementary motor area (SMA) and dorsolateral prefrontal cortex (DLPFC), 
as well as parietal and subcortical areas including the thalamus and basal 
ganglia (Chambers, et al. 2009; Garavan, et al. 2006; Simmonds, et al. 2008). 
Experimental studies have provided information on the specific contribution of 
these regions to implement inhibitory control. A recent hypothesis for the role of 
the right IFG in inhibitory control is that it detects behaviorally relevant stimuli 
(e.g., NoGo or Stop Signal stimuli) in cooperation with inferior parietal lobe (IPL) 
and temporoparietal junction through its effects on stimulus driven attention 
(Corbetta, et al. 2002; Li, et al. 2006). Given the proximity of the pre-SMA/
dorsal ACC (dACC) to the motor areas, the function of this region may be related 
to response selection and updating of motor plans (Mostofsky, et al. 2008). In 
addition to frontal and parietal regions, the involvement of subcortical basal 
ganglia and thalamic regions in inhibitory control is well established through 
feedback loops that connect these regions with prefrontal and motor areas 
(Chambers, et al. 2009; Garavan, et al. 2006; Li, et al. 2008b) such that activation 
in the subcortical areas modulates response execution via connections with 
motor areas. 
Experimental measures of error-processing
All tasks that have been used to measure error-processing are speeded reaction 
time tasks. The most commonly used paradigms are the Eriksen-Flanker and 
the Go/NoGo task (Overbeek, et al. 2005; Shiels, et al. 2010). In a typical version 
of the Eriksen-Flanker task (Eriksen & Eriksen, 1974), participants are exposed 
to series of stimulus arrays either being letters or arrows. In the congruent 
condition version of the task five equal letters are presented (i.e., HHHHH/
SSSSS), while in the incongruent condition the middle letter differs from the 
other letters (i.e., SSHSS/HHSHH). In both conditions, participants are asked to 
identify the middle letter via a button response. Because of high stimulus conflict 
in the incongruent condition and the emphasis on response speed participants 
usually commit a sufficient amount of errors to analyze the processing of these 
performance errors. For the current review, studies employing the Flanker 
paradigm are only included for the evaluation of performance errors and not for 
the measurement of conflict evoked by the incongruent trials. In Go/NoGo or 
Stop Signal paradigms, false positive reactions for NoGo or Stop trials result in 
an erroneous motor response that are subsequently used to evaluate error-
processing. Regardless of task paradigm, reaction times on trials after 
performance errors are usually longer compared to reaction times on trials 
following correct responses, which is referred to as post-error slowing. Post-
error slowing is regarded as a behavioral index for error monitoring and is 
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argued to reflect cautious post-error behavior aimed at preventing future 
mistakes (Danielmeier, et al. 2011; Rabbitt 1966a). 
ERP measures of error-processing 
ERP investigations of error-processing have revealed two error-related brain 
waves that consistently emerge after performance errors, i.e., the error-related 
negativity (ERN) and the error-positivity (Pe). The ERN and Pe appear to be 
independent as they are differentially sensitive to experimental manipulations, 
individual differences in task performance and both reflect different stages of 
error-processing (Hewig, et al. 2011; Nieuwenhuis, et al. 2001; Overbeek, et al. 
2005). The ERN arises 50-80 milliseconds after making an error and is known 
to reflect initial and automatic error detection (Bernstein, et al. 1995) thereby 
incorporating perceptual and proprioceptive evidence (Wessel, et al. 2011). 
Converging evidence indicates that the ACC is the neural generator of the ERN 
(Gehring, et al. 2000; Herrmann, et al. 2004; Miltner, et al. 2003a; Ridderinkhof, 
et al. 2004a; Van Veen, et al. 2002). The ERN is usually followed by a positive 
deflection in the electroencephalography, the Pe, emerging approximately 300 
ms after incorrect responses (Falkenstein, et al. 2000). Research to identify the 
neural origin of the Pe has provided rather heterogeneous results (Wessel, et al. 
2011). Whereas the ERN signals the initial error detection, the Pe appears to be 
associated with the more conscious evaluation of errors as well as error-
awareness (Overbeek, et al. 2005; Wessel, et al. 2011). In addition, the Pe 
appears to the associated with the motivational significance that is attributed to 
an error (Ridderinkhof, et al. 2009). In line with these accounts, it may be 
concluded that the Pe reflects the conscious evaluation of the motivational 
significance of the error. Together, the ERN and Pe evaluate the correctness of 
ongoing behavior (i.e., a specific outcome or behavior was worse or better than 
expected), which is then used to guide future behavior (Holroyd, et al. 2009).
fMRI measures of error-processing 
The suggested crucial role for the ACC in error-processing by ERP studies has 
been confirmed in fMRI studies. More specifically, Ridderinkhof and colleagues 
(2004b) suggest that a sub-region of the ACC, called the rostral cingulate zone 
(RCZ), that is located at the border of the dACC and the SMA, is consistently 
activated during monitoring of ongoing behavior. Some researchers suggest 
that the ACC monitors response conflict or the likelihood of errors (Brown, et al. 
2005; Magno, et al. 2006) rather than error-processing per se. Two independent 
meta-analyses have shown that both response conflict and response error 
activate approximately the same region within the ACC (i.e., the RCZ: Hester, et 
al. 2004a; Ridderinkhof, et al. 2004a) suggesting that the RCZ may be involved 
in both these functions or that activation emerging in the RCZ as a result of 
response conflict and response error may actually reflect two sides of the same 
coin. FMRI studies investigating error-processing further show that a large 
neural network coactivates with the RCZ including the bilateral insula, the 
DLPFC, the thalamus and right IPL (IPL, Hester, et al. 2004a; Menon, et al. 
2001). Functional interactions between these regions have been reported as 
well, especially between the RCZ and the DLPFC. A study by Kerns et al. (2004) 
showed that the close interaction of the DLPFC and the RCZ is responsible for 
the implementation of adjustments in activation to prevent future mistakes. To 
conclude, performance errors in the human brain are processed by a neural 
circuit that extends beyond the RCZ, and includes the insula, the DLPFC, 
thalamus as well as parietal regions. This error-processing circuit collectively 
monitors and adjusts behavior when necessary.
 
Literature Review
Selection of studies
A comprehensive literature search was conducted in PUBMED and Embase 
including search terms for substance dependent populations and populations 
with a behavioral addiction: ‘substance related disorders (MeSH Term)’, ‘alcohol 
related disorders (MeSH Term)’, ‘amphetamine related disorders (MeSH Term)’, 
‘cocaine related disorders (MeSH Term)’, ‘Marijuana Abuse (MeSH Term)’, 
‘opioid related disorders (MeSH Term)’, ‘smokers’, ‘gambling (MeSH Term)’, 
‘gaming’, ‘gamers’ or ‘internet’. The key search terms for various addicted 
populations had to co-occur in combination with the following search terms 
concerning inhibitory control and error-processing or related task paradigms: 
‘cognitive control’, ‘inhibitory control’, ‘response inhibition’, ‘error-processing’, 
‘error monitoring’, ‘Go NoGo’, ‘Stop Signal’ or ‘Flanker’ and in combination with 
the following search terms for neuroimaging methods and measures: ‘Magnetic 
Resonance Imaging (MeSH Term)’, ‘evoked potentials (MeSH Term)’, ‘error-
related negativity’, ‘error-positivity’, ‘N200’, ‘N2’, ‘P300’, ‘P3’. The search was 
limited to research performed in humans and articles written in English. All 
included articles were required to be published in peer-reviewed journals and 
had to be included in Pubmed or Embase before October 2011. A total of 147 
hits were retrieved. Abstracts of these articles were examined to select articles 
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that fulfilled the following criteria: a) participants included a group of addicted 
individuals (i.e., substance dependent patients for cocaine, (meth) amphetamine, 
opioids, cannabis, alcohol and nicotine, or individuals showing excessive 
addiction-like behaviors such as gambling, gaming or internet use). Social 
drinkers and recreational drug users were excluded; b) the inclusion of a control 
group such that decreased or increased brain activation as well behavioral 
deficits described in this review are always relative to healthy controls (to 
emphasize the clinical relevance of cognitive control, studies without a control 
group were included if they either evaluated the effect of treatment outcome or 
a pharmacological intervention within the addicted group); b) the number of 
participants was at least 10 in each group; c) participants performed the Go/
NoGo, Stop Signal or Eriksen Flanker task to measure inhibitory control or 
error-processing (i.e., see sections on experimental task paradigms for inclusion 
of task paradigms); d) the use of fMRI or ERPs as neuroimaging tools. A total of 
27 studies fulfilled our criteria. Cross-references in those 27 articles were 
searched which yielded another 5 studies that met our inclusion criteria. In total, 
32 articles were included in this review. Six of these studies evaluated both 
inhibitory control and error-processing. Results of all studies are summarized in 
table 1 and table 2, and discussed below. In order to keep the current review 
concise we refer to the tables for study details such as the number of participants. 
In addition, we refer to the tables for a complete overview of fMRI results as we 
will only discuss fMRI findings in key regions involved in inhibitory control and 
error-processing as described in this review.
 
 
 
 
 
 
 
Study Participants Measures Main results 
-behavioral
Main results - Imaging
Opiate dependence
Yang et al. 
(2009)
14 ODI 
14 HC
- ERPs 
- Go/NoGo task
No group 
differences
NoGo N2: no group differences 
Go N2: ODI > HC at midline cluster 
P3: No group differences
Fu et al. 
(2008)
30 ODI 
18 HC
- fMRI 
- Blocked Go/NoGo task
RTs: ODI > HC Contrast: Go/NoGo block minus Go 
Block 
ODI < HC: bil-medPFC, bil-ACC, bil-
FG, l-MFC, l-insula, l-uncus, PHG,  
r- precuneus, r-SPL, r-MTG
Stimulant dependence
Sokhadze et al. 
(2008)*
19 CoDI  
15 HC
- ERPS 
-  Combined Flanker &  
Go/NoGo task
RTs: CoDI > HC 
ACCU: CoDI 
< HC in the 
congruent 
Flanker 
condition
N2 NoGo minus Go: CoDI < HC for 
incongruent trials at frontal cluster 
P3 NoGo minus Go: CoDI < HC at 
frontal cluste
Hester & 
Garavan 
(2004)
15 CoDI  
15 HC
- fMRI 
-  Go/NoGo task with 
varying WM demands
ACCU: CoDI 
< HC
Contrast: NoGo C versus baseline 
CoDI < HC: r-SFG, r-pre-SMA, l-ACC
Kaufman et al. 
(2003)*
13 CoDI  
14 HC
- fMRI  
- Go/NoGo task
ACCU: CoDI 
< HC
Contrast: NoGo C versus baseline 
CoDI < HC: r-dACC, r-insula
Leland et al. 
(2008)
17 MDI 
19 HC
- fMRI  
-  Go/NoGo task 
with warning cues
ACCU after 
warning > 
ACCU without 
warning in CoDI 
and not in HC
Contrast: NoGo C minus Go 
No group differences  
Contrast: Warning GO cues > 
Go cues 
MDI > HC: vACC, dACC
Li et al. (2008) 15 CoDI  
15 HC
- fMRI 
- Stop Signal Task
No group 
differences
Contrast: Stop C minus Stop E 
CoDI < HC: ACC, r-SPL, l-SPL, l-IOG
Li et al. (2010) 10 CoDI - fMRI 
- Stop Signal Task 
-  after placebo and single 
dose of MP
SSRT MP < PL Contrast: Stop C minus Stop E 
MP > PL: bil-striatum, bil-thalamus,  
r-cerebellum 
PL < MP: STG 
SSRT MP < SSRT PL 
pos corr: l-MFG,  
neg corr.: r-VMPFC
Table 1 
Overview of ERP and fMRI studies investigating inhibitory control in substance dependence and behavioral addictions
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Alcohol dependence
Cohen et al. 
(1997)
17 ADI 
30 HC
- ERPs 
-  Go/NoGo task with 
selection of response 
hand
RTs ADI > HC N2: not investigated 
NoGo P3: ADI < HC, whole brain  
Go P3: ADI < HC, whole brain 
Go versus NoGo P3: not different 
in ADI. In HC Go > NoGo in central, 
parietal and temporal clusters
Colrain et al. 
(2011)
10 ADI 
25 HC
- ERPs 
-  Combined Oddball &  
Go/NoGo task
No behavioral 
data reported
N2: not investigated 
NoGo P3: ADI < HC at CZ 
Go P3: No group differences
Fallgatter et al. 
(1998)
20 ADI 
20 HC
- ERPs 
-  Go/NoGo task with 
warning cues
No group 
differences
N2: not investigated 
P3: Location of Go P3 more posterior 
in ADI. The more anterior the NoGo 
P3 the lower the sensation seeking 
score in ADI
Kamarajan et 
al. (2005)
30 ADI 
30 HC
- ERPs 
-  Go/NoGo task with 
reward properties
ACCU: ADI < 
HC
N2: not investigated 
NoGo P3: ADI < HC in frontal and 
central clusters.  
Go P3: ADI < HC for Go in parietal 
cluster 
Go versus NoGo P3 Go > NoGo in 
parietal and occipital clusters
Karch et al. 
(2007)**
16 ADI 
8 ANX+, 8 
ANX-16 HC
- ERPs 
-  Go/NoGo task with 
warning cues
No group 
differences
N2: not investigated 
P3: No group differences 
No differences between ANX+ and 
ANX-
Pfefferbaum et 
al. (1987)
42 ADI 
66 HC
- ERPs 
-  Go/NoGo task with 
varying Go/NoGo 
probabilities
No group 
differences
N2: not investigated 
NoGo P3: No group differences 
Go P3: ADI < HC at Cz and Pz
Karch et al. 
(2008)**
16 ADI 
8 ANX+, 8 
ANX-16 HC
- fMRI 
-  Go/NoGo task with 
warning cues
No group 
differences
Contrast: NoGo versus baseline  
No Group differences 
ANX+ > ANX-: l-MFG, bil-SFG, 
bil-MTG, r-IFG, bil-IPL,bil-precuneus, 
r-PCC, l-thalamus 
ANX+ < ANX-: r-SFG, r-PCG, l-STG,  
bil-IPL
Li et al. (2009)* 24 ADI 
24 HC
- fMRI 
- Stop Signal Task
RTs: ADI > HC 
ACCU: ADI > 
HC
Contrast: Stop C minus Stop E 
ADI < HC: l-DLPFC
Study Participants Measures Main results 
-behavioral
Main results - Imaging Study Participants Measures Main results 
-behavioral
Main results - Imaging
Table 1 
Continued
Table 1 
Continued
Cannabis dependence
Hester et al. 
(2009)*
16 CaDI 
16 HC
- fMRI 
- Go/NoGo task
No group 
differences
Contrast: NoGo C versus baseline 
CaDI > HC: r-IPL, r-putamen,  
r-pre-SMA
Tapert et al. 
(2007)
16 CaDI 
(adolescents) 
17 HC 
(adolescents)
- fMRI Go/NoGo task No group 
differences
Contrast: NoGo versus baseline  
CaDI > HC: bil-SFG, bil-MFG, 
r-insula, bil-medFG, bil-IPL, bil-SPL, 
r-lingual, r-MOG 
Contrast: Go versus baseline 
CaDI > HC: r-IFG, r-insula, r-SFG, 
r-SPL , r-IPL, r-precuneus
Nicotine dependence
Evans et al. 
(2009)
49 NDI 
22 HC
- ERPs 
- Go/NoGo task
No group 
differences
N2: not investigated 
P3 NoGo minus Go: NDI < HC in 
central and parietal clusters
Luijten et al. 
(2011)
19 NDI 
20 HC
- ERPs 
-  Go/NoGo task with 
smoking and neutral 
pictures
ACCU: NCI < 
HC
NoGo N2: NDI < HC for both 
smoking and neutral pictures at 
frontocentral cluster 
Go N2: no group differences 
Go and NoGo P3: no group 
differences
Berkman et al. 
(2011)
27 NDI - fMRI 
- Go/NoGo task
n/a Contrast: NoGo C minus Go 
The higher the activatin in  
bil-IFG, bil-SMA, bil-putamen and 
l-caudate the lower the correlation 
between craving and smoking after a 
quit attempt. This moderation effect 
was opposite for r-amygdala
de Ruiter et al. 
(2011)*+
18 NDI 
17 HC
- fMRI 
- Stop Signal Task
No group 
differences
Contrast: Stop C minus control 
NDI < HC: r-dACC
Galvan et al. 
(2011)
25 NDI 
(adolescents) 
25 NDI 
(adolescents)
- fMRI 
- Stop Signal task
No group 
differences
Contrast: Stop C minus Go 
No group differences  
Neg corr within NDI group with 
heaviness of smoking in bil-MFG, 
ACC, SMA, l-OFC, r-SFG, l-IFG
Nestor et al. 
(2011)*
13 NDI 
10 ex-NDI 
13 HC
- fMRI  
- Go/No Go task
RTs:  
NDI & HC < 
ex-NDI 
ACCU:  
NDI < ex-NDI 
& HC
Contrast: NoGo C versus baseline 
NDI < HC: r-SFG, l-MFG, r-ACC, 
bil-IPL 
NDI & ex-NDI < HC: l-IFG, bil-PCG,  
r-STG, r-MTG, bil-insula, l-PHG 
NDI < ex-NDI & HC: l-MTG 
NDI < ex-NDI: l-ACC
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Inhibitory control in opiate dependence
Currently one ERP study investigated inhibitory control in opiate dependent 
individuals. No differences between groups on NoGo accuracy or N2 and P3 
amplitudes were found in this study (Yang, et al. 2009), suggesting that inhibitory 
control was not impaired in this sample of opiate dependent individuals. It should 
be noticed, however, that inhibitory requirements in this task were low given the 
high probability of NoGo trials (i.e., 50% of the trials were NoGo trials), so that 
the task may have been too easy to reveal differences in inhibitory control 
between opiate dependent individuals and healthy controls. 
 Using fMRI and a Go/NoGo task in which accuracy levels were 
deliberately kept constant across individuals, abstinent opiate dependent 
individuals were found to have slower Go reaction times and reduced brain 
activation in the key regions implicated in inhibitory control such as the ACC, the 
IFG and the left insula (Fu, et al. 2008). However, Go and NoGo stimuli were 
presented in blocks in this study, such that inhibitory requirements in this study 
were low. Findings in this study should therefore be replicated in a design with 
stronger inhibitory requirements and currently provide only preliminary 
evidence that possible deficits in inhibitory control could be the result of 
hypoactivation in the ACC, IFG in opiate dependent individuals. Generally, 
studies investigating inhibitory control in opiate dependent individuals are 
scarce and future studies could benefit from improvements in task design.
 
Inhibitory control in stimulant dependence 
N2 and P3 amplitudes in a Flanker task that incorporated NoGo trials were 
evaluated in current cocaine dependent individuals (Sokhadze, et al. 2008). It 
was found that the enhancement of NoGo N2 and P3 amplitudes relative to Go 
amplitudes was less pronounced in cocaine dependent individuals compared to 
healthy controls. However, behavior findings did not show decreased accuracy 
for NoGo trials among cocaine dependent individuals such that ERP results 
should be interpreted cautiously. 
 
 Using fMRI, Hester and Garavan (2004b) and Kaufman et al. (2003) 
both found reduced accuracy in Go/NoGo tasks in cocaine dependent 
individuals accompanied by reduced activation in the ACC/preSMA. Reduced 
activation was also found in the right superior frontal gyrus (SFG, Hester, et al. 
2004b) and the right insula (Kaufman, et al. 2003). The Go/NoGo task in the 
Hester et al. study involved different levels of working memory load in order to 
mimic high working memory demands that are usually present during exposure 
Note table 1 * Study is also included in the error-processing section, ** These articles are based on data from the same 
participants, + This study includes a NDI, PG and HC group and therefore is included in NDI and behavioral addiction 
sections. Abbreviations: CoDi: cocaine dependent individuals; MDI: methamphetamine dependent individuals; ODI: opioid 
dependent individuals; ADI: alcohol dependent individuals; CaDi: cannabis dependent individuals; NDI: nicotine dependent 
individuals; PG: Pathological gamblers; EIU: excessive internet users; HC: healthy controls; NoGo C: NoGo Correct; Stop 
C: NoGo Correct; Stop E: NoGo Error; r-: right, l-: left, bil-: bilateral, RTs: reaction times, ACCU: accuracy, ANX+: high levels 
of anxiety, ANX-: low levels of anxiety, n/a: not applicable, MP: methylphenidate, PL: placebo, pos corr: positive correlation, 
neg corr: negative correlation, Cz, Pz: names of EEG electrodes referring to the location of the electrode.
Excessive addiction-like behaviors
Dong et al. 
(2010)
12 EIU 
12 HC
- ERPs 
- Go/NoGo task
No Group 
differences
NoGo N2: EIU < HC at frontal, central 
and parietal clusters 
Go N2: No group differences 
NoGo P3: EIU > HC at frontal, central 
and parietal clusters 
Go P3: No group differences
Zhou et al. 
(2010)
26 EIU 
26 HC
- ERPs 
-  Go/NoGo task with 
reward properties
ACCU: EIU < 
HC
NoGo N2: EIU < HC at frontal and 
central clusters.  
Go N2: not analyzed 
P3: not investigated
de Ruiter et al. 
(2011)*+
18 PG 
17 HC
- fMRI 
- Stop Signal Task
No group 
differences
Contrast: Stop C minus control 
PG < HC: r-dACC
Study Participants Measures Main results 
-behavioral
Main results - Imaging
Table 1 
Continued
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to drug-related cues. The hypoactivation associated with inhibitory control in 
the ACC was most pronounced when working memory load was high, suggesting 
that inhibitory control is most compromised in situations requiring high working 
memory loads. Li et al. (2008) confirmed hypoactivation associated with 
inhibitory control in the ACC in cocaine dependent individuals using a stop-
signal task, which was extended to the bilateral superior parietal lobe (SPL). 
However, no differences were found between groups regarding SSRTs. A later 
study from the same group investigated the role of dopamine in inhibitory 
control by administration of a single dose of methylphenidate (Li, et al. 2010). It 
was found that methylphenidate enhanced inhibitory control in cocaine 
dependent individuals (i.e., the SSRT was shorter after methylphenidate). 
Furthermore, methylphenidate-induced decreases in SSRT were positively 
correlated with activation in left middle frontal cortex (MFC) and negatively with 
activation in the right ventromedial prefrontal cortex (VMPFC), suggesting that 
these regions may constitute a biomarker for the dopamine induced increase in 
inhibitory control. Another study in abstinent stimulant dependent individuals 
with methamphetamine as their primary drug of choice showed an alternative 
strategy to improve inhibitory control (Leland, et al. 2008). This study, employing 
a Go/NoGo task, did not find evidence for deviant performance or brain 
activation associated with inhibitory control in methamphetamine dependent 
individuals. Nevertheless, it was found that accuracy for NoGo trials was 
enhanced in methamphetamine dependent individuals (and not in healthy 
controls) when NoGo trials were preceded by an explicit warning cue that 
signaled the need for inhibition on the next trial. In addition, methamphetamine 
dependent individuals showed increased activation in the ACC for warning cues 
which was positively correlated with improved accuracy due to the warning 
cues. These findings imply that inhibitory control can be improved by explicit 
environmental cues that predict the need for inhibitory control via pre-activation 
of the ACC. Alternatively, methamphetamine dependent individuals may benefit 
from exogenous cues by boosting attention to NoGo stimuli. 
 Several conclusions can be drawn from the neuroimaging studies in 
stimulant dependent individuals. First, the single ERP study in cocaine 
dependent individuals suggests that neural deficits may be present in cocaine 
dependent individuals both in early and late stages of the inhibition process, 
however, it is unclear whether this may be associated with behavioral deficits. 
Second, hypoactivation in the ACC during inhibitory control in cocaine 
dependent individuals was found in multiple studies, however, this was not 
always associated with impaired task performance making interpretation of 
hypoactivation difficult (see discussion section for an in-depth discussion 
concerning the interpretation of differences in behavioral performance and 
brain activation). Third, both explicit external cues as well as methylphenidate 
may improve inhibitory control, both via increasing activation associated with 
inhibitory control in the medial prefrontal cortex.
 
Inhibitory control in alcohol dependence
Six ERP studies were identified that investigated inhibitory control in alcohol 
dependent individuals (Cohen, et al. 1997; Colrain, et al. 2011; Fallgatter, et al. 
1998; Kamarajan, et al. 2005; Karch, et al. 2007; Pfefferbaum, et al. 1987). 
Remarkably, none of these studies investigated N2 amplitudes so we cannot 
evaluate whether early cognitive processes contributing to inhibitory control 
are affected in alcohol dependent individuals. The study by Kamarajan et al. 
(2005) found a reduction in accuracy in alcohol dependent individuals whereas 
all other studies did not observe accuracy differences between alcohol 
dependent individuals and healthy controls. Reduced accuracy in the 
Kamarajan et al. study was accompanied by smaller NoGo P3 amplitudes in 
alcohol dependent individuals. Reduced P3 amplitudes for NoGo trials were 
replicated by Colrain et al. (2011). However, several other studies (Cohen, et al. 
1997; Fallgatter, et al. 1998; Pfefferbaum, et al. 1987) found reduced P3 
amplitudes in alcohol dependent individuals for both Go and NoGo trials. A 
general reduction in P3 amplitudes suggest that group differences in these 
studies do not merely reflect differences in inhibitory capacities but may be 
related to more overall deficits in attention, or, alternatively may reflect the use 
of different strategies during task performance. Karch et al. (2007) on the other 
hand, did not find deficits in alcohol dependent individuals on either Go or 
NoGo P3 amplitudes. Comparisons of results and interpretation of the 
conclusions for some of these studies are hampered due to considerable 
methodological differences and drawbacks. First, task paradigms differ greatly 
between the studies, in some studies Go and NoGo probabilities varied across 
blocks (Pfefferbaum, et al. 1987) or NoGo probabilities were high resulting in 
low inhibitory requirements (Fallgatter, et al. 1998; Kamarajan, et al. 2005). In 
addition, some task paradigms involved reward evaluation (Kamarajan, et al. 
2005) or cueing for NoGo trials (Fallgatter, et al. 1998). Second, data analyses 
in some studies were not focused on regions in which NoGo amplitudes usually 
peak (Cohen, et al. 1997), or were focused on P3 localization rather than 
amplitudes (Fallgatter, et al. 1998). Altogether, evidence for neural deficits in 
the later stages of inhibitory control is mixed, most likely as a result of large 
methodological differences. However, one of the more carefully designed 
studies (Colrain, et al. 2011) did find a reduction of NoGo P3 amplitudes in 
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alcohol dependent individuals suggesting that these deficits can be revealed if 
task design and analyses are optimal.
 Notably, ERPs in the study by Karch et al. (2007) were recorded while 
brain activation was simultaneously measured with fMRI (Karch, et al. 2008). 
The fMRI findings confirm ERP findings of comparable brain activation levels for 
alcohol dependent individuals and healthy controls (Karch, et al. 2008). This 
combined ERP and fMRI study further investigated differences between high 
and low anxious alcohol dependent individuals. It was found that P3 amplitudes 
in high and low anxious alcohol dependent individuals were comparable. 
However, high anxious alcohol dependent individuals show enhanced activation 
in prefrontal regions (including SFG, MFG and IFG) and the IPL as compared to 
low anxious alcohol dependent individuals. These findings raise the possibility 
that elevated anxiety levels in alcohol dependent individuals may be associated 
with increased activation levels when inhibitory control is executed. Another 
fMRI study investigating inhibitory control in alcohol dependent individuals (Li, 
et al. 2009) showed reduced activation in the left DLPFC in alcohol dependent 
individuals compared to healthy controls, while SSRTs were intact. 
 Altogether, neuroimaging and behavioral evidence for neural deficits 
associated with inhibitory control is weak, most likely due to large methodological 
differences between studies and general study limitations. For example, N2 
amplitudes were not evaluated in any of the ERP studies. However, a reduction 
in NoGo P3 amplitudes in alcohol dependent individuals was found when task 
design and analyses were optimal, suggesting that the last minute inhibitory 
brake concerning the motor-response may be suboptimal in alcohol dependent 
individuals. The two discussed fMRI studies did not show convincing inhibitory 
control deficits yet, although tentative evidence suggests that brain activation 
associated with inhibitory control in the DLPFC may be dysfunctional in alcohol 
dependent individuals.
 
Inhibitory control in cannabis dependence
Currently, no ERP studies in cannabis dependent individuals have been 
published that evaluated N2 or P3 amplitudes in the context of inhibitory control, 
while two fMRI studies have been published (Hester, et al. 2009b; Tapert, et al. 
2007). Both studies did not find behavioral deficits in cannabis dependent 
individuals in Go/NoGo tasks. However, active cannabis dependent individuals 
showed increased activation during inhibitory control in the AAC/pre-SMA, 
right IPL and putamen (Hester, et al. 2009b). These findings can be interpreted 
as a compensatory mechanism given that cannabis dependent individuals did 
not show behavioral deficits. The finding of increased neural effort was also 
found in abstinent adolescent cannabis dependent individuals, as they showed 
increased activation associated with inhibitory control in a large network of 
brain regions involving the right SFG and left medial frontal gyrus (medFG) as 
well as the right IPL and SPL (Tapert, et al. 2007). Clearly, more research is 
needed in order to confirm these findings. In addition, the time course of the 
neural deficits in cannabis dependent individuals should be investigated by 
measuring N2 and P3 amplitudes in order to obtain information about the time 
frame of possible decrements in cannabis dependent individuals in inhibitory 
control. 
Inhibitory control in nicotine dependence
Evens et al. (2009) investigated inhibitory control in nicotine dependent 
individuals and healthy controls who did smoke in the past but never became 
regular smokers by evaluating P3 (but not N2) amplitudes in a Go/NoGo task. 
While NoGo P3 amplitudes were reduced in nicotine dependent individuals, no 
differences between groups were found for behavioral performance. Additional 
findings in this study show that reduced NoGo P3 amplitudes in nicotine 
dependent individuals may not be a static process but may vary across nicotine 
dependent individuals depending on variations in genotypes coding for 
dopamine receptors, smoking withdrawal and mood states. Luijten et al. (2011a) 
investigated whether inhibitory control in nicotine dependent individuals was 
influenced by the presence of smoking cues. Nicotine dependent individuals 
showed reduced accuracy on the Go/NoGo task accompanied by reduced 
NoGo N2 amplitudes. P3 amplitudes did not differ between groups. Interestingly, 
NoGo accuracy and N2 amplitudes were reduced both when neutral and 
smoking pictures were presented at the background, suggesting that the 
observed deficit in inhibitory control reflects a general inhibition problem that is 
not further impaired when smoking cues are present.
 Four fMRI studies in smokers in the domain of inhibitory control were 
included in the current review. The study performed by De Ruiter et al. (2012) 
showed reduced BOLD activation associated with inhibitory control in the dACC 
in nicotine dependent individuals on a Stop-Signal task, while SSRTs were not 
impaired. Nestor et al. (2011) found reduced accuracy on a Go/NoGo task in 
nicotine dependent individuals compared to both healthy controls and ex-
smokers. Reduced brain activation associated with inhibitory control in nicotine 
dependent individuals in the ACC was confirmed in this study and extended to 
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the right SFG, left MFG and bilateral IPL. In addition, nicotine dependent 
individuals and ex-smokers both showed reduced activation in the left IFG and 
the bilateral insula compared to healthy controls. The comparison of nicotine 
dependent individuals and ex-smokers is interesting, because it provides 
information on the reversibility of deficits in inhibitory control. The results of the 
Nestor et al. study suggest that behavioral and activation deficits in nicotine 
dependent individuals may be reversible to some extent, while hypoactivation in 
other regions persist even after prolonged periods of giving up smoking. An 
alternative interpretation for the findings that NoGo accuracy and neural 
activation differs between nicotine dependent individuals and ex-smokers may 
be that more heavy dependent smokers show more pronounced behavioral and 
neural deficits and that they are the ones who fail to give up smoking. The idea 
that more heavy nicotine dependent individuals show more pronounced 
hypoactivation is supported by findings in adolescent nicotine dependent 
individuals (Galvan, et al. 2011). While adolescent nicotine dependent individuals 
and healthy controls had similar accuracy rates and brain activation, it was found 
that heaviness of smoking within nicotine dependent individuals was associated 
with reduced activation in those regions critically involved in inhibitory control, 
i.e., ACC, SMA, left IFG, bilateral MFG, and right SFG. 
 Importantly, a study by Berkman et al. (2011) investigated the link 
between brain activation during inhibitory control on a Go/NoGo task and real 
world inhibition of craving. Nicotine dependent individuals reported craving and 
the number of smoked cigarettes at several times during the day in the first 
three weeks after a quit attempt. It was found that higher activation levels in the 
bilateral IFG, SMA, putamen and left caudate during task performance 
attenuated the association between craving and real world smoking. Two 
important conclusions can be drawn from this study. First, brain activation in an 
abstract laboratory task to measure inhibitory control is associated with 
inhibition of feelings of craving in daily life. Secondly, lower brain activation in 
those regions critical for inhibitory control is actually disadvantageous because 
it is associated with a strong coupling between craving and smoking. 
 To summarize, ERP findings suggest that N2 as well as P3 amplitudes 
are reduced in nicotine dependent individuals. Later inhibitory processes, as 
reflected in P3 amplitudes, appear to be co-dependent on genetic variability, 
smoking status and mood states. fMRI studies consistently show hypoactivation 
in the inhibitory neural network which is associated with heaviness of smoking 
and may be partly reversible after giving up smoking. Hypoactivation during 
inhibitory control has also been shown to be disadvantageous for daily life 
smoking behavior as it was associated with increased coupling between craving 
and smoking after a quit attempt. Again, decreased brain activation associated 
with inhibitory control was not always accompanied by behavioral deficits, 
thereby hampering the interpretation of some of the observed findings.
 
Inhibitory control in excessive addiction-like behaviors
Two ERP studies investigating inhibitory control in excessive addiction-like 
behaviors were included in the current literature review. The ERP study 
performed by Zhou and colleagues (2010) in excessive internet users showed 
reduced NoGo N2 amplitudes along with reduced accuracy in excessive internet 
users compared to casual internet users. P3 amplitudes were not evaluated in 
this study. Dong et al. (2010) confirmed reduced NoGo N2 amplitudes in male 
excessive internet users compared to casual internet users, while P3 amplitudes 
in excessive internet users were enhanced. No differences in behavioral 
performance were found in the latter study. It may be that enhanced activation 
in the final stage of inhibitory control in this group of excessive internet users 
served as a compensation for the reduced early inhibitory mechanisms in 
excessive internet users in order to obtain behavioral performance levels equal 
to casual internet users. 
 An fMRI study in pathological gamblers found reduced activation in the 
dACC for successful stops in a Stop Signal task (De Ruiter, et al. 2012). Although 
SSRTs were not impaired in pathological gamblers, this finding suggests similar 
hypoactivation in the dACC as found in substance dependent individuals. FMRI 
studies in excessive gamers and excessive internet users should be performed 
in order to see whether this also holds for other behavioral addictions.
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Note table 2 * Study is also included in the inhibitory control section, + This study includes a NDI, PG and HC group and 
therefore is both included in NDI and behavioral addiction sections. Abbreviations: CoDi: cocaine dependent individuals; 
ODI: opioid dependent individuals; ADI: alcohol dependent individuals; CaDi: cannabis dependent individuals; NDI: nicotine 
dependent individuals; PG: Pathological gamblers; HC: healthy controls; NoGo E: NoGo Error; Stop E: NoGo Error; Stop C: 
NoGo Correct; r-: right, l-: left, bil-: bilateral, RTs: reaction times, ANX+: high levels of anxiety, ANX-: low levels of anxiety, 
corr: correlation, Fz, FCz, Cz, CPz, Pz: names of EEG electrodes referring to the location of the electrode. 
Opiate dependence
Forman et al. 
(2004)
13 ODI 
13 HC
- fMRI  
- Go/NoGo task
RTs: ODI > HC 
ERRORS: ODI 
> HC
Contrast: NoGo E versus baseline 
ODI < HC: r-ACC
Stimulant dependence
Franken et al. 
(2007)
14 CoDI  
13 HC
- ERPs 
- Flanker task
ERRORS: CoDI 
> HC  
Repeated 
ERRORS: CoDI 
> HC
ERN error: CoDI < HC at Fz, FCz, Cz 
ERN correct: No group differences 
Pe error: CoDI < HC at Fz, FCz, Cz 
Pe correct: No Group differences
Sokhadze et al. 
(2008)*
6 CoDI  
6 HC
- ERPs 
-  Combined Flanker &  
Go/NoGo task
RTs: CoDI > HC 
ERRORS: CoDI 
> HC
ERN error: CoDI < HC at frontal 
cluster 
ERN correct: No Group differences 
Pe: not investigated
Kaufman et al. 
(2003)*
13 CoDI  
14 HC
- fMRI  
- Go/NoGo task
ERRORS: CoDI 
> HC
Contrast: NoGo E versus baseline 
CoDI < HC: r-medFG, l-IFG, r-dACC, 
 l-insula
Alcohol dependence
Padilla et al. 
(2011)
14 ADI 
14 HC
- ERPs 
-  Flanker task with high 
and low conflict and 
stimuli and response
No group 
differences
ERN error: ADI > HC at FCz 
ERN correct: ADI > HC at FCz 
Pe: not investigated
Schellekens et 
al. (2010)
29 ADI 8 
with and 
21 without 
anxiety 
disorder 
15 HC
- ERPs  
- Flanker task
RTs: ADI > HC 
ERRORS: ADI 
> HC
ERN error: ADI > HC at FCz 
ERN correct: not investigated 
ERN error: ADI ANX+ > ADI ANX- at 
FCz 
Pe: not investigated
Li et al. (2009)* 24 ADI 
24 HC
- fMRI 
- Stop Signal Task
No group 
differences
Contrast: Stop E minus Stop C 
ADI > HC: bil-MTG, bil-SPL, bil-SFG,  
bil-MFG, r-CS, l-ACC, r-SOG, r-MOG 
corr. Post-Error RTs  
ADI < HC: r-DLPFC
Cannabis dependence
Hester et al. 
(2009)*
16 CaDI 
16 HC
- fMRI  
-  Go/NoGo task with 
aware and unaware 
errors
ERROR 
awareness: CaDI 
< HC
Contrast: NoGo E aware versus 
baseline 
CaDI > HC: bil-precuneus, l-putamen, 
left caudate, left hippocampus  
Contrast: NoGo E unaware versus 
baseline 
CaDI (and not HC) hypoactivation in  
r-ACC, r-putamen, r-IPL, bil -MFG
Study Participants Measures Main results 
-behavioral
Main results - Imaging Study Participants Measures Main results 
-behavioral
Main results - Imaging
Table 2 
Overview of ERP and fMRI studies investigating error processing in substance dependence and behavioral addictions
Table 2 
Continued
Nicotine dependence
Franken et al. 
(2010)
23 NDI 
28 HC
- ERPs 
- Flanker task
No group 
differences
ERN: no group differences 
Pe error: NDI < HC at Fz, Cz, Pz  
Pe correct: No group differences
Luijten et al.  
(2011)
13 NDI 
14 HC
- ERPs 
-  Flanker task with 
smoking and neutral 
pictures
RTs: HC (and not 
NDI) show post-
error slowing
ERN error: NDI < HC at FCz, Cz, CPz  
ERN correct: No group differences  
Pe error: NDI < HC at FCz, Cz, CPz  
Pe correct: No group differences
de Ruiter et al. 
(2011)*+
18 NDI 
17 HC
- fMRI 
- Stop Signal Task
No group 
differences
Contrast: Stop E minus control 
NDI < HC: r-dACC 
NDI > HC: r-DMPFC
Nestor et al. 
(2011)*
13 NDI 
10 ex-NDI 
13 HC
- fMRI  
- Go/NoGo task
RTs:  
NDI & HC < 
ex-NDI 
ERRORs:  
NDI > ex-NDI 
& HC
Contrast: NoGo E versus baseline 
NDI < HC: r-SFG, l-STG 
NDI < ex-NDI: r-SFG, l-ACC, l-PCC, 
l-MTG, l-cerebellum 
NDI & HC < Ex-NDI: bil-SFG, r-MFG,  
l-MTG, bil-PHG, l-cerebellum 
Ex-NDI > HC : l-SFG, r-MFG, l-insula,  
bil-STG
Excessive addiction-like behaviors
de Ruiter et al. 
(2011)*+
18 PG 
17 HC
- fMRI 
- Stop Signal Task
No group 
differences
Contrast: Stop E minus control 
PG < HC: r-dACC
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Error-processing in opiate dependence
At present, only one study was identified that has investigated error-processing 
in opiate dependent individuals (Forman, et al. 2004). Brain activation associated 
with performance errors on a Go/NoGo task in opiate dependent individuals 
was compared to brain activation in healthy controls. It was found that opiate 
dependent individuals made more errors and that error-related activation in the 
ACC was reduced. Furthermore, an associated between ACC activation and 
behavioral performance in opiate dependent individuals was lacking, whereas 
this brain-behavior correlation was present in healthy controls. Obviously, the 
finding of reduced ACC activation for error-processing in opiate dependent 
individuals should be replicated. Furthermore ERP studies should be performed 
to evaluate whether possible deficits in error-processing in opiate dependent 
patients are due to reduced initial error detection, as reflected in decreased 
ERN amplitudes, due to more conscious evaluation of errors, as reflected in 
decreased Pe amplitudes, or as a consequence of both reduced initial and 
elaborative processing of errors.
 
Error-processing in stimulant dependence
Two ERP studies investigated error-processing in active cocaine dependent 
individuals (Franken, et al. 2007; Sokhadze, et al. 2008). Participants in Franken 
et al. (2007) performed a Flanker task. ERP findings showed that both the initial 
automatic processing of errors and the later more conscious processing of 
errors is reduced in cocaine dependent individuals since both ERN and Pe 
amplitudes were attenuated. Furthermore, cocaine dependent individuals 
committed more errors. More specifically, they committed more errors following 
an error on the previous trial which suggests that behavioral adaptation is 
suboptimal. Sokhadze et al. (2008) confirmed both reduced task performance 
as well as reduced ERN amplitudes in active cocaine dependent individuals 
compared to controls in a combined Flanker & Go/NoGo task. Pe amplitudes 
were not investigated in this study. One fMRI study in cocaine dependent 
individuals investigated brain activation associated with error-processing 
employing a Go/NoGo task (Kaufman, et al. 2003). Reduced error-related brain 
activation in cocaine dependent individuals compared to healthy controls was 
found in the ACC, right medFG, left insula and left IFG. In addition, cocaine 
dependent individuals committed more errors during task performance.
 To conclude, both ERP and fMRI studies show reduced error-processing 
in cocaine dependent individuals. Decreased activation after performance 
errors in regions critical for optimal error-processing such as the ACC, insula 
and IFG was found in cocaine dependent individuals. Reduced ERN and Pe 
amplitudes in cocaine dependent individuals suggest that problems with error-
processing may emerge both as a consequence of deficits in initial error 
detection as well as from deficits in the more conscious evaluation of 
performance errors. 
 
Error-processing in alcohol dependence
A remarkably different pattern of error-processing was found in alcohol 
dependent individuals. Padilla et al. (2011) and Schellekens et al. (2010) 
investigated ERN (and not Pe) amplitudes in abstinent alcohol dependent 
individuals evoked by errors on a Flanker task. Alcohol dependent individuals in 
Padilla et al. (2011) performed the task as accurately as controls but showed 
increased ERN amplitudes suggesting enhanced monitoring of performance 
errors. However, enhanced monitoring of behavior may not be specific for errors 
since the alcohol dependent individuals in this study also showed increased 
amplitudes for correct trials. Another ERP study in alcohol dependent individuals 
confirmed increased ERN amplitudes specific for errors (Schellekens, et al. 
2010). In addition, these alcohol dependent individuals showed increased error 
rates for congruent trials. Interestingly, when alcohol dependent individuals with 
comorbid anxiety disorder were compared to alcohol dependent individuals 
without anxiety disorder, it was found that ERN amplitudes were larger in the 
high anxious group. Enhanced ERN amplitudes in high anxious individuals is in 
line with theories suggesting that internalizing psychopathology is associated 
with enhanced monitoring of behavior such as performance errors (Olvet, et al. 
2008). In line with ERP findings, an fMRI study performed by Li and colleagues 
(2009) showed increased error-related brain activation in alcohol dependent 
individuals in a Stop Signal task in the right ACC, and bilateral MFG and SFG, as 
well as in parietal and occipital brain regions (see table 2 for a complete 
overview).
 To summarize, it appears that the processing of errors is enhanced in 
alcohol dependent individuals as it was found that ERN amplitudes and ACC 
activation was increased. Currently, none of the ERP studies evaluated Pe 
amplitudes, therefore no information is available concerning more conscious 
processing of errors in alcohol dependent individuals. These findings suggest 
that alcohol dependent individuals are a specific sub-population in substance 
dependent individuals regarding error-processing, maybe because of 
differences between substance dependent populations such as elevated levels 
of internalizing psychopathology in alcohol dependent individuals. 
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Error-processing in cannabis dependence
Research investigating error-processing in cannabis dependent individuals is 
scarce. No ERP studies were identified for in the current review that have 
investigated error-processing in cannabis dependent individuals, and only one 
fMRI study was identified (Hester, et al. 2009b). In this study, participants were 
asked to press a button in a Go/NoGo task whenever they were aware that they 
made a mistake such that aware and unaware errors could be evaluated 
separately. For aware errors, activation in regions critical for error processing 
was similar in cannabis dependent individuals and controls (see table 2 for 
group differences in other regions). The proportion of errors in cannabis 
dependent individuals was not increased, however, cannabis dependent 
individuals showed reduced error-awareness. In addition, cannabis dependent 
individuals showed less activation in the right ACC, and bilateral MFG for 
unaware errors compared to aware errors, while controls did not show a 
difference between unaware and aware errors in these regions. The difference 
in activation in the ACC for aware relative to unaware errors was positively 
associated with reduced error-awareness suggesting that the failure of the ACC 
to activate for unaware errors may underlie the poor awareness for errors in 
cannabis dependent individuals. More fMRI studies should be performed to 
confirm reduced error processing and accompanied hypoactivation in the ACC 
in cannabis dependent individuals. Also, ERP studies should evaluate whether 
the initial automatic stage of error-processing is reduced and should replicate 
reduced error-awareness in cannabis dependent individuals by evaluating Pe 
amplitudes.
Error-processing in nicotine dependence
Several ERP and fMRI studies have addressed the investigation of error-
processing in nicotine dependent individuals. Utilizing a Flanker task, Franken et 
al. (2010) found that task performance as well as ERN amplitudes for incorrect 
trials were not impaired in nicotine dependent individuals. However, Pe 
amplitudes were reduced in nicotine dependent individuals. These findings may 
indicate that initial error detection in nicotine dependent individuals is intact but 
that more conscious evaluation of errors may be reduced. Luijten et al. (2011b) 
investigated whether error-processing is altered in nicotine dependent 
individuals when smoking cues are presented during task performance using an 
adapted Flanker task. Nicotine dependent individuals were not impaired on task 
performance, but nicotine dependent individuals did not adapt their behavior 
after an error (i.e., post-error slowing was not observed in nicotine dependent 
individuals). Furthermore, both ERN and Pe amplitudes were reduced in nicotine 
dependent individuals. Results of this study, combined with results of Franken et 
al. (2010) suggest that initial error detection may be specifically compromised in 
nicotine dependent individuals when limited cognitive resources are available 
for error-monitoring such as during exposure to smoking cues. On the other 
hand, the more conscious processing of errors may be generally reduced in 
nicotine dependent individuals.
 An fMRI study in which participants performed a Stop-Signal task 
showed reduced activation after an error in nicotine dependent individuals in 
the dorsal ACC coupled with increased activation in a more anterior region of 
the dorsomedial prefrontal cortex (DMPFC, De Ruiter, et al. 2012). Using a Go/
NoGo task, Nestor et al. (2011) found that nicotine dependent individuals made 
more errors accompanied by reduced brain activation in the right SFG, whereas 
no activation deficits were found in the ACC or insula. This study also included a 
group of ex-smokers who showed enhanced error-related activity in the ACC, 
bilateral SFG and right MFG. These findings suggest that more elaborate neural 
monitoring of errors may increase chances to quit smoking or that the deficits in 
nicotine dependent individuals are reversible.
 In conclusion, results from ERP studies suggest that initial error 
detection may be reduced in nicotine dependent individuals during more 
cognitive challenging situations, whereas the more conscious evaluation of 
errors may also be reduced in affectively neutral conditions. Hypoactivation in 
the ACC reaction to an error was found in one of the two fMRI studies in nicotine 
dependent individuals. Further research should clarify under which conditions 
neural deficits associated with error-processing are present in nicotine 
dependent individuals. 
 
Error-processing in excessive addiction-like behaviors
No ERP studies that addressed error-processing in subjects with excessive 
addition-like behaviors were identified. In an fMRI study by De Ruiter and 
colleagues (2012) error processing was investigated in the context of behavioral 
addiction. It was found that error-related brain activation in the dACC on the Stop 
Signal task was reduced in pathological gamblers, while task performance was 
intact. This finding suggests reduced monitoring of errors in pathological 
gamblers in the most important region for error-processing. This result resembles 
findings in substance dependent individuals. More fMRI and ERP studies are 
needed to be able to compare excessive addition-like behaviors with substance 
dependence in terms of brain activation associated with error-processing.
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Discussion 
The current review provides an overview of ERP and fMRI studies that have 
addressed inhibitory control and error-processing in substance dependent 
individuals and in individuals showing excessive addiction-like behaviors. Results 
of included studies are summarized in table 1 and 2 and were discussed in the 
text. This discussion provides a summary and critical review of major results in 
light of current addiction theories as well as suggestions for future research and 
treatment implications.
 ERP studies of inhibitory control, as operationalized using Go/NoGo 
and Stop Signal paradigms, have found deficits in addicted individuals both on 
N2 and P3 amplitudes. Among the studies that evaluated N2 amplitudes, several 
studies showed reduced N2 amplitudes in substance dependent individuals as 
well as in excessive internet users. Reduced N2 amplitudes suggest that deficits 
in inhibitory control in addiction may be due to problems with early cognitive 
processes such as conflict detection that are necessary to execute inhibitory 
control. Results regarding P3 amplitudes are less consistent with some studies 
showing no deficits in addicted individuals, some showing reduced and others 
increased P3 amplitudes. Reduced versus enhanced P3 components in addicted 
individuals imply hypoactivation versus compensatory activation during the late 
urgent inhibitory brake. Complementary to reduced N2 amplitudes, several fMRI 
studies showed hypoactivation associated with inhibitory control in addicted 
individuals mainly in the ACC, IFG and DLPFC but also in inferior and superior 
parietal gyri (see figure 1 for summary of fMRI findings for inhibitory control in 
the ACC). From these findings, it can be concluded that substantial parts of the 
network underlying inhibitory control are dysfunctional in addicted individuals.
 Reduced error-related brain activation in addicted individuals in the 
ACC, the most critical area for error-processing, was found in several fMRI 
studies (see figure 2 for summary of fMRI findings for error-processing in the 
ACC). Additionally, reduced activity in other regions such as superior and inferior 
frontal gyri and the insula was reported. ERP findings both confirm and 
complement fMRI findings. Reduced ERN amplitudes were found in substance 
dependent individuals confirming reduced initial error detection in addicted 
individuals. Given that the ACC is the neural generator of the ERN (Herrmann, et 
al. 2004; Ridderinkhof, et al. 2004a; Van Veen, et al. 2002), both ERN and fMRI 
findings suggest that ACC dysfunction could be a biomarker for reduced error-
processing in addicted individuals. Pe findings complement fMRI findings by 
providing information on the timeframe of error-processing deficits. Reduced Pe 
amplitudes in substance dependent individuals suggest that, besides the initial 
error detection, more conscious processing of errors is reduced in addicted 
individuals.
 Two findings in the current review constitute an exception to the above 
mentioned conclusions. First, fMRI findings in cannabis users with regard to 
inhibitory control show hyper- instead of hypo- activation in several brain regions 
including the pre-SMA, DLPFC, insula and IPG. The enhanced activation in 
cannabis users can be interpreted as increased neural effort in order to reach 
control sample levels of behavior performance (i.e., no behavioral deficits were 
found in cannabis users). This hyperactivation could also be problematic in more 
challenging or real world situations when the brain may no longer be able to 
compensate, which is illustrated by findings in cocaine dependent individuals 
who showed more pronounced deficits in inhibitory control under high working 
memory loads (Hester, et al. 2004b). Another explanation for hyperactivation in 
cannabis users is the relatively young age of cannabis users in both fMRI studies 
relative to other studies in substance dependent individuals (Hester, et al. 2009b; 
Tapert, et al. 2007). In addition, participants in Tapert et al. (2007) were abstinent 
from cannabis for 28 days, which is longer than in most other studies, suggesting 
that brain activation may change as a function of abstinence duration 
(Schweinsburg, et al. 2010). 
 ERP and fMRI findings regarding error-processing in alcohol 
dependence constitute the second exception on the generally observed 
hypoactivation in addicted individuals. In contrast to other addicted individuals, 
alcohol dependent individuals show enhanced processing of errors as reflected 
by enlarged ERN amplitudes and increased error-related activation in the ACC. 
Findings in the study by Schellekens et al. (2010) provide a plausible explanation 
for these findings as ERN amplitudes in high anxious alcohol dependent 
individuals were larger than in low anxious alcohol dependent individuals. These 
findings of increased ERN amplitudes in high anxious alcohol dependent 
individuals suggest that the often observed comorbid internalizing 
psychopathology (i.e., anxiety-related disorders) in alcohol dependent 
individuals (Bacon, et al. 2010; Baillie, et al. 2010) may be responsible for the 
increase in error-processing. An overview of ERN findings in both internalizing 
and externalizing psychopathology confirms that internalizing psychopathology 
is associated with enhanced ERN amplitudes while externalizing 
psychopathology is associated with reduced ERN amplitudes (Olvet, et al. 
2008). The effects of anxiety in alcohol dependent individuals on error-related 
brain activation suggest that comorbidity with internalizing psychopathology 
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may be a confounding factor in studies in substance dependent individuals. It 
would be interesting if future studies report comorbidity and investigate 
individual differences within substance dependent individuals. 
 A secondary goal of this review was the evaluation of possible neural 
deficits associated with cognitive control in individuals showing excessive 
addiction-like behaviors such as pathological gambling, excessive internet use 
and excessive gaming. If observed deficits are similar to those in substance 
dependent individuals, this could be interpreted as an argument for the 
classification of these behaviors as an ‘addictive disorder’ which may have 
important consequences for diagnoses and treatment programs. Indeed, 
studies showed similar findings in excessive internet users and pathological 
gamblers to those observed in substance dependent individuals. More 
specifically, reduced N2 amplitudes reflecting early cognitive processes 
associated with inhibitory control have been found in excessive internet users 
(Dong, et al. 2010; Zhou, et al. 2010). In addition, reduced activity in the ACC for 
both inhibitory control and error-processing has been found in pathological 
gamblers (De Ruiter, et al. 2012), which is among the most often observed 
findings in substance dependent individuals. It appears that neural deficits in 
behavioral addictions are not the result of comorbid substance use or 
dependence, as this was an exclusion criterion in two of the reviewed studies 
(De Ruiter, et al. 2012; Zhou, et al. 2010). Since neuroimaging studies in the 
Figure 1
Summary of Anterior Cingulate dysfunction in addicted individuals for inhibitory control 
Note figure 1 Circles represent hypoactivation and squares hyperactivation for inhibitory control in 
addicted individuals relative to healthy controls. Red: opioid dependent individuals; Green: cocaine 
dependent individuals; Dark blue: cannabis dependent individuals; Cyan: nicotine dependent 
individuals; Yellow: pathological gamblers. Locations are based on reported Talairach or MNI 
coordinates in studies reporting group differences included for this review. Talairach coordinates were 
converted to MNI using the GingerALE toolbox. Foci of activation were projected onto the midline for 
ease of viewing. 
Figure 2
Summary of Anterior Cingulate dysfunction in addicted individuals for error processing 
Note figure 2 Circles represent hypoactivation and squares hyperactivation for error processing in 
addicted individuals relative to healthy controls. Red: opioid dependent individuals; Green: cocaine 
dependent individuals; Purple: alcohol dependent individuals; Dark blue: cannabis dependent 
individuals; Cyan: nicotine dependent individuals; Yellow: pathological gamblers. Locations are based 
on reported Talairach or MNI coordinates in studies reporting group differences included for this 
review. Talairach coordinates were converted to MNI using the GingerALE toolbox. Foci of activation 
were projected onto the midline for ease of viewing. 
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domain of cognitive control in individuals showing excessive addiction-like 
behaviors are still scarce, we conclude that current findings in those individuals 
provide only preliminary support for similar neurocognitive deficits as substance 
dependent individuals. Clearly, more studies addressing other critical aspects of 
addictive behaviors than cognitive control (craving, desire to reduce addictive 
behavior, failure to fulfill obligations etc.) are needed in order to provide solid 
evidence to list these excessive behaviors under ‘substance use and addictive 
disorders’ in the upcoming DSM editions. 
 Overall, the results of this review point to a reduction in the function of the 
neural circuits underlying inhibitory control and error-processing in both substance 
dependent individuals and individuals showing excessive addition-like behaviors, 
which is in line with several theoretical and animal models of addiction. These 
models explain substance dependence as a consequence of insufficient control 
applied by the hypoactive cognitive control circuit in the brain over the overactive 
reward and motivational brain circuit (Goldstein, et al. 2002; Jentsch, et al. 1999; 
Volkow, et al. 2010). Insufficient functioning of the cognitive control brain circuit 
may arise from both the overwhelming effect of the motivational circuit (enhanced 
“drive”) due to repeated substance intake and from individual differences in the 
strength of cognitive control circuits that renders an individual vulnerable to 
develop substance dependence (George, et al. 2010; Kirisci, et al. 2006; Tarter, et 
al. 2003; Verdejo-Garcia, et al. 2008). The findings in the current review provide 
empirical support for reduced functioning of the control circuits in the brain both 
when it comes to the inhibition of inappropriate behavior and behavior monitoring. 
The correspondence of the preliminary findings in behavioral addictions with 
those in substance dependent individuals is in line with theoretical accounts that 
pathological gambling and other proposed behavioral addictions share common 
underlying mechanisms with substance dependence (Grant, et al. 2010; Potenza 
2006; Van Holst, et al. 2010).
Combined evaluation of ERP and fMRI studies
The combined evaluation of ERP and fMRI studies in this review is unique and 
offers information regarding neural deficits in cognitive control in addicted 
individuals with a high temporal and spatial resolution. Several findings in the 
current review provide examples for complementary insights when ERP and fMRI 
findings are compared. First, given the neural generators of the N2 and P3 
components (i.e., ACC and right IFG versus motor cortices respectively) the 
observed hypoactivation in addicted individuals in fMRI studies in the ACC and 
right IFG for inhibitory control may be linked to reduced N2 rather than P3 
amplitudes. Although speculative, such a comparison between fMRI and ERP 
results suggest that fMRI findings in these regions are linked to the early processes 
associated with inhibitory control such as conflict detection and resolution. 
 Another illustration of the added value of ERP findings for fMRI research 
are findings in excessive internet users. Reduced N2 amplitudes accompanied 
by increased P3 amplitudes were found in excessive internet users when 
behavioral performance is intact (Dong, et al. 2010; Zhou, et al. 2010). Enhanced 
P3 amplitudes point to a late compensation mechanism for the observed deficits 
in early inhibitory processes (i.e., reduced N2 amplitudes). Combined hypo-and 
hyperactivation is often found in fMRI studies, however, given the limited 
temporal resolution of fMRI it is not possible to draw inferences on hyperactivation 
as compensation in the final stage of inhibitory control. ERP findings such as 
those observed in excessive internet users provide clues on the exact role of 
hyperactivation coupled with hypoactivation. A final illustration of complementary 
insights from fMRI and ERP are the findings regarding error-processing in 
smokers. FMRI studies in smokers show reduced activation in the dorsal ACC 
after a performance error (De Ruiter, et al. 2012; Nestor, et al. 2011). Additionally, 
results from ERP studies provide details on the time frame of deficits in error-
processing. In fact, ERP findings suggest that initial error detection is reduced in 
smokers only during cognitively challenging situations, whereas the more 
conscious evaluation of errors is generally reduced in smokers (Franken, et al. 
2010; Luijten, et al. 2011b).
 Unfortunately, not all ERP studies investigating error-processing or 
inhibitory control evaluated both ERN and Pe, or N2 and P3 amplitudes, 
respectively. The evaluation of only one ERP component limits the unique 
possibility of ERP research to provide information regarding the timeframe of 
cognitive control deficits. Therefore, it is recommended that future studies 
evaluate both ERN and Pe or N2 and P3 amplitudes. In addition, the neuroimaging 
field could make a step forward if they take advantage of current technological 
advances to simultaneously acquire ERP and fMRI data. By doing this, rich data 
sets with both high temporal and spatial resolution can be obtained and 
comparison of ERP and fMRI data will become more straightforward. 
 
Limitations and strengths
Although consistent results in addicted individuals regarding neural deficits 
underlying cognitive control were identified, inconsistencies have been reported 
as well. For example, addicted individuals in some studies showed hyper- 
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instead of hypo-activation associated with cognitive control. Generally, the 
interpretation of hypo-versus hyperactivation in ERP and fMRI studies in clinical 
populations relative to healthy controls remains equivocal. Behavioral findings 
such as reduced accuracy or reaction time differences are crucial to guide the 
interpretation of hypo- or hyperactivation. Hypoactivation in combination with 
reduced accuracy is relatively straightforward and most likely signals reduced 
neural capacities leading to behavioral deficits. Although often observed in both 
ERP and fMRI studies, hypoactivation without behavioral deficits is less 
straightforward. One possible explanation for hypoactivation without behavioral 
deficits is that brain activation is a more sensitive measure to detect abnormalities 
in addicted individuals, which is suggested by Goldstein and Volkow (Goldstein, 
et al. 2011). In this context it would be interesting to investigate associations 
between the amount of substance use or the level of dependency on one hand 
and the extent of hypoactivation on the other hand. For example, accuracy on a 
Go/NoGo task was the same for smokers and non-smokers in the study by 
Galvan et al. (2011), while the level of nicotine dependence in smokers was 
found to be associated with hypoactivation in several prefrontal brain regions. 
These findings imply that hypoactivation without a behavioral deficit is indeed 
associated with addictive behaviors. Finally, hyperactivation coupled with intact 
behavioral performance is often interpreted as increased neural effort or the 
use of alternative cognitive strategies to reach normal levels of behavioral 
performance. In line with this notion, literature in the field of aging shows that 
initial cognitive decline is characterized by a combination of increased frontal 
engagement and intact behavioral performance (for review see: Goh, et al. 
2009). Results in the current review should be interpreted with these 
considerations in mind. 
 Inconsistencies in results are probably due to differences in 
methodology, participant selection, data acquisition and analyses techniques. A 
strength of the current review is that we strictly selected task paradigms to 
measure inhibitory control and error-processing, thereby reducing variability in 
results due different cognitive processes evoked by different task designs. For 
example, studies employing the Stroop task were excluded because it is known 
to evoke cognitive processes such as conflict resolution, response selection and 
attention (Nigg 2000; Ridderinkhof, et al. 2004b), consequently ERPs in Stroop 
paradigms differ from those in Go/NoGo and Stop Signal paradigms (i.e., N250 
and conlfict slow waves versus N2 and P3: Atkinson, et al. 2003; Chen, et al. 
2011; Larson, et al. 2009). Additionally, the Stroop task employed in several 
fMRI studies often involved drug-related words (Ersche, et al. 2010; Goldstein, 
et al. 2009a; Goldstein, et al. 2010) which is known to reflect attentional bias 
rather than cognitive control (Field, et al. 2008; Franken 2003). However, some 
findings in fMRI and PET studies employing the classic color-word Stroop task 
are in line with the current findings by showing reduced activation in addicted 
individuals in the ACC and DLPFC (Bolla, et al. 2004; Potenza, et al. 2003; Salo, 
et al. 2009). Despite the strict selection of task paradigms, variance within Go/
NoGo and Stop Signal paradigms may still explain some of the inconsistencies 
in results for inhibitory control. For example, brain activation associated with 
inhibitory control has been found to be linearly depending on the frequency of 
NoGo trials (De Zubicaray, et al. 2000; Nieuwenhuis, et al. 2003). Also, 
Go/NoGo tasks in which NoGo trials are rather frequent (e.g., 40% or more) 
may reduce cognitive requirements to a level at which differences between 
addicted individuals and healthy controls are strongly attenuated. The same is 
true for task designs in which NoGo trials are predictable (e.g., in a block design). 
Differences in analysis techniques further contribute to inconsistencies in 
results. For fMRI studies, whole brain versus regions of interest analysis is a 
major source of variance as well as the use of different contrasts for analyses 
(i.e., Stop Correct minus Go versus Stop Correct minus Stop Error) and different 
methods to correct for multiple comparisons. Finally, anatomical localization of 
fMRI activation may be influenced by different naming conventions and 
anatomical atlases. A related issue exists in ERP studies, in which the selection 
of electrodes contributes to variance in results. Ideally, task design and analysis 
techniques should become much more standardized such that results of future 
studies are better comparable and may become more consistent.
 
Treatment implications and future research directions
Contemporary effective treatments for addiction involve pharmacotherapy, 
cognitive-behavior therapy and contingency management (McHugh, et al. 
2010a; Rawson, et al. 2006; Van den Brink, et al. 2003). Nevertheless, relapse 
rates are still high so there is ample room for improvement. Several treatment 
targets based on the findings in this review merit further investigations. First, 
cognitive control capacities and underlying neural networks could be trained to 
increase cognitive control. It has been shown that explicit training of inhibition of 
drinking cues via pairing with NoGo trials is associated with a reduction in 
drinking behavior in social drinking (Houben, et al. 2011). Another possibility to 
increase inhibitory control is the direct training of hypoactive brain regions such 
as the ACC, IFG and DLPFC via neurofeedback techniques (see deCharms 
2008 for an overview of clinical applications of real time neurofeedback). 
Previous research has shown that participants can regulate their ACC activation 
by providing them with real-time feedback on ACC activation (deCharms, et al. 
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2005). Another potential treatment method for addiction with the brain as a 
direct target is transcranial magnetic stimulation (TMS, for reviews see: Barr, et 
al. 2008; Feil, et al. 2010b). Repetitive stimulation of the DLPFC in depressive 
individuals reduced Hamilton Depression Rating Scale scores (Wassermann, et 
al. 2012). It would be interesting to see whether repetitive TMS can be effective 
in addicted individuals by improving cognitive control via stimulation of the 
prefrontal cortices. Specific medications with the aim to enhance cognitive 
functions (i.e., cognitive enhancers such as modafinil) may be another possible 
treatment intervention to increases cognitive functioning via its effects on 
catecholaminergic systems (for review see: Brady, et al. 2011). For example, 
modafinil improved inhibitory control in methamphetamine dependent 
individuals on a Go/NoGo task (Dean, et al. 2011). Generally, investigating the 
role of neurotransmitters in cognitive control could provide valuable insights 
concerning the biochemistry of cognitive control deficits. For example, cognitive 
control has been found to be depending on prefrontal dopamine levels (Cools, 
et al. 2011). The association between dopamine and cognitive control could 
have important implications for cognitive control deficits in addicted individuals, 
as it is known that substance dependence is characterized by dysfunctional 
dopamine systems (Volkow, et al. 2009). It is therefore possible that reduced 
cognitive control in addicted individuals result as a consequence of disturbances 
in the dopamine system. Knowledge concerning the role of neurotransmitters in 
cognitive control may eventually contribute to the development of new 
pharmacotherapies. More research into these clinical applications is needed to 
explore which of these potential treatment strategies may eventually be effective 
in the reduction of addictive behaviors. 
 Cognitive control capacities can also be used in clinical practice to 
guide treatment plans according to individual needs. It has been shown that 
deficits in cognitive control are associated with the reduced capacity to 
recognize problems with substance abuse and lower motivation to enter 
treatment (Severtson, et al. 2010). Furthermore, an increasing number of 
studies indicate that substance dependent individuals with reduced cognitive 
control tend to drop out in treatment programs more often (Ersche, et al. 2007). 
The Berkman et al. (2011) study showed that individual differences in activation 
in the inhibitory control network are linked to the ability to inhibit craving in daily 
life in order to prevent smoking. This study provides a good illustration on how 
neuroimaging research can develop to become valuable for clinical practice. A 
related line of future research is the prediction of relapse based on neuroimaging 
data. Furthermore, the systematic evaluation of harmful or protective effects 
from individual differences within the population of addicted individuals could 
provide profiles of addicted individuals who suffer from or are protected against 
problems arising from reduced cognitive control. The findings that high levels of 
anxiety in alcohol dependent individuals are associated with enhanced error-
processing (Schellekens, et al. 2010) imply that differences exist within addicted 
populations regarding cognitive control capacities. These differences may point 
to differential treatment options for high and low anxiety subjects. Altogether, 
recent findings regarding cognitive control in addicted individuals highlight the 
need to monitor cognitive deficits during treatment programs and suggest that 
cognitive capacities may be used as an indication to identify addicted individuals 
who are more vulnerable to relapse. It should be noted, however, that more 
information on how to improve reliability of neuroimaging measures is necessary 
for both fMRI and ERP measures to increase the applicability of neuroimaging 
research for clinical practice.
 Besides a shift to more directly clinically relevant research, several 
other future research directions are important. First, the literature search for the 
current review paper revealed that opiate and cannabis dependent individuals 
have been under researched. Also, more studies in individuals showing 
excessive addiction-like behaviors are needed in order to provide a definite 
answer regarding the classification of these disorders as addictive disorders. 
Second, one of the most important remaining questions is the question on 
causality. It is not yet known whether neural deficits associated with cognitive 
control in addiction predispose individuals to substance use or whether they are 
a consequence of substance use. While it cannot be excluded that continuously 
repeating excessive addiction-like behaviors may cause changes in neural 
circuits underlying cognitive control, the correspondence of the neural deficits 
in behavioral addictions to those observed in substance dependent individuals 
suggest that substance intake alone is not sufficient to cause these neural 
deficits. In addition, it has been shown in animal studies that individual differences 
in prefrontal brain function in rats is predictive for the transition to excessive 
drug intake, although these kind of animal studies are still scarce (for review 
see: George, et al. 2010). Two types of research should be performed in order to 
find out whether neural deficits underlying reduced cognitive control are causes 
or consequences of addictions. First, neural performance associated with 
cognitive control in at risk populations, such as children of substance dependent 
parents, should be investigated. For example, a recent meta-analysis (Euser, et 
al. 2012) showed that the P300, which is an ERP reflecting allocation of attention 
resources in oddball paradigms, is reduced in offspring of substance dependent 
individuals, suggesting that a reduced P300 is a vulnerability marker for the 
development of addiction. It remains to be seen whether this is also true for 
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neural correlates of reduced cognitive control. Most importantly, longitudinal 
population based neuroimaging studies should be performed in order to see 
whether neural correlates of cognitive control can differentiate between 
individuals who will develop addiction later in life from those who do not. 
Finally, another relevant research questions that has not yet been investigated 
concerns the role of cognitive control during exposure to environmental cues 
associated with the addiction. Theoretically, it is expected that impairments in 
cognitive control are more pronounced during cue-exposure (Dawe, et al. 
2004a; Goldstein, et al. 2002). However, the only study included in this review 
that evaluated whether the presence of drug-related cues have a negative 
influence on inhibitory control in smokers did not support this theory (Luijten, et 
al. 2011a). More studies are needed in order to clarify this issue. 
 
Conclusions
This review is the first one that systematically evaluated ERP and fMRI findings 
concerning inhibitory control and error-processing in substance dependent 
individuals as well as in excessive addiction-like behaviors. The combined 
evaluation of ERP and fMRI in the current review offers new insights and future 
research directions. Overall, results show that substance dependence is 
characterized by neural deficits associated with inhibitory control and error-
processing. The most consistent findings being reduced N2 and ERN amplitudes 
and hypoactivation in the ACC, IFG and DLPFC. In addition, preliminary evidence 
has been found to support the idea that excessive addiction-like behaviors are 
characterized by similar neural deficits as those observed in substance dependent 
individuals. Notably, neuroimaging research in the domain of cognitive control 
should use much more standardized methods in order to improve comparability 
between studies and to be able to contribute to the development and evaluation 
of treatment programs.
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Diminished error-processing  
in smokers during smoking cue 
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Abstract
Deficits in error-processing may contribute to the continuation of impulsive 
behaviors such as smoking. Previous studies show deficits in error-processing 
among substance abuse patients. However, these studies were all conducted 
during affectively neutral conditions. Deficits in error-processing in smokers may 
become more pronounced under affectively challenging conditions, such as 
during smoking cue exposure. The aim of the present study was to investigate 
whether smokers showed initial error-processing deficits, as measured with the 
error-related negativity (ERN), and decreased motivational significance attributed 
to an error, as measured with the error positivity (Pe) when exposed to smoking 
cues. Additionally, we examined the nature of the ERN and Pe amplitudes in 
more detail by investigating their associations with trait impulsivity, nicotine 
dependence levels and cigarette craving. Event-related potentials were measured 
during a modified Erikson flanker task in both smokers and non-smoking controls. 
Smokers showed reduced ERN and Pe amplitudes after making an error, 
accompanied by diminished post-error slowing of reaction times. These results 
suggest that initial error-processing and decreased motivational significance 
attributed to an error are affected in smokers during smoking cue exposure. 
Furthermore, individual variation in impulsivity and nicotine dependence were 
associated with reduced ERN amplitudes.
Introduction
Substance abuse is characterized by a variety of impulsive behaviors including 
diminished inhibitory control and the preference of immediate rewards over 
delayed larger rewards (Dawe, et al. 2004a; Li, et al. 2008a; Reynolds 2006; 
Verdejo-Garcia, et al. 2008). A common behavioral pattern that accompanies 
these processes is an apparent failure to learn from harmful behavior for self 
or others (Franken, et al. 2007). The ability to monitor ongoing performance is 
a crucial function of the human brain in order to adapt behavior appropriately 
to situational demands and to continue goal directed behavior (Ridderinkhof, 
et al. 2004b). Deficits in error-processing may, therefore, contribute to the 
continuation of impulsive behaviors (such as drug use) despite negative 
consequences. Hypothetically, the impulsivity observed in substance abuse 
patients may result from the fact that errors are processed in a limited way and 
are therefore not detected optimally.
 The processing of errors can be measured both at behavioral and 
physiological levels. On the electrophysiological level, at least two different 
error-related brain waves can be distinguished in the Event-Related Potential 
(ERPs: Falkenstein, et al. 2000; Herrmann, et al. 2004). The Error-Related 
Negativity (ERN) arises after 50-80 milliseconds after making an error in 
speeded response tasks and is followed by the ongoing error positivity (Pe) 
potential. The ERN and the Pe are regarded as two independent components 
of error-processing (Herrmann, et al. 2004; Overbeek, et al. 2005). The ERN 
is a fast and automatic response reflecting initial error detection (Bernstein, et 
al. 1995). A growing body of evidence supports the notion that the ERN is 
modulated by dopaminergic brain systems (Holroyd, et al. 2002). Haloperidol, 
a dopamine (DA) antagonist, significantly attenuated ERN amplitudes to self-
detected errors during a flanker task (Zirnheld, et al. 2004). In contrast, the 
indirect DA agonist d-amphetamine leads to an enlargement of ERN 
amplitudes (De Bruijn, et al. 2004). The reinforcement learning theory predicts 
that a disruption of the mesencephalic dopamine system should affect the 
ERN (Holroyd, et al. 2002; Holroyd, et al. 2009). This theory further suggests 
that the ERN arises from a dopaminergic midbrain learning signal that is 
conveyed to the anterior cingulate cortex. Converging evidence indeed 
indicates that the anterior cingulate cortex is the neural generator of the ERN 
(Gehring, et al. 2000; Herrmann, et al. 2004; Mathalon, et al. 2003; Miltner, et 
al. 2003b; Ridderinkhof, et al. 2004a; Stemmer, et al. 2004; Van Veen, et al. 
2002). 
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The Pe has been linked with the motivational significance attributed to 
an error (Falkenstein, et al. 2000) and the more conscious reflection on an error 
(Overbeek, et al. 2005). Recent research confirmed that the Pe covaried with the 
stimulus locked P3 that is known to be involved in conscious processing of 
motivationally significant events (Ridderinkhof, et al. 2009). 
 Very few ERP studies investigated error-processing in substance 
dependence (Franken, et al. 2007; Franken, et al. 2010; Sokhadze, et al. 2008). 
Results of studies among cocaine dependent patients suggest a disruption in the 
brain’s error-processing system as indicated by reduced ERN (Franken, et al. 
2007; Sokhadze, et al. 2008) and Pe amplitudes (Franken, et al. 2007). In a study 
among smokers, Franken et al. (2010) did not show reduced ERN amplitudes, but 
did show reduced Pe amplitude as compared to controls, suggesting that initial 
error-processing seems to be intact, while the motivational significance attributed 
to errors might be compromised. Interestingly, these findings of affected error-
processing are not specific to substance abusers. Reduced error-processing has 
also been observed in ADHD patients (Liotti, et al. 2005; Van Meel, et al. 2007; 
Zhang, et al. 2009), in psychopaths (Brazil, et al. 2009; Munro, et al. 2007) and in 
borderline personality disorder patients (Ruchsow, et al. 2006). Results of these 
studies are in line with a recent theory proposing that patients with externalizing 
psychopathology share the inability to monitor performance errors (Hall, et al. 
2007; Olvet, et al. 2008). These similarities in error-processing among clinical 
populations may be the result of shared personality traits in externalizing 
psychopathology including sensitivity to reward and enhanced impulsivity levels. 
Reduced ERN components in high impulsive people in the normal population 
provide further support for the idea that reduced error-processing may be related 
to personality traits (Potts, et al. 2006; Ruchsow, et al. 2005). 
 Although Franken et al. (2010) suggest that initial error-processing is 
intact in smokers, possible error-processing deficits may remain undetected 
unless the smoker is tested in more challenging environments, such as during 
smoking cue exposure. A possible mechanism for enhanced cognitive deficits 
during cue exposure is that through the course of developing nicotine addiction, 
increased incentive salience has been assigned to smoking-related cues, which 
results in increased attentional priority given to these cues (Field, et al. 2008; 
Franken 2003; Littel, et al. 2007; Robinson, et al. 2008). This attentional bias for 
smoking-related cues might reduce the overall cognitive resources available to 
monitor ongoing behavior resulting in reduced ERN and Pe amplitudes. The 
possibility that cue exposure may interfere with error-processing is further 
supported by the idea that both cue exposure and error-processing are depending 
on dopamine release in the ventral striatum (Brody, et al. 2004; Holroyd, et al. 
2002) suggesting that cue exposure may change the ERN by changing the 
underlying dopaminergic system. A previous study among psychopaths indeed 
showed a reduced ERN during an emotion recognition task, but not during an 
affective neutral task (Munro, et al. 2007), suggesting that error-processing is 
indeed dependent on the presence of environmental, motivational relevant, 
stimuli. Therefore, the current study investigated error-processing in smokers 
and non-smoking controls while being exposed to smoking cues. For this purpose, 
the Erikson Flanker task was adapted by adding smoking-related pictures. It is 
expected that error-processing will be reduced in smokers as compared to 
controls while being exposed to these smoking-related cues. More specifically, 
we expect to find reduced post-error slowing of reaction times on the behavioral 
level and reduced ERN and Pe components at the physiological level. Additionally, 
we examined the nature of the ERN and Pe amplitudes in more detail by 
investigating their associations with trait impulsivity, severity of nicotine 
dependence and cigarette craving. 
Materials and Methods
Participants
Nineteen smokers and 20 non-smoking controls participated in this study. 
Exclusion criteria for both groups were (a) drug abuse other than nicotine and 
alcohol, and (b) indications of current physical or psychological illness. Six 
smokers and 6 non-smokers were excluded from analyses because they had less 
than ten artifact free error-related EEG epochs (due to too few errors, n = 5, or 
too much artifacts, n = 7). The final group consisted of 13 smokers (mean age = 
20.7 years, SD = 1.3, 9 male) and 14 non-smokers (mean age = 21.4 years, SD 
= 2.6, 10 male). The mean age (t = .96, ns) and gender ratio (chi-square = .02; 
ns) of the smoker and non-smoker groups did not differ. Smokers smoked at 
least 10 cigarettes a day (mean = 16.8 cigarettes per day, range = 10-25) for a 
duration of at least two years (mean = 4.6 years, range = 2-7). The Fagerström 
test for nicotine dependence (FTND) served as a measure of nicotine dependence 
in smokers (mean score = 5.0, range = 0-8) and suggested medium levels of 
nicotine dependence (Heatherton, et al. 1991; Vink, et al. 2005). Non-smokers 
had smoked ten or less cigarettes lifetime (mean = 1.6 cigarettes lifetime, range 
= 0-10). Participants consisted of undergraduate psychology students, who 
received course credit or a small financial compensation for participation. The 
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smoking-related objects, whereas non-smoking pictures showed people 
engaged in non-smoking behavior or neutral objects. The proportion of smoking 
and non-smoking pictures displaying persons versus objects was equal for both 
picture categories. In addition, smoking and non-smoking pictures where 
matched on gender of the displayed persons and visual complexity (e.g., number 
of objects on the picture).
 
Procedure
Smokers were instructed to abstain from smoking for at least one hour before the 
experiment. This short period of smoking deprivation was introduced in order to 
reduce the acute effects of nicotine on ERP amplitudes (Houlihan, et al. 1996; 
Houlihan, et al. 2001) without introducing strong withdrawal effects. After arrival, 
participants approved participation by signing informed consent. The CO breath 
sample was taken and the questionnaires were completed. Subsequently, 
participants were seated in a comfortable EEG chair in a light and sound-
attenuated room. Electrodes were attached and task instructions were explained, 
after which the smoking Flanker task was started. Smokers completed the QSU 
again after completing the task. 
EEG recording and data reduction
The EEG was recorded using the Biosemi Active-Two amplifier system from 34 
scalp sites (10-10 system, and two additional electrodes at FCz and CPz) 
mounted in an elastic cap. Six additional electrodes were attached to left and 
right mastoids, two outer canthi of both eyes (HEOG), and infraorbital and 
supraorbital regions of the right eye (VEOG). All signals were digitalized with a 
sample rate of 512 Hz and 24-bit A/D conversion with a bandpass of 0-134 Hz. 
study was conducted in accordance with the Declaration of Helsinki and all 
procedures were carried out with the adequate understanding and written 
informed consent of the subjects. The ethics committee of the Institute of 
Psychology of the Erasmus University Rotterdam approved the study. 
 
Instruments
Breath carbon monoxide concentration was measured using a Micro+ 
Smokerlyzer (Bedfont Scientific Ltd., Rochester, UK) to objectively define 
smokers and non-smokers. The impulsiveness subscale of the Dutch version of 
the I7 questionnaire (Lijffijt, et al. 2005) was used to measure trait impulsivity. 
Several questionnaires were used in order to investigate possible confounders. 
Alcohol consumption, both quantity and frequency, was measured using a QF-
index (Lemmens, et al. 1992). The positive affect negative affect scale (PANAS: 
Watson, et al. 1988) and the Snaith-Hamilton Pleasure Scale (SHAPS: Snaith, et 
al. 1995) were used to measure mood state and anhedonia. In addition, smokers 
completed the FTND to measure nicotine dependence and the Questionnaire of 
Smoking Urges (QSU: Cox, et al. 2001) to indicate their subjective craving for a 
cigarette.
 
Task paradigm
A modified version of the Erikson Flanker Task was developed for the purpose of 
the current study (see figure 1). Participants had to indicate the direction of the 
middle arrow with a button press using left and right index fingers. To increase 
the amount of errors, participants were instructed to respond as fast as possible. 
In the beginning of each trial participants saw a warning sign (^) for a random 
duration between 300 and 500ms, after which two rows of five horizontal flanker 
arrows appeared. The middle arrow in both rows was either congruent or 
incongruent with the direction of the flanker arrows. The proportion of congruent 
and incongruent trials was equal. Pictures with smoking-related content or non 
smoking-related content were semi-randomly presented in between the five 
flanker arrows. Arrows and pictures remained on the screen until the button 
press. A blank screen appeared with a randomly varying duration between 600 
and 800ms before a feedback symbol (a green plus sign for correct trials or a red 
minus sign for incorrect trials) was presented for 400ms. Seventy-five smoking-
related pictures and 75 non-smoking pictures were each presented six times 
during the total of 900 trials. Sixteen practice trials were presented before the 
start of the task and four rest periods were included during task presentation. 
Smoking-related pictures showed people engaged in smoking behavior or 
Figure 1
Example of an incongruent trial combined with a smoking cue picture during the modified affective 
Flanker task
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Data were off-line re-referenced to computed mastoids. Off-line, EEG and EOG 
activity was filtered with a bandpass of 0.10-30 Hz (phase shift-free Butterworth 
filters; 24dB/octave slope). Data were segmented in epochs of 1 second (200ms 
before and 800ms after response or stimulus presentations). After ocular 
correction (Gratton, et al. 1983) epochs including an EEG signal exceeding ± 75 
μV were excluded from the average. The mean 200 ms pre-response or pre-
stimulus period served as baseline. After baseline correction, average ERP waves 
were calculated for artifact-free trials at each scalp site for correct and incorrect 
responses separately. The ERN was defined as the mean value in the 25-75 ms 
time segment after onset of the response. The Pe was defined as the mean value 
in the 250-350 ms time segment after onset of the response. Both the ERN and 
Pe were studied at the midline electrodes, FCz, Cz and CPz. The chosen time 
windows include ERN and Pe peaks at these midline electrodes as observed in 
many studies (Overbeek, et al. 2005). In addition, stimulus locked ERP’s were 
calculated by the mean ERP activity between 200 and 300 ms for the N2, 300 
and 500 ms for the P3 and 500 and 800 ms for the slow wave at the same midline 
electrodes. 
 
Statistical analyses
Group differences on demographics and questionnaire data were analyzed using 
independent sample t-tests. The difference in self-reported craving before and 
after task performance was analyzed by means of a paired sample t-test. 
Repeated measures (RM) ANOVA’s were used to analyze task performance and 
ERP data with Greenhouse-Geisser adjusted p-values. Group (smokers versus 
non-smokers) was used as a two-level between subjects factor in all RM-
ANOVA’s. Post-hoc tests for interactions were performed only for interactions 
including the between subject factor Group. For all analyses, the .05 level of 
significance was employed and a Bonferroni correction was applied in post-hoc 
analyses. 
 The current task design resulted in the following two-level within subject 
factors of interest (a) Congruency (congruent versus incongruent arrow 
direction); (b) Picture (smoking versus neutral pictures); (c) Correctness (correct 
versus incorrect trials) and (d) Post-correctness (reaction times on post-correct 
versus post-incorrect trials; a commonly used measure for between group 
comparisons on post-error slowing; Brazil, et al. 2009; Franken, et al. 2007; 
Franken, et al. 2010; Jonkman, et al. 2007; Munro, et al. 2007; Potts, et al. 2006; 
Rabbitt 1966a; Rabbitt 1966b; Van Meel, et al. 2007). For the behavioral accuracy 
(percentage of errors) we employed a Group x Congruency x Picture RM-
ANOVA. Three RM-ANOVA’s were employed for mean reaction time (RT) data: 
(1) Group x Congruency x Picture, (2) Group x Correctness and (3) Group x 
Post-correctness. Electrode (FCz, Cz, CPz) was included as a three-level within 
subject factor in all ERP analyses. The number of analyzable ERN and Pe epochs 
did not differ between smokers (mean = 23.8, SD = 10.3) and controls (mean = 
20.1, SD = 11.3), t(25) = 0.46, ns. However, the number of epochs was too small 
(i.e., resulted in too few segments for each category) to include the Picture within 
subject factor in the ERN and Pe analyses. Therefore a Group x Electrode x 
Correctness RM-ANOVA was conducted for the ERN and Pe. To further 
investigate the nature of the ERN and Pe peaks we calculated Spearman’s rho 
correlation coefficients with trait impulsivity across groups and with nicotine 
dependence and the increase in self-reported craving in smokers only. These 
correlations were performed separately for correct and incorrect trials and with 
FCz, Fz and CPz averaged together in order to avoid multiple comparisons. For 
each stimulus locked ERP (N2, P3, slow wave) a Group x Electrode x Congruency 
x Picture RM-ANOVA was conducted.
 
Results
Breath CO levels and questionnaires
As expected, smokers showed higher carbon monoxide (CO) parts per million 
concentration (mean CO = 11.6, SD = 6.4) than non-smoking controls (mean 
CO = 1.1, SD = 1.2), t(25) = 6.1, p <0.001. Smokers and controls did not differ 
on positive and negative affect as measured by the PANAS, on anhedonia as 
measured by the SHAPS, and on habitual alcohol drinking patterns, that is 
alcohol drinking quantity and frequency. However, smokers scored higher 
(mean = 10.1, SD = 4.4) than controls (mean = 6.4, SD = 4.3) on the 
impulsiveness subscale of the Dutch version of the I7 questionnaire, t(25) = 2.3, 
p< .05, which indicates that smokers reported higher trait impulsivity levels than 
non-smokers. Subjective craving in smokers was significantly increased after 
task performance, t(12) = 4.7, p= .001. 
 
Behavioral data
Table 1 shows the percentages of errors and reaction times for both groups on 
the affective flanker task. A robust main effect for congruency, F(1,25) = 34.0, 
p< .001, η2 = 0.58 showed that more errors were made on incongruent than on 
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Non-Smokers Smokers
Percentage errors smoke incongruent 6.2 (2.6) 5.7 (4.0)
Percentage errors smoke congruent 3.8 (3.2) 4.0 (2.8)
Percentage errors neutral incongruent 5.7 (3.9) 7.2 (4.2)
Percentage errors neutral congruent 3.0 (1.9) 3.4 (2.9)
Reaction time smoke incongruent 390 (54) 376 (40)
Reaction time smoke congruent 381 (52) 362 (35)
Reaction time neutral incongruent 394 (53) 376 (42)
Reaction time neutral congruent 378 (52) 364 (35)
Reaction time correct trials 389 (57) 374 (37)
Reaction time incorrect trials 328 (55) 302 (51)
Reaction time post-correct trials 384 (52) 370 (37)
Reaction time post-incorrect trials 418 (62) 381 (44)
congruent trials (mean difference = 2.7%). No main effect of Picture was 
observed. There was no overall effect of Group on percentage of errors, neither 
an interaction effect including Group, suggesting similar percentage of errors 
between smokers and non-smokers regardless of Congruency and Picture 
type. 
 A main effect for Congruency, F(1,25) = 67.3, p< .001, η2 = 0.73 on 
reaction times, showed the expected effect that reaction times to incongruent 
trials were longer than to congruent trials (mean difference 13.23 ms). No main 
effect of Picture was observed. Also as expected, a main effect of Correctness 
showed that reaction times to incorrect trials were faster than reaction times to 
incorrect trials, F(1,25) = 42.0, p< .001, η2 = 0.63 (mean difference 66.65 ms). 
Furthermore, a main effect for Post-correctness, F(1,25) = 17.6, p< .001, η2 = 
0.41 showed that reaction times to trials following an incorrect trial were longer 
than reaction times to trials that followed a correct trial (mean difference 22.93 
ms). No main effect for Group was observed nor interactions between group 
and one or more of the within-factors Congruency, Picture and Correctness. 
However, a significant interaction effect of Group x Post-correctness, F(1,25) = 
4.4, p< .05, η2 = 0.15 was found. Post-hoc tests showed that the difference 
between post-incorrect and post-correct was significant for non-smokers, t(13) 
= 4.7, p< .001, but not for smokers. These results indicate that non-smokers 
adjusted their behavior after making an error by slowing down reaction times, 
whereas smokers did not. In addition, a negative correlation, r = -.40, p< 0.05, 
between post error slowing (defined as the difference between averaged reaction 
times for post error trials versus post correct trials) and the overall percentage of 
errors showed that post error slowing is related to more accurate task performance.
 
Event-related potentials
 
ERN
ERN and Pe amplitudes at the midline electrodes on correct and incorrect trials 
are displayed in figure 2. As expected, a significant main effect was found for 
Correctness F(1,25) = 120.14, p<.001, η2 = 0.83 on the ERN at the midline 
electrodes showing that ERN amplitudes were larger for incorrect trials than for 
correct trials. We also found a significant main effect for Electrode, F(2,50) = 
56.10, p< .001, η2 = 0.69. No main effect was found for Group. The Group x 
Correctness x Electrode interaction was not significant F(2,50) = 1.74, ns. The 
interaction effect for Electrode x Correctness was significant F(2,50) = 11.81, p= 
0.001, η2 = 0.32 and, most importantly, an interaction effect for Group x 
Correctness was found F(1,25) = 7.83, p= .01, η2 = 0.24. Post-hoc analysis 
indicated that the ERN to incorrect trials was significantly reduced in smokers as 
compared to non-smokers t(25) = 2.09, p< .05. Smokers and non-smokers did 
not differ on correct trials. 
 
Pe
As expected, a main effect for Correctness was found F(1,25) = 15.02, p= .001, 
η2 = 0.38 on the Pe amplitude, being larger for incorrect trials than for correct 
trials. No significant main effect was found for Electrode. A significant main effect 
of Group was found, F(1,25) = 8.82, p< .01, η2 = 0.26 which showed that 
smokers have overall lower Pe amplitudes. The Group x Correctness x Electrode 
interaction was not significant. Furthermore, the interaction effect for Electrode x 
Correctness was non significant. Importantly, the interaction effect for Group x 
Correctness was significant F(1,25) = 5.07, p< .05, η2 = 0.17. Post-hoc analysis 
indicated that the Pe to incorrect trials was significantly reduced in smokers as 
compared to non-smokers t(25) = 3.00, p< .01. Smokers and non-smokers did 
not differ on correct trials.
Table 1
Percentage errors and reaction times in milliseconds on the affective flanker task. Standard deviations 
are displayed in brackets
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Figure 2 
Grand-average response-locked waveforms at FCz, Cz, CPz of correct 
and incorrect responses for smokers and non-smoking controls
Correct Controls
Incorrect Controls
Correct Smokers
Incorrect Smokers
Figure 3 
Correlation between the mean amplitude of the Error Related Negativity for incorrect responses and self-reported trait 
impulsivity (left panel) and nicotine dependence levels (right panel).  
Note figure 3 * significant at the .05 level, ** significant at the .01 level.  
Note table 2 a Correlations includes smokers and non-smokers, b Correlations includes smokers only,  
c significant at the .05 level, d significant at the .01 level.
ERN incorrect trials ERN correct trials Pe incorrect trials Pe correct trials
Impulsivenessa r = .44c r = .04 r = -.09 r = 0.20
Nicotine Dependenceb r = .69d r = - .20 r = .19 r = .09
Cravingb r = .14 r = .23 r = -.03 r = .00
Table 2 
Correlations between Impulsiveness, Nicotine dependence, Craving and mean ERN and Pe responses over 
FCz, Cz and CPz (collapsed)
Error-processing in smokersChapter Three   
 
74 75
Correlations  
Correlations between ERN and Pe components with trait impulsivity, FTND 
scores and self-reported craving are displayed in table 2 and figure 3. Results 
show that reduced ERN amplitudes on incorrect trials across groups are as-
sociated with higher levels of impulsiveness, r = .44, p< .05, just like stronger 
nicotine dependence in smokers, r = .69, p<.01. Higher self-reported craving 
is not related to magnitude of ERN response. No significant correlations were 
found on Pe amplitudes.
Stimulus locked ERPs
Data analysis did not reveal any significant main effect of Group, or interaction 
effects including Group on stimulus locked ERP components including the N2, 
P3 and slow wave. 
 
Discussion
The current study showed behavioral and physiological evidence of reduced 
error-processing in smokers during a task in which participants were exposed to 
smoking cues. More specifically, this study showed reduced ERN and Pe 
amplitudes following incorrect responses and accompanied diminished post-
error slowing in smokers as compared to non-smoking controls. In addition, 
self-reported levels of impulsivity, which were higher in smokers, were 
associated with a reduced ERN across smokers and non-smokers. Moreover, 
higher nicotine dependence levels among smokers were also associated with 
smaller ERN responses. On the behavioral level, smokers showed less post-
error slowing than non-smoking controls suggesting that also behavioral 
adaptation (e.g., slowing down after an incorrect response in order prevent 
another error) is reduced in smokers. However, it must be noted that smokers 
and non-smokers made comparable numbers of errors. Both groups made 
more errors on incongruent trials and were faster to respond on error trials. 
Analyses of stimulus locked ERP waves further suggest that the findings of 
reduced error-processing in smokers are not influenced by an overall reduced 
cognitive ability that may arise as a result of possible withdrawal effects, as no 
differences between smokers and non-smokers were found on the stimulus 
locked ERPs. 
 Reduced error-processing in smokers is in line with previous ERP 
studies in cocaine users (Franken, et al. 2007; Franken, et al. 2010; Sokhadze, et 
al. 2008) and smokers (Franken, et al. 2010). Furthermore, several functional 
imaging studies show reduced activation in the ACC related to error-processing 
in various substance use disorder patients including opiate (Forman, et al. 
2004), cocaine (Kaufman, et al. 2003), cannabis (Hester, et al. 2009b), and 
methamphetamine (London, et al. 2005) abusers. As expected, we did find a 
reduced ERN in smokers, in contrast to a previous study of our lab (Franken, et 
al. 2010). A plausible explanation for this discrepancy is the exposure to smoking-
related cues during task performance in the current study. Unfortunately, this 
hypothesis could not directly been tested because participants made not 
enough errors to analyze error trials for smoking and neutral pictures separately. 
However, the idea that smoking cues influence the cognitive state of smokers is 
supported by the significant increase in craving for cigarettes following task 
performance. The current results, in combination with those of Franken et al. 
(2010), therefore suggest that fast and automatic error-processing may be 
specifically compromised in smokers when limited cognitive resources are 
available for error monitoring such as during exposure to smoking cues. Munro 
et al. (2007) found similar results related to psychopathy. Violent offenders 
showed reduced ERN amplitudes only during emotion recognition and not 
during a neutral task paradigm. However, findings of a study of Wiswede et al. 
(2009) offer an alternative explanation for the reduced ERN in smokers. 
Wiswede et al. found that ERN amplitudes in healthy controls are enlarged after 
viewing unpleasant pictures. It may be that the current sample of non-smoking 
controls considers the smoking pictures as unpleasant and consequently had 
larger ERN amplitudes than the smokers.
 The reduced Pe in smokers confirms the Franken et al. (2010) finding 
that the motivational significance attributed to an error may be diminished in 
smokers. It appears that smokers not only process their errors less intensely, 
they seem to be less worried by their mistakes. However, self-report studies are 
needed to confirm this finding. Furthermore, the Pe in the current study is, in 
contrast to the ERN, not correlated with trait impulsivity or nicotine dependence 
levels, which is in line with the idea that the Pe and ERN reflect independent 
processes (Overbeek, et al. 2005; Ridderinkhof, et al. 2009). 
 The finding in the current study that higher levels of self-reported trait 
impulsivity across groups are related to lower ERN amplitudes provides further 
evidence for the idea that personality traits may be associated with reduced 
error-processing. Ruchsow et al. (2006) demonstrated similar results in 
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borderline personality disorder patients. They showed reduced ERN amplitudes 
in borderline personality disorder patients and correlations with enhanced 
impulsivity and reduced ERN components. Studies performed in the normal 
population also confirm that high levels of impulsivity are related to lower ERN 
amplitudes (Potts, et al. 2006; Ruchsow, et al. 2005). These studies, together 
with the findings of the current study, provide evidence for the idea that 
impulsivity may explain reduced error-processing in smokers. Note, however, 
that enhanced impulsivity in smokers was found on self-reported trait impulsivity, 
while smokers did not show diminished impulse control on behavioral 
performance indices of the adapted Flanker task. This clearly suggests that 
although self-reported trait impulsivity and behavioral errors both reflect 
impulsivity, they tap different aspects of impulsivity (Alderson, et al. 2007; Van 
Mourik, et al. 2005). More research is needed to elucidate the discrepancy 
between self-reported and behavioral impulsivity. Furthermore, the current 
study design does not allow drawing conclusions on causality. It may be that 
impulsivity and reduced error-processing are a predisposition to start smoking, 
or that impulsive behavior, including smoking, contributes to diminished error-
processing. However, since the ERN in smokers in the current study also varied 
with the degree of nicotine dependence, an impulsive predisposition cannot 
fully explain diminished error-processing. Other characteristics specific for 
nicotine dependence may have a complementary effect on the deficit in error-
processing. A possible explanation for the association between the level of 
nicotine dependence and reduced ERN amplitudes is the compromised function 
of the dopaminergic system in the ventral striatum in addiction (Volkow, et al. 
2009). In either case, reduced error-processing undermines the ability to 
monitor ongoing behavior and may be related to the continuation of addiction-
related behaviors. 
 A limitation of the current study is the relatively small size of the 
samples, such that replication of the current results in larger groups of 
participants is essential. In addition, it must be kept in mind that the present 
smokers are relative young smokers in an early stage of smoking dependence. 
Although generalization to other categories of smokers is limited, the current 
sample of smokers can be considered heavy smokers within the student 
population of smokers (Berg, et al. 2010), which is further supported by 
moderate levels of FTND scores (Heatherton, et al. 1991). 
 To conclude, results of the current study showed reduced error-
processing in smokers both at the behavioral and physiological level. Decreased 
ERN and Pe amplitudes in smokers were accompanied by reduced post-error 
slowing. Furthermore, self-reported impulsivity levels were associated with 
reduced ERN amplitudes in smokers and non-smokers and nicotine dependence 
was associated with lower ERN amplitudes in smokers specifically. Together, 
these results suggest that both personality traits and specific nicotine dependent 
characteristics, such as a disturbed dopamine system, are associated with 
diminished error-processing. Since adequate error-processing is required to 
adapt behavior properly, reduced error-processing may contribute to the 
development and maintenance of addictive behaviors.
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Introduction
Several contemporary models of addiction highlight the role of impulsivity and 
executive functioning in the development and maintenance of addiction (Dawe, 
et al. 2004a; Feil, et al. 2010a; Field, et al. 2008; Goldstein, et al. 2002; Jentsch, 
et al. 1999; Olmstead 2006; Verdejo-Garcia, et al. 2008; Wiers, et al. 2007). A 
core component of executive functioning is response inhibition which is 
generally defined as the ability to adaptively suppress behavior when 
environmental contingences demand this (Groman, et al. 2009). It has been 
proposed that poor response inhibition in substance-dependent individuals is 
associated with difficulties to resist the consumption of a substance especially 
when exposed to highly salient substance-related cues (e.g., Dawe, et al. 2004a).
 Reduced response inhibition has been observed in several substances 
dependent patient populations including alcohol (Rubio, et al. 2008), cocaine 
(Fillmore, et al. 2002), and opioid (Fu, et al. 2008) dependent patients. Some 
studies have also investigated response inhibition in smokers. In these studies, 
inhibitory control was generally assessed by means of behavioral paradigms, 
such as Go/NoGo tasks. In the Go/NoGo task, participants have to respond as 
quickly as possible to frequently occurring ‘Go’ stimuli, and to inhibit responses 
to infrequent ‘NoGo’ stimuli. Results of studies on response inhibition in smokers 
have been inconsistent. That is, some studies have found response inhibition 
during a Go/NoGo task to be impaired in smokers relative to controls (Spinella 
2002) whereas other studies did not find this group difference in performance 
on the Go/NoGo task (Dinn, et al. 2004), nor on other behavioral tasks measuring 
response inhibition (Monterosso, et al. 2005; Reynolds, et al. 2007). The 
recording of electroencephalographic (EEG) activity during response inhibition 
has been suggested to yield more sensitive indices (i.e., event-related potentials, 
ERPs) of response inhibition and may therefore clarify the inconsistent results. 
Two major ERP components have been reported to be enhanced for NoGo 
trials as compared to Go trials suggesting that these reflect changes in brain 
activity related to response inhibition in a Go/NoGo task. The first of these ERP-
components is the NoGo N2 which is a negative wave that emerges 
approximately 200-300 ms after stimulus presentation and has maximum 
peaks on frontal scalp sites. Mounting evidence suggests that the NoGo N2 
amplitude is a valuable measure for response inhibition. The NoGo N2 amplitude 
has been consistently found to be related to behavioral outcomes of inhibitory 
control on Go/NoGo tasks (Falkenstein, et al. 1999) irrespective of the stimulus 
modality used in these tasks (Kaiser, et al. 2006; Nakata, et al. 2004). Although, 
Go and NoGo trials differ with respect to the overt motor response, which could 
Abstract
Introduction The role of inhibitory control in addictive behaviors is highlighted in 
several models of addictive behaviors. Although reduced inhibitory control has 
been observed in addictive behaviors, it is inconclusive whether this is evident in 
smokers. Furthermore, it has been proposed that drug abuse individuals with 
poor response inhibition may experience greater difficulties not consuming 
substances in the presence of drug cues. The major aim of the current study was 
to provide electrophysiological evidence for reduced inhibitory control in smokers 
and to investigate whether this is more pronounced during smoking cue exposure.
Methods Participants (19 smokers and 20 non-smoking controls) performed a 
smoking Go/NoGo task. Behavioral accuracy and amplitudes of the N2 and P3 
event-related potential (ERP), both reflecting aspects of response inhibition, 
were the main variables of interest.
Results Reduced NoGo N2 amplitudes in smokers relative to controls were 
accompanied by decreased task performance, whereas no differences between 
groups were found in P3 amplitudes. This was found to represent a general lack 
of inhibition in smokers, and not dependent on the presence of smoking cues.
Conclusions The current results suggest that smokers have difficulties with 
response inhibition, which is an important finding that eventually can be 
implemented in smoking cessation programs. More research is needed to clarify 
the exact role of cue exposure on response inhibition.
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influence the difference between Go and NoGo N2 amplitudes, it has been 
found that the NoGo N2 is not restricted to tasks requiring these overt motor 
responses (Burle, et al. 2004), furthermore a modulation of the N2 ERP by 
response inhibition requirements has been observed in other inhibition-related 
paradigms besides the Go/NoGo task (Dimoska, et al. 2006; Heil, et al. 2000; 
Kopp, et al. 1996). 
 The second ERP component that has been associated with response 
inhibition research, is the NoGo P3 which is a positive wave that emerges circa 
300-500 ms after stimulus onset and has a more central distribution. There are 
some concerns about the exact role or meaning of P3 amplitudes in response 
inhibition processes (Falkenstein, et al. 1999; Smith, et al. 2008). In contrast to 
the NoGo N2, the NoGo P3 does not seem to be consistently related to response 
inhibition on a behavioral level. However, some studies show a clear relationship 
between NoGo P3 amplitude and behavioral outcomes of response inhibition 
tasks (Bruin, et al. 2002; Burle, et al. 2004). Moreover, because the P3 is a rather 
late ERP-component (> 300 ms) it has been suggested that it does not reflect 
the initial reflexive stage of the inhibition process but rather a later stage of the 
inhibition process that is closely related to the actual inhibition of the motor 
system in the premotor cortex (Dimoska, et al. 2006; Kok, et al. 2004). In any 
event, both decreased NoGo P3 and N2 amplitudes have been reported in 
various populations with reduced inhibitory control such as children with ADHD 
(Johnstone, et al. 2009; Smith, et al. 2004) and impulsive violent offenders 
(Chen, et al. 2005) suggesting that both ERP components are adequate indices 
of inhibitory processes in impulsive populations.
 Few studies have used ERPs to investigate response inhibition with ERPs 
in substance-dependent patients (Evans, et al. 2009; Gamma, et al. 2005; 
Kamarajan, et al. 2005; Pfefferbaum, et al. 1987; Yang, et al. 2009) and, to our 
knowledge, only one of these studies has focused on smokers (Evans, et al. 2009). 
Remarkably, with the exception of the study by Yang et al. (2009), analyses of all 
these studies were confined to the P3 amplitude whereas studies in other 
psychiatric populations have usually investigated both the N2 and P3 amplitudes 
(Chen, et al. 2005; Johnstone, et al. 2009; Kaiser, et al. 2003; Kiehl, et al. 2000; Kim, 
et al. 2007; Ruchsow, et al. 2007; Ruchsow, et al. 2008a; Ruchsow, et al. 2008b; 
Smith, et al. 2004). ERP studies investigating response inhibition in substance-
dependent patients have generally found NoGo P3 amplitudes to be reduced 
(Evans, et al. 2009; Gamma, et al. 2005; Kamarajan, et al. 2005) as compared to 
healthy controls. However, in heroin patients only the NoGo N2 amplitude appeared 
to be reduced; no differences were found on the NoGo P3 (Yang, et al. 2009).
 All the above-mentioned studies investigated general response 
inhibition in addicted individuals by using affectively neutral task paradigms. It 
has been proposed, however, that the reactivity to conditioned drug-related 
stimuli and processes of executive functioning may impact each other in a 
synergistic way (Dawe, et al. 2004a; Jentsch, et al. 1999). This means that 
persons with a stronger reactivity towards drug-related cues may experience 
more problems with inhibiting their behavior. Over the course of addiction drug-
related stimuli become extremely attractive to the addicted person and tend to 
grab the attention (i.e., attentional bias: Field, et al. 2008; Franken 2003). A 
recent study demonstrated that participants’ attentional bias for alcohol-related 
words was positively correlated with reduced inhibitory control in decision-
making, particularly when the decisions were related to obtaining alcohol (Field, 
et al. 2007). Altogether, a reciprocal relation between the attention grabbing 
properties of drug cues and inhibitory control has been proposed suggesting 
that decreased inhibitory control may be more enhanced during direct exposure 
to drug-related stimuli (Field, et al. 2008). 
 To test the idea that inhibitory control in substance-dependent 
individuals is particularly impaired in the presence of substance-related cues, 
the current study investigated response inhibition to both neutral and smoking-
related cues in smokers and non-smoking controls. For this purpose a novel Go/
NoGo paradigm was developed including smoking and neutral pictures. It is 
expected that smokers will generally show reduced response inhibition as 
compared to non-smoking controls. More specifically, on a behavioral level, it is 
expected that smokers will make more mistakes when they have to inhibit their 
response to infrequent NoGo stimuli. On an electrophysiological level we expect 
that N2 and P3 amplitudes during NoGo trials will be decreased in smokers as 
compared to non-smokers. Finally, we expect these effects to be more 
pronounced on trials which include smoking-related stimuli.
Materials and Methods
Participants
Nineteen smokers (mean age = 21.36 years, SD = 1.98, 14 male) and 20 non-
smoking controls (mean age = 21.55 years, SD = 2.18, 14 male) participated in 
this study. Exclusion criteria were (a) the current abuse of a substance (other 
than nicotine for the smoking group), and (b) the current presence of a physical 
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picture was presented for four times during the whole task, once as a NoGo 
stimulus and three times as a Go stimulus. This means that 25% of all trials were 
NoGo trials and that the proportion of smoking and non-smoking pictures in the 
task was equal (i.e., 112 NoGo trials per picture category and 336 Go trials per 
picture category). The order of picture content (smoking versus neutral) was 
completely randomized and the order of trial type (Go versus NoGo) was quasi 
randomized such that at most four Go and two NoGo trials were presented 
consecutively. Before the start of the actual task, participants were given to 
opportunity to practice in 23 practice trials, involving additional non-smoking 
pictures. At four time moments during the task, participants were given the 
opportunity to take a short break. Total task duration was about 22 minutes, 
depending on the length of the breaks. 
 
Procedure
Smokers were instructed to abstain from smoking for at least one hour before 
the start of the experiment. This short period of smoking deprivation was 
introduced in order to reduce the acute effects of nicotine on ERP amplitudes 
(Houlihan, et al. 1996; Houlihan, et al. 2001) without introducing withdrawal 
effects. Participants approved participation by signing informed consent. The 
CO breath sample was taken and questionnaires were completed. Subsequently, 
participants were seated in a comfortable EEG chair in a light and sound-
attenuated room. Electrodes were attached and task instructions were 
explained. Participants performed the smoking Go/NoGo tasks during EEG 
recording. Smokers completed the QSU-brief a second time at the end of the 
experiment. 
or psychiatric illness. There were no significant differences between the groups 
in mean age, t(37) = .27; ns, or gender ratio, χ2 (1, n = 39) = .07; ns. Smokers 
smoked at least 10 cigarettes per day (M = 17.95, SD = 5.88; range 10-30) for a 
duration of at least two years (M = 5.74, SD = 3.53, range = 2-17). Fagerström 
scores (FTND) were suggestive of medium levels of nicotine dependence, M = 
5.05, SD = 2.27, range = 0-8 (Heatherton, et al. 1991; Vink, et al. 2005). Non-
smokers had smoked ten or less cigarettes in their lifetime (M = 1.22, SD = 
2.34, range = 0-10). Participants were undergraduate students, who received 
course credits or a financial compensation for their participation. The study was 
conducted in accordance with the Declaration of Helsinki and all procedures 
were carried out with the adequate understanding and written informed consent 
of the subjects. The study protocol was approved by the Ethics Committee of 
the Institute of Psychology of the Erasmus University Rotterdam. 
Instruments
Breath carbon monoxide concentration was measured using a Micro+ 
Smokerlyzer (Bedfort Scientific Ltd., Rochester, UK) in order to objectively 
identify smokers and non-smokers. Next to the FTND, smokers also completed 
the brief version of the Questionnaire of Smoking Urges (QSU, Cox, et al. 2001) 
to assess their subjective craving for a cigarette.
Task paradigm
A smoking-related Go/NoGo task was developed for the aim of the current 
study. In this task participants were presented with a series of pictorial stimuli 
with a smoking or non-smoking-related content. Each picture was displayed for 
200 ms and had a blue or yellow frame (see figure 1 for an example of a smoking 
and non-smoking trial). The frame color indicated whether a stimulus was a Go 
or a NoGo trial. The attribution of the frame color to Go versus NoGo trials was 
counterbalanced across participants. Each stimulus was followed by a black 
screen for a randomly varying duration between 1020 ms and 1220 ms. 
Participants were instructed to respond to the pictures in Go trials by pressing a 
button with the right index finger as fast as possible, and to withhold their 
response in the NoGo trials. They were explicitly instructed to maintain accuracy 
during the whole task. The task consisted of 112 different smoking-related 
pictures and 112 non-smoking-related pictures. Smoking-related pictures 
displayed smoking related objects (e.g., lighter, ashtray etc.) or scenes of people 
engaged in smoking behavior, whereas non-smoking-related pictures displayed 
neutral items or scenes of people engaged in non-smoking behavior. Each 
Figure 1 
Example of a Go and NoGo trial combined with a smoking and a neutral pictures in the 
smoking cue Go/NoGo task
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EEG recording and data reduction
The EEG was recorded using the Biosemi Active-Two amplifier system (Biosemi, 
Amsterdam, the Netherlands) from 34 scalp sites (positioned following the 10-
20 International System with two additional electrodes at FCz and CPz) with 
active Ag/AgCl electrodes mounted in an elastic cap. Six additional electrodes 
were attached to the left and right mastoids, to the two outer canthi of both eyes 
(HEOG), and to an infraorbital and a supraorbital region of the right eye (VEOG). 
All signals were digitalized with a sample rate of 512 Hz and 24-bit A/D 
conversion with a bandpass of 0-134 Hz. Data were off-line re-referenced to 
computed mastoids. Off-line, EEG and EOG activity was filtered with a bandpass 
of 0.10-30 Hz (phase shift-free Butterworth filters; 24dB/octave slope). Data 
were segmented in epochs of 1 second (200ms before and 800ms after 
response or stimulus presentations). After ocular correction (Gratton, et al. 
1983) epochs including an EEG signal exceeding ± 75 μV were excluded from 
the average. The mean 200 ms pre-response or pre-stimulus period served as 
baseline. After baseline correction, average ERP waves were calculated for 
artifact-free trials at each scalp site for correct and incorrect responses 
separately. Segments with incorrect responses (miss for GO trials or false alarm 
for NoGo trials) were excluded from EEG analyses. The N2 was defined as the 
most negative value within the 200-300 ms time interval after stimulus onset 
and was studied at a cluster of frontocentral electrodes, including Fz, FC1, FC2, 
FCz and Cz (Kiefer, et al. 1998). The P3 was defined as the most positive value 
within the 300-500 ms time interval after stimulus onset. The P3 was studied at 
a cluster of central electrodes, including FCz, Cz, C3, C4 and CPz (Kiefer, et al. 
1998). The mean number of analyzable Go and NoGo epochs for smoking 
pictures was 248.50 and 56.00 respectively and 250.57 and 55.26 for non-
smoking pictures. One non-smoker was excluded from ERP analyses because 
of less than 10 artifact free ERP epochs in at least one of the task conditions. 
This participant was included in all remaining data analyses. 
 
Statistical analysis
The difference in self-reported craving before and after task performance was 
analyzed by means of a paired samples t-test. Repeated Measures Analyses of 
Variance (RM-ANOVA; with Greenhouse-Geisser adjusted p-values) were 
applied to analyze behavioral outcomes of performance on the Go/NoGo task, 
as well as ERP indices of response inhibition. The between-subjects factor in all 
RM-ANOVA’s was Group (smokers versus non-smokers). Two-level within-
subject factors were of interest, namely (a) Inhibition (Go versus NoGo), and (b) 
Picture (smoking versus non-smoking pictures). A Group x Inhibition x Picture 
RM-ANOVA was employed to analyze the behavioral accuracy during the 
Go/NoGo task, and a Group x Picture RM-ANOVA was chosen to analyze 
reaction times in Go trials. Electrode (Fz, FC1, FC2, FCz, Cz for N2 and FCz, Cz, 
C3, C4, and CPz for P3) was included as a five-level within subject factor in the 
ERP analyses. That is, a Group x Inhibition x Picture x Electrode RM-ANOVA was 
performed for the ERP analyses. Post-hoc tests for interactions were performed 
only for interactions including the between subject factor Group. A Bonferroni 
correction for multiple comparisons was applied in all post-hoc analyses. Finally, 
Spearman correlation coefficients were calculated for the number of cigarettes 
per day on the one hand and NoGo accuracy rates and average cluster peaks 
across all electrodes for the NoGo N2 and P3 on the other hand. 
 
Results
Breath CO levels and questionnaires
In line with expectancies, smokers had a higher breath concentration of carbon 
monoxide (CO; in parts per million, M = 12.89, SD = 7.15) as compared to non-
smoking controls (M = 1.15, SD = 1.04), t(37) = 7.27, p< 0.001. Subjective 
craving in smokers increased significantly from the start (M = 37.53, SD = 
10.02) to the end (M = 46.05, SD = 9.79) of the experiment, t(18) = 4.35, 
p< .001. 
Behavioral data
The accuracy rates for both the smoking and non-smoking group on the 
smoking-related Go/NoGo task are displayed in figure 2. A robust main effect of 
Inhibition was found, F(1,37) = 184.55, p< 0.001 showing that participants were 
less accurate on NoGo trials (69.63% versus 96.86% respectively). There was 
also a main effect for Group, F(1,37) = 4.12, p= .05, which indicated that overall 
task performance was less accurate in smokers than in non-smoking controls 
(80.47% 86.03%, respectively). A trend to significance was found for the Group 
x Inhibition interaction, F(1,37) = 3.27, p= 0.08. Post-hoc t-tests revealed that, 
particularly on NoGo trials, smokers performed less accurate than non-smoking 
controls (p= 0.05; 65.05% versus. 74.23 %), whereas there was no difference 
on accuracy between the groups for Go trials. No main or interaction effects of 
Picture were found for accuracy of responding. We additionally performed two 
separate RM-ANOVA’s for Go and NoGo accuracy scores because of differences 
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in the distribution for Go and NoGo accuracy which may lead to subsequent 
differences in the magnitude of effects for Go and NoGo accuracy. Results 
showed the same pattern as the combined analysis. A main effect for Group was 
found for NoGo accuracy. F(1,37) = 4.02, p= 0.05 confirming that smokers 
were less accurate than controls on NoGo trials. No difference on accuracy 
between groups was found for Go trials. No main or interaction effects of Picture 
were found for accuracy of responding in either NoGo or Go trials. 
 With regard to the reaction time data, a main effect of Picture was 
found, F(1,37) = 6.28, p< .05 indicating that participants generally responded 
faster to smoking-related Go trials than to neutral Go trials (M = 259.69 ms 
versus M = 261.89 ms). No other significant effects were found for reaction 
times. No significant correlations were found between the number of cigarettes 
smoked per day and accuracy rates for NoGo trials.
N2 amplitudes
The N2 amplitude for smoking-related and neutral pictures in both groups is 
displayed in figure 3. In line with the hypotheses, a robust main effect was found 
for Inhibition, F(1,36) = 36.83, p<.001 on the N2 component at the frontocentral 
electrode cluster. This result demonstrates that N2 amplitudes were generally 
Figure 2 
Accuracy rates in smokers and non-smoking controls on the smoking cue Go/NoGo task
Figure 3 
Grand-average stimulus-locked waveforms for neutral and smoking pictures at Fz for correct Go and 
NoGo trials in smokers and non-smoking controls 
Figure 4 
Grand-average stimulus-locked waveforms for neutral and smoking pictures at Cz for correct Go and 
NoGo trials in smokers and non-smoking controls
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larger for NoGo trials than for Go trials. Importantly, a Group x Inhibition 
interaction effect was found, F(1,36) = 6.31, p= .017. Post-hoc t-tests indicated 
that only on NoGo trials the N2 was significantly reduced in smokers as 
compared to non-smoking controls (p= .046), whereas there were no between-
group differences on N2 amplitude in response to Go trials. Furthermore, a 
main effect for electrode was found, F(4,144) = 25.67, p<.001. No Picture-
related main or interaction effects were found for the N2 component. No 
significant correlations were found between the number of cigarettes smoked 
per day and the cluster combined N2 peak amplitudes for NoGo trials.
 
P3 amplitudes
Figure 4 shows the P3 amplitudes for smoking and neutral pictures in both 
groups. As expected for the P3 at the central electrode cluster, a robust main 
effect was found for Inhibition, F(1,36) = 138.85, p<.001. This result indicates 
that the P3 peaks were generally larger for NoGo trials than for Go trials. 
Furthermore, a main effect for electrode was found, F(4,144) = 18.73, p<.001. 
No other significant main or interaction effects including Group were found for 
P3 amplitude. No significant correlations were found between the number of 
cigarettes smoked per day and the cluster combined P3 peak amplitudes for 
NoGo trials.
Discussion
The main purpose of the present study was to investigate differences in 
response inhibition on a behavioral as well as on an electrophysiological level 
using a smoking-modified Go/NoGo paradigm in combination with the recording 
of event-related potentials. Consistent with the notion that the N2 reflects an 
inhibitory process, the N2 was significantly enhanced on NoGo trials as 
compared to Go trials. More importantly and in line with our primary hypothesis 
differences between smokers and non-smokers were found on both behavioral 
and electrophysiological indices of response inhibition. That is, performance on 
the Go/NoGo task was generally less accurate in smokers than non-smokers in 
such that smokers displayed significantly more difficulties to inhibit their 
responses in NoGo trials. This deficit in general response inhibition was also 
reflected in reduced N2 amplitudes in NoGo trials in smokers as compared to 
non-smokers. 
 Previous studies on inhibitory control in smokers, which used 
behavioral paradigms, such as the Go/NoGo task generally yielded inconsistent 
results (Dinn, et al. 2004; Monterosso, et al. 2005; Reynolds, et al. 2007; 
Spinella 2002). The difficulty level of the task of the current study, however, 
was different than previous studies. The Go/NoGo task that was used in the 
present study placed high demands on inhibition capacities because stimulus 
presentation was fast and NoGo trials were infrequent. This is supported by the 
fact that 31.4% of the NoGo trials resulted in commission errors in the current 
study while this is usually much lower (e.g., 5% percent in Dinn et al. 2004). In 
addition, the present study was the very first to include the N2 component as 
an additional index of inhibitory control in smokers. The NoGo N2 amplitude is 
an index of response inhibition which is believed to be more sensitive than 
behavioral outcomes in the Go/NoGo paradigm (Falkenstein 2006; Nakata, et 
al. 2006). The fact that reduced inhibitory control was found in behavioral 
accuracy as well on the N2 component of the ERP provides support for the 
hypothesis that there is a general shortcoming in response inhibition in smokers 
relative to non-smokers. It must be noted, however, that the current study 
design does not allow drawing conclusions on causality. It may be that reduced 
inhibitory control is the result of prolonged nicotine dependence, for example 
via abnormalities in the dopamine system, or that reduced inhibitory control is 
a predisposition to start smoking. The latter interpretation may be more 
convincing according to the results of the current study because of the lack of 
association between measures of inhibitory control and nicotine exposure (i.e., 
the number of cigarettes smoked per day). This association could be expected 
if reduced inhibitory control is the result of a modulation of brain systems by 
nicotine intake. 
 With regard to P3, enlarged amplitudes in NoGo trials than Go trials 
were observed confirming that, like the N2 amplitude, P3 amplitude is related 
to response inhibition processes. However, contrary to N2 and behavioral 
accuracy, no differences between groups were found in NoGo P3 amplitude. It 
has been suggested that, whereas the NoGo N2 might be related to an early 
stage of the response inhibition process, the NoGo P3 might reflect a later 
stage of the inhibition process that is closely related to the actual inhibition of 
the motor system (Kok, et al. 2004). Accordingly, the present study results 
suggest that the reduced inhibitory control in smokers reflect a dysfunctional 
activation of inhibitory processes at an early stage of cortical processing while 
later stages of the inhibition process may be intact. This is in line with findings 
in heroin dependent patients (Yang, et al. 2009) but in contrast to previous 
findings in alcohol dependent patients (Kamarajan, et al. 2005), ecstasy 
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polydrug users (Gamma, et al. 2005) and smokers (Evans, et al. 2009). 
Unfortunately, the latter studies did not investigate N2 amplitudes making 
complete comparisons with the present study impossible. Furthermore, the 
diverse characteristics of the Go/NoGo paradigms used in these studies might 
have contributed to differential findings (Kamarajan, et al. 2005). For example, 
the probability of NoGo trials, and thereby the demand on response inhibition 
capacities, varies largely among these ERP studies just as in the studies 
investigating behavioral accuracy. Furthermore, it is not clear whether previous 
studies separated successful and unsuccessful trials in examining P3 
amplitudes which is important because P3 amplitudes are influenced by 
inhibition success or failure (Kok, et al. 2004). 
 The present study was the first that investigated not only general 
response inhibition in smokers, but specific response inhibition towards 
smoking-related stimuli as well. Several authors suggest that inhibitory control 
in substance-dependent individuals is especially reduced when exposed to 
drug-related cues and that this eventually may contribute to compulsive cue-
elicited drug intake (Dawe, et al. 2004b; Field, et al. 2008; Jentsch, et al. 1999). 
The findings in the current study could not confirm that reduced inhibitory 
control in smokers is more pronounced in the presence of smoking cues. In 
fact, the current findings show that inhibitory control is reduced in smokers 
during smoking cue exposure and during neutral affective conditions 
suggesting that these deficits found in smokers are of a more general category, 
which may be in favor of the diagnostic value and theoretical importance of the 
Go/NoGo task paradigm. Furthermore, these results imply that decreased 
inhibitory control may not only influence smoking-related behavior but also 
other impulsive and possibly maladaptive behaviors. This idea is supported by 
the high proportion of smokers in, for example, conduct disorder (Bagot, et al. 
2007) and problem gambling (Verdejo-Garcia, et al. 2008). However, the 
influence of drug cue-exposure on levels of inhibitory control should be further 
investigated in future studies. Possibly, the overall reduced inhibitory capacity 
of smokers, which was observed in the present study, reflects a general effect 
of nicotine craving. That is, controlling the craving elicited by the smoking-
related pictures during the task might have required cognitive resources 
(Tiffany 1999) which might have resulted in an overall reduced inhibitory 
capacity. In the present study, smokers reported significantly increased craving 
after task performance as compared to before showing that smokers had to 
deal with increasing levels of craving evoked by the smoking-related pictures 
used in the Go/NoGo task. One way to examine if craving has a general effect 
on performance of the smoking-modified Go/NoGo paradigm, could be to 
present the stimuli to participants in a blocked design, with one block of neutral 
pictures being presented first, followed by a block of smoking-related pictures 
to measure response inhibition under low and high conditions of craving 
separately.
 In conclusion, results of the current study showed reduced inhibitory 
control in smokers both at behavioral and physiological measures. Decreased 
N2 amplitudes for NoGo trials were accompanied by reduced accuracy for 
NoGo trials. However, the hypothesis that reduced response inhibition would be 
more pronounced for smoking-related cues could not be confirmed. These 
results suggest that smokers have difficulties with inhibitory control, which 
might be an important factor in the initiation and continuation of smoking 
behaviors as well as relapse in smoking behaviors. These findings can eventually 
be implemented in smoking cessation programs. 
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Introduction
Reduced cognitive control has been identified as one of the key mechanisms 
contributing to addictive behaviors (Dawe, et al. 2004a; Goldstein, et al. 2011; 
Jentsch, et al. 1999; Verdejo-Garcia, et al. 2008). Previous studies have shown 
that smokers, as well as other addicted groups, show poor inhibitory control 
(e.g., Kaufman, et al. 2003; Luijten, et al. 2011a; Nestor, et al. 2011). Poor 
inhibitory control refers to the decreased ability to suppress automatic and 
habitual behaviors. Research examining the neural mechanisms underlying 
decreased inhibitory control in smokers has shown dysfunctional cortical 
activity in regions critically involved in inhibitory control, such as the inferior 
frontal gyrus (IFG), the dorsolateral prefrontal cortex (DLPFC), the anterior 
cingulate cortex / pre-supplementary motor area (ACC / pre-SMA) and the 
anterior insula (De Ruiter, et al. 2012; Nestor, et al. 2011). Reduced inhibitory 
control as a consequence of impaired prefrontal brain function may be especially 
problematic when habitual and rigid behavioral patterns require alteration, such 
as during an attempt to give up smoking. Difficulties inhibiting substance-related 
behaviors may be the result of the preference for an immediate small reward 
relative to a larger delayed reward (Reynolds 2006) or may be the result of 
insensitivity to punishment (Vanderschuren, et al. 2004). However, the neural 
mechanisms that contribute to reduced inhibitory control in substance 
dependent humans have not been investigated as yet. Therefore, the current 
study examined whether enhanced reward sensitivity and/or reduced 
punishment sensitivity is associated with reduced inhibitory control in smokers.
 The preference for smaller immediate rewards over larger delayed 
rewards has consistently been found in addicted individuals and is referred to as 
increased delayed discounting (Bickel, et al. 2001; Hoffman, et al. 2008; Petry 
2002; Reynolds 2006; Sheffer, et al. 2012). Increased discounting of delayed 
rewards implicates that the extent to which outcomes influence the effectiveness 
to control behavior decreases to a larger extent in addicted individuals as a 
function of the delay to their occurrence (Reynolds 2006). Decreased delay 
discounting in smokers has been associated with higher smoking rates (Heyman, 
et al. 2006) and unsuccessful quit attempts (Sheffer, et al. 2012). In line with 
addiction theories, it is likely that persons with heightened reward sensitivity for 
the substance of abuse will experience stronger prepotent approach tendencies 
and these would require greater levels of cognitive inhibition (Dawe, et al. 
2004a; Goldstein, et al. 2002; Volkow, et al. 2004). Thus far, research examining 
inhibitory control in substance use typically employed Go/NoGo and Stop 
Signal tasks involving neutral, rather than rewarding stimuli. A few studies in 
Abstract
Difficulties inhibiting substance related behaviors may be the result of the 
preference for an immediate small reward relative to a larger delayed reward or 
may be the result of insensitivity to punishment. The current fMRI study examined 
the neural basis of inhibiting an immediately rewarding stimulus in order to obtain 
a larger delayed reward in smokers and non-smoking controls. We also 
investigated whether punishment insensitivity contributed to deficient inhibitory 
control. The Monetary Incentive Go/NoGo task was administered that provided 
three types of reward outcomes contingent on inhibitory control performance 
over rewarding stimuli: inhibition failure was either followed by no monetary 
reward (neutral condition), a small monetary reward with immediate feedback 
(reward condition) or immediate monetary punishment (punishment condition). 
In the reward and punishment conditions, successful inhibitory control resulted in 
larger delayed rewards. Nineteen smokers were compared with seventeen 
demographically matched non-smoking controls. Results showed that smokers 
had hyperactivation in the pre-SMA, right anterior insula, right IFG/MFG and 
right DLPFC both during inhibition of an immediately rewarding stimulus in order 
to obtain a larger delayed reward, and during inhibition of neutral stimuli. Group 
differences in brain activity were no longer significant in the punishment condition, 
most likely as a result of increased activation in non-smoking controls. The 
current results suggest that smokers need additional neural resources to inhibit 
rewarding stimuli and provide tentative evidence that smokers are less sensitive 
to punishment as a strategy to guide control over rewarding stimuli. 
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smokers, however, have investigated control over craving evoked by smoking-
related pictures or videos. Although this may represent a slightly different 
process compared to inhibitory control measured using Go/NoGo and Stop 
Signal tasks, these studies may provide clues about the neural mechanism 
underlying the inhibition of rewarding stimuli. For example, Kober and colleagues 
(2010) showed that inhibition of craving is associated with increased activation 
in regions implicated in inhibitory control, such as the right inferior frontal gyrus, 
while reductions in activity were reported in reward-related areas such as the 
striatum. Similarly, increased dorsal ACC and decreased activation bilaterally in 
the cuneus and occipital gyrus was found in another study in which smokers 
were instructed to resist craving during exposure to smoking-cues (Brody, et al. 
2007). These studies suggest that applying control over reward-related stimuli 
may be associated with changes in the balance between prefrontal control 
regions and subcortical regions, as well as brain regions involved in visual 
processing. The current study examined whether inhibition of an immediately 
rewarding stimulus over a larger delayed reward also requires additional 
recruitment of control regions, consistent with the patterns of activation reported 
for the suppression of craving evoked by drug-related stimuli.
 Punishment insensitivity in addicted individuals may be another factor 
contributing to deficient inhibitory control (Vanderschuren, et al. 2004). 
Although this is a relatively unexplored area, reduced sensitivity to punishment 
in behavioral performance has been shown in addicted individuals (Bechara et 
al., 2002; Ersche et al., 2005; Fridberg et al., 2010; Goudriaan et al., 2008; Grant 
et al., 2000). Neuroimaging studies of drug dependent patients have also shown 
a diminished neural response to monetary loss (Beck et al., 2009; Bjork et al., 
2008a; Bjork et al., 2008b; Wrase et al., 2007), in both sub-cortical ‘limbic’ 
regions including the striatum as well as cortical regions such as the anterior 
cingulate cortices. In addition, a recent fMRI study in smokers showed reduced 
activity in the ventrolateral prefrontal cortex when compared to healthy controls 
during punishment trials of a reversal learning task (De Ruiter, et al. 2009). 
These studies have typically not examined the consequences of such a reduced 
loss-response to the ability to control behavior (Hommer et al., 2011). Importantly, 
preclinical research in rats showed that with extended cocaine self-administration 
the rats develop resistance to the inhibitory effect of punishment on drug self-
administration, while punishment stimulated the inhibition of drug self-
administration in rats without a history of extended self-administration of 
cocaine (Pelloux, et al. 2007; Vanderschuren, et al. 2004; Xue, et al. 2012). Thus, 
reduced punishment sensitivity may be a critical factor contributing to 
unsuccessful control over drug use.
 To examine the effect of reward and punishment on brain activation 
associated with inhibitory control, a modified version of the Go/NoGo response-
inhibition paradigm (i.e., the Monetary Incentive Go/NoGo task) was 
administered to smokers and non-smoking controls. This task was designed to 
examine neural activity during attempts to inhibit a prepotent response to a 
rewarding NoGo stimulus. To mimic the reward scenario present during an 
abstinence intervention, the following contingencies were introduced to 
participants: First, NoGo stimuli were assigned that had been employed in the 
previous block as a monetary reward Go stimulus. Second, in the reward 
condition of the task, failed inhibitory control over NoGo trials resulted in small 
immediate monetary rewards, while in the punishment condition failure to inhibit 
resulted in immediate money loss. Successful inhibitory control over NoGo 
trials in both reward and punishment conditions resulted in a larger reward 
(calculated using the sum of the longest consecutive run of correct inhibitions). 
Finally, the task also involved NoGo trials without any rewarding or punishing 
contingencies, to be able to compare inhibitory control over rewarding NoGo 
trials under immediate reward and punishment conditions to an effectively 
neutral condition. In line with the above-mentioned addiction theories, we 
hypothesized that smokers would have significantly greater difficulty inhibiting 
their response to a rewarding stimulus when compared to matched control 
participants, neutral conditions or both. With regard to punishment sensitivity, 
we expected that non-smoking controls would adopt a more cautious responding 
style when failed inhibition resulted in an immediate punishment, while this was 
not expected to influence behavior to the same extent in smokers.
Materials and Methods
Participants
Nineteen smokers (mean age = 26.89 years, SD = 8.11, 6 male) and seventeen 
non-smoking controls (mean age = 27.47 years, SD = 7.79, 7 male) participated 
in this study. There were no significant differences between the groups in mean 
age, t(34) = 0.22; ns, estimated IQ (National Adult Reading Test: Nelson 1982), 
t(26) = 0.97, ns, Msmokers = 114.72, SDsmokers = 5.00, Mcontrols = 114.80, 
SDcontrols = 7.67, and gender ratio, χ2 (1, n = 36) = 0.55; ns. Exclusion criteria 
for both groups were (a) current substance abuse or dependence (other than 
nicotine for the smoking group), (b) the current presence of any physical or 
psychological illness, (c) any use of psychotropic medication or medication that 
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may affect blood circulation and/or respiration, (d) fMRI contraindications, and 
(e) left-handedness (as determined by the Edinburgh Handedness Inventory, 
(Oldfield 1971). Smokers smoked at least 15 cigarettes per day (M = 18.95, SD 
= 4.40; range 15-30) for a duration of at least two years (M = 9.19, SD = 4.61, 
range = 2.5-25). The average score on the Fagerström Test for Nicotine 
Dependence (FTND: Heatherton, et al. 1991) for smokers was 3.79, SD = 2.10, 
range = 1-8. Non-smokers had smoked ten cigarettes or less during their 
lifetime. Smokers were instructed to abstain from smoking for one hour before 
the experiment. This short period of smoking deprivation was introduced in 
order to reduce the acute effects of nicotine on cognitive performance without 
introducing significant withdrawal effects on cognitive performance. The study 
was conducted in accordance with the Declaration of Helsinki and all procedures 
were carried out with the adequate understanding and written informed consent 
of the subjects. The ethics committee of the Melbourne School of Psychology 
– The University of Melbourne approved this study.
 
Task paradigm
Participants completed the Monetary Incentive Go/NoGo (MI-Go/NoGo) task 
(see figure 1) that consisted of 8 separate blocks. A similar version of the 
MI-Go/NoGo task has previously been described elsewhere (O’Connor, et al. in 
press; Rossiter, et al. 2012). The MI-Go/NoGo task consisted of two types of Go 
trials and three types of NoGo trials. Regular Go trials consisted of the presentation 
of white double-digit numbers (different, e.g., 21, 23 but not 22), centrally on a 
black background for 750ms, followed immediately by a 1250ms inter stimulus 
interval (ISI) presenting only the black background. Participants were asked to 
respond to Go trials by making a single button press response as quickly as 
possible upon Go trial presentation. The second type of Go trials, referred to as 
Go-Money trials, consisted of same-digit double-digit numbers (e.g., 11, 22 or 
33) and required participants to make a single button press response as quickly 
as possible. Go-Money trials were presented for 750ms, followed by a feedback 
screen for 750ms and blank-screen ISI (500ms) and paid monetary rewards in 
proportion to how quickly participants responded to the Go-Money trial 
presentation. Successful button presses for a Go-Money trial stimulus provided 
an immediate monetary reward with a maximum value of 20c (AUD). The 
monetary reward for Go-Money trials was calculated by subtracting the reaction 
time from the 1000ms response window duration. For example, if a participant’s 
reaction time was 300ms in a Go-Money trial, the monetary gain would be 14 
cents [(1000 – 300)/50) = 14]. Two different same-digit double-digit numbers 
(e.g., 22 and 44) were presented as Go-Money trial stimuli for each block. 
 NoGo trials were pseudo-randomly interspersed throughout the Go 
and Go-Money trials. The NoGo stimulus was presented for 750ms, followed by 
a 1250ms ISI, a 1000ms feedback screen and 1000ms ISI. Participants were 
informed prior to the beginning of each block which double-digit number was 
designated as the forthcoming NoGo stimulus. Participants were asked to 
withhold their button response upon presentation of this NoGo stimulus. The 
MI-Go/NoGo task involved three different types of NoGo trials (NoGo neutral, 
NoGo reward, NoGo punishment) that varied according to the task condition. 
During the Neutral condition, no monetary reinforcement was applied to 
inhibition success or failure of NoGo trials, only Go-Money trials were rewarded. 
NoGo trials in the neutral condition consisted of new same-digit double-digits. 
In the reward and punishment condition, NoGo stimuli were selected that had 
been employed in the previous block as a Go-Money trial that was monetarily 
rewarded for rapid responses with immediate feedback. Consequently, the 
double-digits used as NoGo trials in the Reward and Punishment conditions 
were learned to be associated with immediate monetary reward in the previous 
block. NoGo reward and NoGo punishment trials were differentiated by their 
contingencies relating to inhibitory control success and failure during these 
trials. During the Reward condition, rather than receiving an immediate reward 
for successful inhibitory control during the NoGo trial, participants were 
provided with monetary reward feedback at the end of each block based upon 
the highest number of consecutive successfully inhibited NoGo trials during the 
block, multiplied by 40c. For example, if, within one block, the highest number of 
successful consecutive response inhibitions were seven, then the participant 
was awarded $2.80 (7 x 40c). Consequently, immediate feedback for successful 
inhibitory control of individual NoGo trials in the reward condition informed 
participants that no money had yet been accrued. In contrast, failure to inhibit 
during a NoGo trial in the reward condition led to an immediate reward. Feedback 
during the ISI period signaled performance failure and a monetary reward 
commensurate with RT, thereby remaining consistent with the response-reward 
relationship experienced during Go-Money trials. Such a paradigm was devised 
to model real-world behavior in which abstinence is required over an immediate 
and tangible reward (i.e., reward amount is based on reaction time with 
immediate feedback) in order to obtain a larger yet less tangible reward (i.e., 
reward amount is based on an accumulation of consecutive inhibitions with no 
immediate feedback). 
 In summary, the reward-response associations of Reward NoGo trials 
were cultivated in two ways. First, Reward NoGo stimuli were selected from the 
Go-Money trial stimuli that had been employed in the previous block, wherein 
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these stimuli had received monetary rewards for rapid responses. Second, 
failure to exert control over Reward NoGo trials resulted in small monetary 
rewards for which immediate feedback was provided, whereas successful 
inhibitory control resulted in no immediate reward, but a larger delayed reward 
comprising the sum of the longest run of consecutive successful inhibitions. 
Feedback during the Punishment condition for correct NoGo trials was similar 
to that of the Reward condition (i.e., no immediate feedback, however, feedback 
at the end of each block based upon the highest number of consecutive 
successfully inhibited NoGo trials during the block). Incorrect NoGo 
performance in the punishment condition resulted in immediate negative 
feedback (40c punishment), such that failed inhibition of the previously 
rewarding stimulus (from the preceding block) resulted in immediate 
punishment.
 The current MI-Go/NoGo task consisted of eight blocks divided over 
the three conditions. Three consecutive blocks of Reward and Punishment 
conditions were presented to participants, with a Neutral condition block 
preceding each of these. Block order for reward and punishment was 
counterbalanced across participants. Each block consisted of 120 Go trials, 20 
Go-Money trials and 20 NoGo trials. Trial types were pseudo-randomly 
presented such that NoGo and Go-Money trials were always separated by at 
least two Go trials.
 
Image acquisition
Functional MR images were acquired at a 3T scanner (Siemens Magnetrom 
TrioTim, Erlangen, Germany). 183 echo-planar imaging (EPI) sequences 
providing T2*-weighted blood oxygenation level-dependent (BOLD) were 
acquired for each functional run with the following parameters: repetition time 
(TR), 2000ms; echo time, 35ms; flip angle, 90°; 32 contiguous slices of 4mm 
thickness. Eight functional runs were collected for each participant. A rapid-
acquisition gradient echo T1-weighted image was acquired in 208 contiguous 
axial slices with TR of 1900 ms, TE of 2.3 ms, FOV of 250 mm, and isotropic 
voxel size of 0.8 mm3 for anatomical reference. 
 
Data analyses
Imaging data were analyzed using SPM8 (Statistical Parametric Mapping; 
Wellcome Trust Centre for Neuroimaging, London, UK). Pre-processing of the 
functional data included realignment of all functional images. Next, the 
anatomical scan was coregistered to the mean T2*-weighted image and 
subsequently segmented into grey and white matter and cerebrospinal fluid. 
Segmentation parameters were used for normalization using the SPM 
T1-weighted MNI template. Functional scans were spatially smoothed using a 
3D full-width at half-maximum Gaussian kernel of 8 mm. Correct trials for the 
NoGo conditions (NoGo neutral, NoGo reward and NoGo punishment) as well 
as Go-Money trials were modeled in the context of the general linear model 
using delta functions convolved with a canonical hemodynamic response 
function. Additional regressors for events not of interest to this study included 
errors and feedback epochs. The baseline estimate was the mean activation 
recorded during the ongoing trial period (Go trials), such that the activation 
observed during successful NoGo trial responses represents activation over 
and above that required for the ongoing Go trials. Group activation clusters in 
whole-brain analyses for the three NoGo conditions (Neutral, Reward, and 
Figure 1 
Schematic illustration of the Monetary Incentive Go/NoGo task
Note figure 1 The upper row of numbers represents the stimuli presented one by one to the 
participants. Different-digits double-digits are Go-stimuli. Number 22 in this figure is an example of a 
Go-Money trial for which responses are rewarded corresponding to response speed. Subsequently, 
this number is transferred to the next block (either a block in the reward or punishment condition) 
in which it is now presented as a NoGo stimulus. Feedback and reward/punishment contingencies 
for NoGo trials in the Neutral, Reward and Punishment are displayed in the dashed squares. Correct 
inhibition of NoGo trials in the reward and punishment condition is rewarded by a large delayed 
monetary reward at the end of a block based on the highest number of consecutive correct inhibited 
NoGo trials. Failed inhibition of NoGo trials in the reward and punishment condition is followed by a 
small immediate reward or a large immediate punishment respectively. 
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Punishment) for smokers and controls separately were used to create 
functionally-derived regions of interest (ROIs), thereby preventing biases in ROI 
selection for either group or condition. The group activation maps were 
determined with one-sample t-tests and thresholded at p< 0.05, Family Wise 
Error (FWE) corrected and required cluster size of at least 50 voxels (400 mm3). 
Activation clusters from these whole-brain analyses were used to create a 
combined activation map including significant voxels in any of the constituent 
maps (NoGo Neutral, Reward or Punishment in either smokers or non-smokers). 
Beta-values (activation estimates) for both groups in the three NoGo conditions 
were extracted in activated clusters in the combined map using Marsbar (Brett, 
et al. 2002). Due to a priori interest in the activity of the ventral striatum an 
anatomically defined ROI (8 mm sphere, x = ±10, y = 12, z = -2: Knutson, et al. 
2008) was created in the right and left nucleus accumbens (NAcc). Activation 
estimates in the regions of interest were analyzed using a Group x Condition 
Repeated Measures Analyses of Variance (RM-ANOVA) in SPSS. Group was 
included as a two-level between-subject factor (smokers versus controls) and 
Condition as a two level within subject factor (NoGo Neutral versus NoGo 
Reward for the first research question and NoGo Neutral versus NoGo 
Punishment for the second research question). Accuracy rates and reaction 
times for Go, NoGo and Go-Money trials were analyzed using the same Group x 
Condition RM-ANOVA’s. In addition, the amount of money smokers and non-
smoking controls earned during the punishment and reward conditions was 
compared using two-sample t-tests. In order to investigate NAcc activation 
associated with immediate reward without the need for inhibition, activation 
estimates for Money trials in the NAcc were analyzed using a Group x Condition 
RM-ANOVA. Condition was included as a 3-level within subject factor in this 
analysis as no specific hypotheses were specified for Go-Money activation 
during the Reward or Punishment condition versus the Neutral condition.
 
Results 
The accuracy rates and reaction times for both the smoking and non-smoking 
group on the Go/NoGo task are displayed in table 1. A Group (smokers versus 
controls) x Trial (NoGo, Go, Go-Money) RM-ANOVA was performed to show 
overall accuracy and reaction times patterns irrespective of task condition (i.e., 
irrespective of whether the trial was presented in the neutral, reward or 
punishment condition). A main effect of Trial was found for both accuracy rates 
and reaction times, F(2,33) = 106.17, p< 0.001 and F(2,21) = 45.48, p< 0.001 
respectively. Post-hoc tests revealed that accuracy rates for NoGo trials were 
lower than Go and Go-Money trials. Accuracy for Go trials was higher than for 
Go-Money trials (all p’s < 0.001). Reaction times showed that reaction times for 
failed NoGo trials were faster compared to Go and Go-Money trials (p’s < 
0.001). Reaction times did not differ between Go and Go-Money trials (p= 0.11). 
No group effects were observed.
Behavioral results reward
Group (smokers versus controls) x Condition (Neutral versus Reward) RM-
ANOVA’s did not show significant main or interaction effects of Group and 
Condition for either NoGo, Go and Go-Money accuracy rates (all p’s > 0.08). 
NoGo reaction times did not show a main effect of Group or Condition. However, 
a Group x Condition interaction was found, F(1,23) = 4.19, p= 0.05. Post-hoc 
t-tests revealed that NoGo reaction times in smokers were faster in the reward 
condition relative to the neutral condition (p< 0.05), whereas there was no 
effect of Condition on NoGo reaction times for non-smoking controls. Go 
reaction times showed a main effect of Condition, F(1,34) = 18.17, p< 0.001, 
indicating Go reaction times were faster for both groups in the reward versus 
neutral condition. No main or interaction effects of Group were found for Go 
reaction times (p’s > 0.95). Go-Money reaction times showed a similar pattern. 
A main effect of Condition, F(1,34) = 30.06, p< 0.001, showed that Go-Money 
reaction times were faster in both groups in the reward versus neutral condition. 
No main or interaction effects of Group were found for Go-Money reaction 
times (p’s > 0.65). The amount of money that smokers and non-smoking 
controls earned (Msmokers = $AUD 22.01, SDsmokers = 5.44; Mcontrols = $AUD 
19.55, SDcontrols = 4.39) during the reward condition did not differ significantly 
t(34) = 1.48, p= 0.15).
Behavioral results punishment
Group (smokers versus controls) x Condition (Neutral versus Punishment) RM-
ANOVA’s did not show significant main or interaction effects of Group and 
Condition for either NoGo, Go and Go-Money accuracy rates (all p’s > 0.06). 
NoGo reaction times did not show a main effect of Group or Condition. However, 
a Group x Condition interaction was found, F(1,23) = 4.19, p= 0.05. Post-hoc 
t-tests revealed that NoGo reaction times in controls were slower in the 
punishment condition relative to the neutral condition (p< 0.05), whereas there 
was no effect of Condition on NoGo reaction times for smokers. No significant 
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Note table 1 a RM-ANOVA revealed that NoGo reaction times in smokers were faster in the reward condition rela-
tive to the neutral condition (p< 0.05). b RM-ANOVA revealed that NoGo reaction times in controls were slower in 
the punishment condition relative to the neutral condition (p< 0.05). c RM-ANOVA revealed that Go-Money reac-
tion times were faster in both groups in the reward versus neutral condition (p< 0.001). d RM-ANOVA revealed that 
Go-Money reaction times were faster in both groups in the reward versus neutral condition (p< 0.001). 
main or interaction effects of Group and Condition were found for either Go or 
Go-Money reaction times (all p’s > 0.18). The amount of money that smokers 
and non-smoking controls earned (Msmokers = 12.29, SDsmokers = 7.19; Mcontrols 
= 14.59, SDcontrols = 5.84) during the punishment condition did not differ 
significantly t(34) = 1.06, p=0.30).
 
Imaging results
Activation associated with inhibitory control in the combined activation map 
was primarily right lateralized and included the right inferior/middle frontal 
gyrus (IFG/MFG), the dorsolateral prefrontal cortex (DLPFC), the right pre-
supplementary motor area (pre-SMA), the right anterior insula, the right inferior 
parietal lobe (IPL), the right superior temporal gyrus (STG) and bilateral occipital 
regions. MNI coordinates and cluster volumes are shown in table 2. These 
regions were subsequently used for functionally defined ROI analyses to 
investigate the effects or reward and punishment on inhibitory control related 
brain activation. 
 
NoGo imaging results in the reward condition
Activation for inhibitory control during neutral and reward conditions showed 
increased activation in smokers relative to non-smoking controls in the right 
IFG/MFG, the right DLPFC, the right anterior insula, the pre-SMA and the right 
IPL. No main effect of Condition, nor Group x Condition interaction effects were 
found indicating that activation in smokers relative to controls is increased both 
during neutral and reward conditions. No main effect of Group, Condition or 
Group x Condition interactions was found in the bilateral NAcc, the right STG 
and occipital regions. See figure 2 and table 2 for details of results in all regions 
of interest, including F- and p-values.
NoGo imaging results in the punishment condition
Activation for inhibitory control during neutral and punishment conditions 
showed Group x Condition interactions in the right anterior insula, right IFG/
MFG, right DLPFC and the right occipital region. Post-hoc tests in the right 
insula, right IFG/MFG and right DLPFC revealed similar activation patterns. 
During the neutral condition, smokers showed increased activation relative to 
controls in these regions, whereas no group differences were found during the 
punishment condition. Post-hoc tests in the right occipital region revealed that 
inhibitory control related brain activation in controls was increased in the 
punishment condition relative to the neutral condition, whereas there was no 
effect of Condition on activity for smokers. Brain activation associated with 
inhibitory control in the pre-SMA and right IPL was increased in smokers relative 
to control regardless of task condition. No main effect of Group, Condition or 
Group x Condition interactions were found in the bilateral NAcc, the right STG 
and left occipital region. See figure 2 and table 2 for details of results in all 
regions of interest such as F- and p-values.
Accuracy Reaction Times
Smokers Controls Smokers Controls
Category M SD M SD M SD M SD
NoGo
Neutral 79.16 14.83 81.12 13.15 376.70a 65.56 359.72b 51.15
Reward 82.65 10.29 82.29 10.29 349.30a 47.59 370.80 49.26
Punishment 78.00 11.67 82.65 7.47 362.13 38.11 389.46b 46.77
Go
Neutral 99.11 2.28 96.59 12.38 407.13c 52.54 406.26c 47.97
Reward 99.42 0.96 97.41 8.13 392.25c 44.92 391.16c 43.80
Punishment 95.53 1.02 99.29 1.96 408.90 40.47 414.83 53.07
Go-Money
Neutral 96.63 4.03 93.76 12.16 398.92d 38.42 404.07d 42.07
Reward 98.05 3.36 96.76 8.34 379.49d 38.20 381.11d 44.49
Punishment 97.47 2.59 97.41 4.64 407.23 32.67 406.47 51.30
Table 1 
Accuracy rates and reaction times for both the smoking and non-smoking group on the Go/NoGo task
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Figure 2 
Activation patterns during successful NoGo trials in Neutral, Reward and Punishment conditions
Note figure 2 * p <0.05;  ** p ≤ 0.001; NEU: neutral; REW: reward; PUN: punishment; MFG/IFG: middle frontal gyrus / 
inferior frontal gyrus; DLPFC: dorsolateral prefrontal cortex; IPL: inferior parietal lobe; STG: superior temporal gyrus; OCC: 
occipital; NAcc: Nucleus accumbens.
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Nucleus accumbens activation for Go-Money trials
A main effect of Group in the left NAcc showed that brain activation in smokers 
was enhanced for Go-Money trials across Neutral, Reward and Punishment 
conditions F(1,34)=4.41, p< 0.05. No main or interaction effect of Condition 
was found. No main effect of Group, Condition or Group x Condition interactions 
were found for activation in the right NAcc during Go-Money trials (all p’s > 
0.06). 
 
Discussion
The current study examined the neural basis of inhibiting an immediately 
rewarding response in order to obtain a larger delayed reward in smokers and 
non-smoking controls. We also investigated whether punishment insensitivity 
could contribute to inefficient inhibitory control. Results showed enhanced 
activation in the left NAcc in smokers relative to controls when they could earn 
money without the need for inhibition (i.e., in Go-Money trials), which confirms 
increased sensitivity in addicted individuals for immediate reward (Bjork, et al. 
2008; Van Hell, et al. 2010). With regard to the inhibition of rewarding stimuli, the 
hypothesis that smokers would have difficulty inhibiting an immediate reward in 
order to obtain a larger delayed reward was not confirmed by behavioral 
measures such as accuracy rates. However, greater BOLD activity in the pre-
SMA, right IFG/MFG, right DLPFC and right IPL was found in smokers compared 
to non-smoking controls during successful inhibition of rewarding NoGo trials. 
This heightened brain activation in smokers was also found during inhibition of 
neutral stimuli, suggesting that differences in brain activation associated with 
inhibitory controls in smokers may also occur in neutral situations without a 
reward-related context. Increased brain activation in regions that are crucial for 
inhibitory control has previously been found during affectively neutral conditions 
in cannabis users (Hester, et al. 2009b; Tapert, et al. 2007) and has been 
interpreted as a compensatory mechanism (Goh, et al. 2009; Wilkinson, et al. 
2004), where maintaining equivalent performance compared to non-addicted 
individuals requires recruitment of additional cortical activation. As an alternative 
explanation, additional recruitment of cortical activation for NoGo trials might 
be consistent with tonic versus phasic changes in Go/NoGo task related 
activation (Simoes-Franklin, et al. 2010). Research on individual differences in 
response inhibition task performance indicates that better performance on 
tasks such as the Go/NoGo is associated with a more cautious response style, 
or high tonic levels of proactive cognitive control (Braver 2012). Smokers appear 
to implement less tonic control during our task, reflected in faster failed NoGo 
reaction times, hence when a NoGo trial appears, an increased phasic control 
response and associated neural activation must be implemented to successfully 
withhold the prepotent Go response. Also, the relative short time-frame of 
smoking abstinence in the current study (one hour) may have contributed to the 
observed pattern of equal behavioral performance for smokers and non-
smoking controls in combination with increased brain activation in smokers, as 
previous studies have shown that smoking abstinence and withdrawal modulate 
cognitive performance and prefrontal brain function (Azizian, et al. 2010; 
Froeliger, et al. 2012).
 The current study further examined whether punishment insensitivity 
might contribute to inefficient inhibitory control. It was hypothesized that 
punishment, via an immediate monetary fine for failed response inhibition, 
would not significantly improve inhibitory control performance in smokers when 
compared to non-smoking controls. The behavioral data show such a trend, 
with control participants showing improved accuracy during the punishment 
condition (relative to neutral) and smokers showing a decline, but the small 
effect size renders this difference undetectable with our samples. Despite this, 
brain activation in the right anterior insula, right IFG/MFG and right DLPFC was 
increased in smokers relative to non-smoking controls during neutral and 
reward conditions, but not during the punishment conditions. Activation patterns 
(see figure 2) suggest that the lack of group differences under conditions of 
punishment reflects additional activation in non-smoking controls during the 
punishment compared to the neutral condition, an effect that was significant in 
right visual areas and was not observed in smokers. Involvement of visual areas 
in controlling behavior was previously observed by Brody and colleagues 
(Brody, et al. 2007) when smokers decreased visual processing of smoking 
cues in order to inhibit feelings of craving. Increased visual processing of NoGo 
stimuli during the punishment condition by non-smoking controls would be 
consistent with the heightened salience of punishment for non-smoking controls 
and may be associated with avoiding future punishment. Therefore, these 
findings provide tentative evidence that smokers, in contrast to non-smoking 
controls, may be by less sensitive to punishment as a strategy to improve 
inhibitory control. Reduced punishment sensitivity has previously been found in 
harmful drinkers using the same MI-Go/NoGo task (Rossiter, et al. 2012).
 It should be noted that accuracy rates in the current study were not 
significantly influenced by reward and punishment conditions. Consequently, 
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brain activation data should be interpreted in terms of compensation/more 
efficient recruitment of cortical regions leading to similar performance levels 
across conditions (Wilkinson, et al. 2004). Reaction times, however, showed 
expected effects according to task conditions. For example, Go and Go-Money 
reaction times were faster in the reward versus neutral condition, suggesting 
that the availability of immediate reward elicited a higher degree of impulsive 
responding. 
 
 In conclusion, the current study demonstrated that smokers had 
hyperactivation in the pre-SMA, right anterior insula, right IFG/MFG and right 
DLPFC compared to non-smoking controls during inhibition of an immediately 
rewarding stimulus in order to obtain a larger delayed reward. In addition, 
tentative evidence is provided that smokers are insensitive to the inhibitory 
effect of punishment to guide control over rewarding stimuli. Future studies 
should examine the role of punishment insensitivity as a core component of 
compulsive substance use. More knowledge regarding punishment insensitivity 
could guide treatment strategies to stimulate smoking abstinence. 
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Introduction 
Contemporary theoretical models of substance dependence posit that deficits 
in inhibitory control are of key importance in the development and continuation 
of substance dependence (Goldstein, et al. 2011; Jentsch, et al. 1999; Lubman, 
et al. 2004). Deficits in inhibitory control may contribute to the inability to stop 
taking drugs despite negative consequences. Inhibitory control is accomplished 
through a mainly right lateralized brain network including the inferior frontal 
gyrus (IFG), the anterior cingulate gyrus (ACC)/ pre-supplementary motor area 
(pre-SMA) and dorsolateral prefrontal cortex (DLPFC), as well as parietal and 
subcortical areas (Aron, et al. 2006; Chambers, et al. 2009; Swick, et al. 2011). 
Hypoactivation in prefrontal brain regions has been reported in substance 
dependent individuals including smokers (De Ruiter, et al. 2012; Hester, et al. 
2004b; Kaufman, et al. 2003; Li, et al. 2009; Nestor, et al. 2011). Additionally, 
hypoactivation in these regions seems to be related to difficulties in controlling 
substance use in daily life as it was found to be associated with a strong coupling 
between subjective craving and smoking (Berkman, et al. 2011). 
 Although the neural network underlying inhibitory control and its 
association with substance dependence have been widely investigated, the 
pharmacology of inhibitory control is an ongoing scientific endeavor. Animal 
studies suggest that dopamine plays an important role in overall executive 
functioning. For example, a hallmark study by Brozoski and colleagues (1979) 
indicated that dopamine depletion of the monkey prefrontal cortex impaired 
spatial working memory. In addition, reduced dopamine D2/D3 receptor 
availability in rats appeared to be associated with elevated impulsivity levels 
(Dalley, et al. 2007). Based on human studies, theorists assume that the relation 
between dopamine and cognitive control follows an inverted U-shaped curve 
such that either too low or too high levels of prefrontal dopamine are 
disadvantageous for cognitive functioning (Cools, et al. 2011). This hypothesis is 
mainly based on working memory performance, but it is likely that other 
cognitive functions depending on prefrontal brain activation are similarly 
characterized by an inverted U-shaped curve. Recent studies in humans have 
shown that optimal dopamine levels (i.e., extracellular dopamine and receptor 
densities) exist for attentional capacity (Finke, et al. 2010) and also inhibitory 
control (Nandam, et al. 2011), although these studies are still scarce. It is 
important to gain more knowledge on how dopamine affects neural networks 
underlying inhibitory control, especially to better understand disorders such as 
substance dependence that are characterized by dysfunctional dopamine 
systems (Balfour 2009; Berkman, et al. 2011; Diekhof, et al. 2008; Franken, et al. 
Abstract
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inhibitory control play an important role in substance dependence. The neural 
network underlying inhibitory control and its association with substance 
dependence have been widely investigated. However, the pharmacology of 
inhibitory control is still insufficiently clear. The aims of the current study were 
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impaired inhibitory control in nicotine dependence was investigated by comparing 
smokers and non-smoking controls. Haloperidol (2mg), a dopamine D2/D3 
receptor antagonist, and placebo were administered to 25 smokers and 25 non-
smoking controls in a double-blind randomized cross-over design while 
performing a Go/NoGo task during fMRI scanning. Haloperidol reduced NoGo 
accuracy and associated brain activation in the ACC, IFG and MFG, showing that 
optimal dopamine levels are crucial to effectively implement inhibitory control. In 
addition, smokers showed behavioral deficits on the Go/NoGo task as well as 
hypoactivity in the left IFG, right MFG and ACC after placebo, supporting the 
hypothesis of a hypoactive prefrontal system in smokers. Haloperidol had a 
stronger impact on prefrontal brain activation in non-smoking controls compared 
to smokers, which is in line with the inverted ‘U’ curve theory of dopamine and 
cognitive control. The current findings suggest that altered baseline dopamine 
levels in addicted individuals may contribute to the often observed reduction in 
inhibitory control in these populations.
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2005; Koob, et al. 1997; Volkow, et al. 2009). For example, reduced dopamine 
D2 receptor densities in the striatum have been consistently found in substance 
dependent individuals (Martinez, et al. 2004; Volkow, et al. 2001; Volkow, et al. 
2002; Wang, et al. 1997) including smokers (Fehr, et al. 2008). These reduced 
dopamine D2 densities have also been linked to reduced metabolism in 
prefrontal areas (Volkow, et al. 1993; Volkow, et al. 2001; Volkow, et al. 2007). 
Altogether, it is suggested that alterations in dopaminergic functioning in 
substance dependent individuals may underlie the observed deficits in inhibitory 
control as well as hypoactivation in associated prefrontal regions. To the best of 
our knowledge, only one study employed a dopamine manipulation in substance 
dependent individuals while measuring inhibitory control (Li, et al. 2010). It was 
shown that the dopamine agonist methylphenidate enhanced inhibitory control 
compared to placebo in cocaine dependent individuals. The behavioral 
improvement in inhibitory control was positively associated with activation in 
the middle frontal gyrus and negatively with activation in the ventromedial 
prefrontal cortex (Li, et al. 2010). Although this study provided valuable insights, 
a control group consisting of healthy participants was lacking. 
 The aims of the current study were twofold. First, a dopamine 
manipulation was employed to investigate the role of dopamine in inhibitory 
control and associated brain activation. Second, the potential link of dopamine 
with impaired inhibitory control in nicotine dependence was investigated by 
comparing the effects of dopaminergic manipulation between smokers and 
non-smoking controls. As part of a larger study, participants received placebo 
and haloperidol, a dopamine D2/D3 receptor antagonist, in a double-blind 
randomized cross-over design while performing a Go/NoGo task during fMRI 
scanning. In line with previous studies showing beneficial effects of a dopamine 
agonist (Li, et al. 2010; Nandam, et al. 2011), we hypothesized that haloperidol 
will reduce inhibitory control and associated brain activation. Second, based on 
the inverted ‘U’ curve theory of dopamine and cognitive control, and reported 
baseline differences between smokers and controls in dopamine D2 receptor 
density, we expected that haloperidol will have differential effects on brain 
activation associated with inhibitory control in smokers and non-smokers. 
 
Materials and Methods
Participants
Twenty-five smokers and twenty-five non-smoking controls participated in this 
study. Data from two non-smokers were discarded due to technical problems 
during data acquisition and analysis. The final sample consisted of 25 smokers 
(mean age = 22.56 years, SD = 2.84, 18 male) and 23 non-smoking controls 
(mean age = 21.74 years, SD = 1.82, 14 male). Smokers smoked at least 15 
cigarettes per day (M = 19.12, SD = 3.37; range 15-25) for a duration of at least 
three years (M = 7.20, SD = 3.01, range = 3-14). The average score on the 
Fagerström Test for Nicotine Dependence (FTND: Heatherton, et al. 1991; Vink, 
et al. 2005) for smokers was 3.80, SD = 3.37, range = 1-8. Non-smokers had 
smoked ten cigarettes or less during their lifetime (M = 1.73, SD = 2.62, range 
= 0-10). All participants underwent a medical examination by a psychiatrist to 
assure eligibility for a single dose of 2 mg oral haloperidol. Exclusion criteria for 
both groups were (a) current substance abuse or dependence (other than 
nicotine for the smoking group), (b) the current presence of any physical or 
psychological illness, (c) any use of psychotropic medication or medication that 
may affect blood circulation and/or respiration, (d) fMRI contraindications, and 
(e) left-handedness (see supplementary materials for details on medical 
screening). There were no significant differences between the groups in mean 
age, t(46) = 1.20; ns, gender ratio, χ2 (1, n = 48) = 0.67; ns and education level 
χ2 (2, n = 47) = 3.19; ns. The study was conducted in accordance with the 
Declaration of Helsinki and all procedures were carried out with the adequate 
understanding and written informed consent of the subjects. The ethics 
committee of Erasmus MC – University Medical Centre Rotterdam approved 
this study.
 
Dopaminergic manipulation
A single oral dose of 2 mg haloperidol and a placebo was administered to 
participants in a double-blind randomized cross-over design. Haloperidol is a 
selective dopamine D2/D3 receptor antagonist for postsynaptic receptors. 
Using positron emission tomography (PET), Nordstrom, Farde and Halldin 
(1992) demonstrated that striatal D2 receptor occupancy three hours after oral 
administration of a single dose of 2mg haloperidol was 18% and 52% after six 
hours. In the present study, the fMRI session took place four hours after 
administration which, according to the Nordstrom (1992) study results in about 
30% D2 receptor occupancy. Haloperidol has also been found to block 
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dopamine bursts in the prefrontal cortex (Wang, et al. 2004) and previous 
studies showed that 2 mg haloperidol successfully reduced processing biases 
in substance dependent individuals (Franken, et al. 2004; Mahler, et al. 2005). 
None of the participants reported any side effects of medication. After the 
second fMRI session, participants answered a single additional question in 
which they had to guess on the type of medication they received for each 
scanning session. Participants’ guesses were not above chance (46.7% of the 
participants correctly indicated in which test occasion they received haloperidol, 
p=0.7. 
 
Procedures
After confirmation of study eligibility by the medical screening performed by a 
psychiatrist, two scanning sessions were scheduled that were separated by one 
week. Similar to previous studies using haloperidol (Franken, et al. 2008; 
Franken, et al. 2004), participants took the medication four hours before both 
scanning sessions. Smokers were not allowed to smoke after taking the 
medication until scanning was finished to ensure that indirect nicotine effects 
on dopamine levels did not interfere with the binding of haloperidol to D2/D3 
receptors in the brain. Breath carbon monoxide (CO) concentration was 
measured in all subjects using a calibrated Micro+Smokerlyzer (Bedfont 
Scientific Ltd., Rochester, UK) to verify smoking abstinence and to objectively 
define smokers and nonsmokers. In addition, smokers completed the FTND 
(Heatherton, et al. 1991; Vink, et al. 2005) to measure nicotine dependence on 
the first scanning session only and the Questionnaire of Smoking Urges (QSU: 
Cox et al., 2001) to indicate their current subjective craving for a cigarette during 
both scanning sessions. 
 
Task paradigm
Participants completed a Go/NoGo task in which letters were presented at 1 Hz 
(similar to previous studies such as Nestor, et al. 2011). Each letter was presented 
for 700 ms followed by a blank screen (the inter stimulus interval) for 300 ms. 
Participants were required to make a button press response as fast as possible 
to each letter (Go trials) and to withhold this response whenever the letter was 
the same as the previous one (NoGo trials). NoGo trials were presented 
unpredictably by introducing jitter in the number of intervening Go trials (M 
=7.25, range = 3-16). The task consisted of 817 Go and 110 NoGo trials such 
that twelve percent of all trials were NoGo trials. Four fifteen seconds rest 
periods were included in the task. Behavioral outcome measures for this task 
are Go and NoGo accuracy (percentage correct trials) and reaction times for 
correct Go and incorrect NoGo trials
 
Image acquisition
Data were acquired on a 3T GE Healthcare (The Discovery® MRI 750 3.0T, 
Milwaukee, US) scanner. Blood oxygen level-dependent (BOLD) sensitive 
functional T2*-weighted images were acquired in 44 axial slices covering the 
entire supratentorial brain with a repetition time (TR) of 2500 ms, echo time 
(TE) of 30 ms, field of view (FOV) of 240 mm, and isotropic voxel size of 2.5 
mm3. A structural 3-dimensional (3D) inversion recovery fast spoiled gradient 
echo T1-weighted image was acquired in 164 contiguous axial slices with TR of 
7.9 ms, TE of 3.1 ms, FOV of 240 mm, and isotropic voxel size of 1 mm3 for 
anatomical reference.
 
Image processing
Imaging data were analyzed using SPM8 (Statistical Parametric Mapping; 
Wellcome Trust Centre for Neuroimaging, London, UK). Preprocessing of the 
functional data included realignment of all functional images. Next, the 
anatomical scan was coregistered to the mean T2*-weighted image and 
subsequently segmented into grey and white matter and cerebrospinal fluid. 
Segmentation parameters were used for normalization using the SPM T1-
weighted MNI template. Functional scans were spatially smoothed using a 3D 
full-width at half-maximum Gaussian kernel of 4 mm. The four conditions (NoGo 
correct, NoGo incorrect, Go correct and Go incorrect) were modeled in the 
context of the general linear model for both types of medication (placebo, 
haloperidol) using delta functions convolved with a canonical hemodynamic 
response function. Subsequently, the NoGo correct minus Go correct contrast 
representing brain activation associated with inhibitory control was calculated 
for placebo and haloperidol separately. 
 In order to show that the current Go/NoGo task activated the inhibitory 
control network the main effect for brain activation associated with inhibitory 
control was calculated using a single random effects one-sample t-test that 
included both medication types and both groups. 
 
 To investigate the overall effect of haloperidol in all participants on 
brain activation associated with inhibitory control a main effect of medication 
(placebo minus haloperidol and vice versa) was calculated by means of a 
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random effects paired-sample t-test of both groups combined. The same 
analysis was performed for Go trials to investigate whether haloperidol altered 
baseline activation (see supplementary materials for details). 
 To assess Group x Medication interactions for brain activation 
associated with inhibitory control, first an OR map was created according to the 
methods used in Hester et al. (2009b). The OR map shows voxels in which group 
differences were significant in either of the constituent maps (i.e., brain activation 
for placebo and haloperidol). Using the OR map, group differences are identified 
while biases towards either of the medication types are avoided. Second, 
contrast values (parameter estimates) for both groups and medication types 
were extracted for significant clusters in the OR map. Subsequently, extracted 
contrast values were entered in Medication x Group Repeated Measures 
Analyses of Variance (RM-ANOVA) using SPSS (version 17, Armonk). 
In addition, the extracted contrast values from the OR map were correlated with 
NoGo accuracy for both groups and medication types separately to assess 
associations between brain activation and behavioral outcome measures. The 
association between the effects of haloperidol on behavioral measures and 
brain activation was investigated by calculating Pearson correlation coefficients 
for placebo minus haloperidol NoGo accuracy scores and placebo minus 
haloperidol brain activation.
 The correction for multiple comparisons in the between medication 
and the between group analyses (OR map) was performed using a Monte Carlo 
simulation. One thousand permutations determined that a cluster of 536mm3 
was needed to correct an individual voxel type 1 error of p<.01 to a cluster 
corrected threshold of p<.01. The main effect for task related brain activation 
was corrected to p<0.01 using an individual threshold of 0.0000001 and cluster 
size restriction of 16 mm3.
Data analyses questionnaires and behavioral 
performance
RM-ANOVA’s were performed in SPSS for CO levels, QSU scores and behavioral 
outcomes of the Go/NoGo task. Medication was used as two-level within-
subject factor (haloperidol versus placebo) and Group was used as two-level 
between-subject factor (smokers versus controls) for CO levels and behavioral 
outcomes. In addition, Task Condition was added as a within-subject factor for 
behavioral performance (Go versus NoGo correct for accuracy rates and Go 
versus NoGo incorrect for reaction times).
Results
CO levels and questionnaire data 
Smokers had a higher CO breath concentration (in parts per million, Mhaloperidol= 
6.20, SD = 3.39, Mplacebo= 6.72, SD = 3.50) as compared to non-smoking 
controls (Mhaloperidol= 1.43, SD = 0.79, Mplacebo= 1.65, SD = 0.51), F(1,46) = 
52.77, p< 0.001. CO levels did not differ between medication types for either 
group, F(1,46) = 1.68, ns. Subjective craving in smokers was equal for placebo 
(M = 39.71, SD = 11.48) and haloperidol (M = 38.08, SD = 11.80) conditions 
F(1,23) = 0.44, ns. 
 
Behavioral performance
Accuracy rates revealed a robust main effect of Task Condition (Go versus 
NoGo), F(1,46) = 458.45, p<.001, showing that participants were generally less 
accurate for NoGo than for Go trials (57.66 versus 97.97%). Furthermore, a main 
effect of Medication type was found, indicating that accuracy rates were lower 
during the haloperidol than the placebo condition, F(1,46) = 10.62, p<0.01. A 
Medication x Task Condition interaction, F(1,46) = 504.23, p< .01, showed that 
the decrease in performance was driven by the NoGo condition as the effect of 
medication was significant for the NoGo condition (MNoGo/haloperidol= 54.02, SD 
= 17.22, MNoGo/placebo= 61.19, SD = 14.49, F(1,46)= 10.91, p< 0.01), and not for 
the Go condition (MGo/haloperidol= 97.58, SD = 3.59, MGo/placebo= 98.17, SD = 
3.44). No main, F(1,46)= 0.28, ns, or interaction effect, F(1,46)= 0.78, ns, was 
found for Group. We performed an additional explorative Group x Condition RM-
ANOVA for accuracy rates on the first test occasion in order to exclude possible 
learning effects on task performance. A Group x Task Condition interaction was 
found, F(1,46)= 4.72, p< 0.05. Post-hoc t-tests revealed that, for NoGo trials, 
smokers performed less accurately than non-smoking controls (p< 0.05; 
Msmokers=53.31, SD = 14.22, Mcontrols=61.90, SD = 15.10), whereas there was 
no difference for Go accuracy between the groups, F(1,46)= 0.33, ns. 
 With regard to the reaction time data, a main effect of Task Condition 
was found, F(1,46) = 42.03, p< .001, indicating that participants generally 
responded faster for incorrect NoGo trials (MNoGo incorrect/smokers = 350.77, SD 
= 49.31, MNoGo incorrect/controls = 313.85, SD = 41.71) than for Go trials (MGo/
smokers = 367.51, SD = 45.81, MGo/controls = 337.83, SD = 40.50). Furthermore, 
a main effect was found for Group showing that smokers had generally slower 
response times, F(1,45) = 7.10, p<0.05. No main or interaction effects of 
Medication were found for reaction times (all F’s smaller than 0.82). 
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fMRI data
In line with meta-analyses (Garavan, et al. 2006; Swick, et al. 2011), inhibitory control 
was associated with brain activation in bilateral IFG, ACC/pre-SMA, DLPFC, anterior 
insula, temporoparietal junction (TPJ), caudate and putamen, and bilateral superior 
parietal regions (for an overview of activated brain areas for NoGo minus Go see 
supplementary figure 1). 
 Haloperidol was found to decrease, as compared to placebo, brain 
activation associated with inhibitory control across groups in the ACC, right superior 
frontal gyrus (SFG), left IFG, posterior cingulate cortex (PCC), and left middle 
temporal gyrus (MTG; see figure 1 and table 1 for details). There was no increase in 
brain activation with haloperidol compared with placebo. An additional analysis on 
the effect of haloperidol on Go-trials confirmed that the reduction in brain activation 
for inhibitory control was not due to baseline alterations associated with haloperidol 
(see supplementary materials).
 
 The OR map showed differences between smokers and non-smoking 
controls in the ACC, PCC, right middle frontal gyrus (MFG), left IFG, and right 
temporoparietal junction (TPJ). Overall, smokers had reduced activation in the ACC 
relative to controls. Group x Medication interactions were significant in the right 
MFG, left IFG, PCC and right TPJ. Post-hoc analyses revealed that activation 
differences between smokers and non-smoking controls were mainly found after 
placebo. Activation was reduced in smokers relative to controls after placebo in the 
right MFG and left IFG and increased in the TPJ. Haloperidol was found to reduce 
brain activation associated with inhibitory control in the left IFG and right MFG only in 
controls, whereas it reduced brain activation in the PCC in smokers. See figure 2 and 
table 2 for details concerning group differences and Group x Medication interactions.
 Correlation analyses of average contrast values extracted from brain 
activation showing between group differences (ACC, left IFG, right MFG, PCC and 
right TPJ) with NoGo accuracy (figure 3) revealed that activation in the ACC during 
haloperidol was positively associated with NoGo accuracy r= 0.43, p< 0.05 in non-
smoking controls. The difference in NoGo accuracy between placebo and haloperidol 
administration in controls was further associated with the difference in brain 
activation in this area, r=0.41, p= 0.05, indicating that a decrease in brain activation 
after haloperidol administration correlated with a decrease in accuracy. This 
association between haloperidol-induced differences in brain activation and NoGo 
accuracy was also found in controls in the right MFG, r= 49, p< 0.05. No significant 
correlations between brain activation and behavioral measures were found in 
smokers.
Figure 1 
Haloperidol reduced brain activation associated with inhibitory control
Note figure 1 Reduced brain activation associated with inhibitory control after haloperidol of both 
smokers and non-smoking controls. p< 0.01 (corrected for multiple comparisons using a Monte 
Carlo simulation). See table 1 for anatomical localization of active regions.
 
Note table 1 a p< 0.01, corrected for multiple comparisons using a Monte Carlo simulation AAC: 
anterior cingulate cortex; r-SFG: right superior frontal gyrus; l-IFG: left inferior frontal gyrus; PCC: 
posterior cingulate cortex; l-MTG: left middle temporal gyrus.
Region MNI coordinates 
(X Y Z)
mm3 Z-valuea
ACC -8  52  2 7816 4.12
r-SFG 20  -12  30 744 3.48
l- IFG -52  34  2 544 3.54
PCC -8  -46  38 1304 3.44
l-MTG -50  -70  26 768 3.95
Table 1
Medication effects for brain activation associated with inhibitory control
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Figure 2 
Group differences of brain activation associated with inhibitory control
Note figure 2 This figure shows brain regions in which group differences were significant either 
after placebo or after haloperidol, p< 0.01 (corrected for multiple comparisons using a Monte Carlo 
simulation). Group x Medication effects were significant in the right middle frontal gyrus (r-MFG), 
left inferior frontal gyrus (l-IFG), right temporoparietal junction (r-TPJ) and posterior cingulate cortex 
(PCC). See table 2 for details regarding interaction and medication effect.
Note table 2 a Z-value for group differences in OR map with p< 0.01, corrected for multiple comparisons using 
a monte-carlo simulation; b degrees of freedom F-test: 1,46; r-MFG: right middle frontal gyrus; l-IFG: left in-
ferior frontal gyrus; AAC: anterior cingulate gyrus; r-TPJ: right temporoparietal junction; r-PCC: right posterior 
cingulate cortex; ns: non significant; PL: placebo; HA: haloperidol.
Region MNI
coordinates
(X Y Z)
mm3 ZValuea Group x 
Medicationb
Group effectsb Medication 
effectsb
r-MFG 20 64 12 640 3.59 F = 4.55, p< 0.05 PL: smokers < 
controls
F = 16.30, p<0.001
HA: ns
HA < PL in 
controls
F = 3.29, p=0.08
l-IFG -52 18 16 592 3.27 F = 4.20, p< 0.05 PL: smokers < 
controls
F = 13.71, p=0.001
HA: ns
HA < PL in 
controls
F = 6.92, p<0.05
ACC 14 40 8 888 3.66 ns Main effect:
smokers < control
F = 14.60, p<0.001
Main effect: HA 
< PL
F = 3.37, p= 0.07
r-TPJ 64 -20 30 864 3.57 F = 4.18, p<0.05 PL: smokers > 
controls
F = 19.67, p<0.001
HA: ns
HA < PL in 
smokers
F = 2.87, p=0.10
r-PCC 8 -38 42 672 4.23 F = 5.63, p< 0.05 PL: ns
HA: smokers < 
controls
F = 17.33, p<0.001
HA < PL in 
smokers
F = 14.54,  
p <0.001
Table 2 
Group differences in brain activation associated with inhibitory control
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Discussion 
The aim of the current study was to elucidate the role of dopamine in inhibitory 
control and associated brain activation. In addition, by comparing smokers and 
non-smokers the potential link between dopamine and reduced inhibitory 
control in addiction was investigated. The current results confirmed the 
hypothesis that reduced dopamine levels after haloperidol intake are associated 
with impairments in inhibitory control. Haloperidol reduced NoGo accuracy 
rates in both groups, while Go accuracy and reaction times were unaffected, 
indicating a specific effect of dopamine on inhibitory control. Impaired inhibitory 
control after haloperidol was accompanied by reduced activation in prefrontal 
regions associated with inhibitory control including the ACC, IFG and MFG. The 
relationship between reduced regional brain activation and impaired behavioral 
performance was corroborated by correlations in non-smoking controls 
showing an association between a decrease in brain activation in the ACC and 
right MFG after haloperidol and a decrease in behavioral performance. These 
findings are in line with the notion that low dopamine levels are disadvantageous 
for cognitive control (Cools, et al. 2011; Nandam, et al. 2011). Previous studies 
that investigated the role of dopamine in cognitive control employed working 
memory and mental flexibility paradigms, which do not specifically address 
inhibitory control (Bertolino, et al. 2010; Braskie, et al. 2011; Stelzel, et al. 2010). 
As far as we know, the current study is the first to demonstrate the link between 
dopamine levels and brain activation associated with inhibitory control in healthy 
controls and in smokers. 
 Results of the current study also replicated previous findings of impaired 
performance on a Go/NoGo task in smokers (Luijten, et al. 2011a; Nestor, et al. 
2011). Smokers had generally longer reaction times and reduced NoGo accuracy 
rates for the first test occasion. Longer reaction times on Go trials suggest less 
efficient task performance or the use of different strategies. Besides behavioral 
performance deficits, group differences between smokers and non-smoking 
controls in brain activation associated with inhibitory control were mainly found 
after placebo. Activation in prefrontal brain regions including the ACC, left IFG 
and right MFG was found to be reduced in smokers relative to non-smoking 
controls. These results therefore replicate previous studies showing hypoactivity 
during inhibitory control in smokers in prefrontal areas (De Ruiter, et al. 2012; 
Nestor, et al. 2011). In addition to reduced prefrontal activation, activation of the 
right TPJ was enhanced in smokers, suggesting compensational activation of this 
brain region known to be involved in attention processing (Corbetta, et al. 2002). 
In contrast to these findings during the placebo condition, no differences between 
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smokers and controls were found in the r-MFG, l-IFG and r-TPJ after haloperidol 
administration. Haloperidol intake, however, was associated with reduced activity 
relative to placebo in prefrontal regions in non-smoking controls, but not in 
smokers. This implies that dopamine D2/D3 receptor blockade by haloperidol 
renders non-smoking controls more similar to smokers regarding reduced 
inhibitory control and hence presumably regarding dopamine levels. The lack of 
an effect of haloperidol administration on prefrontal brain activation in smokers 
further implies a relative insensitivity in prefrontal brain regions to dopamine 
antagonist administration in this group. Differences in baseline dopamine levels 
between smokers and non-smoking controls may underlie the differential effects 
of haloperidol in both groups. The findings of this study are in line with the 
inverted ‘U’ shape theory stating that there is an optimum for dopamine levels in 
the brain to efficiently execute cognitive control (Cools, et al. 2011). The reduction 
in inhibitory control after haloperidol in both groups and the larger impact of 
haloperidol on prefrontal brain activation in non-smoking controls provides 
indirect evidence that impairments in inhibitory control in smokers and other 
addicted population may be due to suboptimal dopamine levels. Therefore it can 
be concluded that the effects of reduced dopamine receptor densities in smokers 
(Fehr, et al. 2008), or in substance dependence in general, may not be limited to 
motivational processes linked to dopamine such as reward sensitivity, but could 
also be the underlying neurobiological mechanism for reduced inhibitory control. 
It would be interesting for future studies to administer both a dopamine agonist 
and antagonist in order to examine the full range of the inverted U-curve theory 
on dopamine levels and cognitive control and their consequences for nicotine 
dependence. In addition, future studies may seek to combine fMRI with 
simultaneous PET imaging to directly assess dopaminergic transmission 
together with brain activation associated with specific cognitive processes such 
as inhibitory control (Judenhofer, et al. 2008).
 In conclusion, an experimental reduction in dopamine levels was 
associated with impaired inhibitory control and reduced brain activation in 
smokers and non-smokers. In line with contemporary theories on addiction, 
smokers showed behavioral deficits on the Go/NoGo task as well as hypoactivity 
in the left IFG, right MFG and ACC during placebo, thereby confirming previous 
findings of prefrontal hypoactivation in smokers. Prefrontal brain activation 
associated with inhibitory control in smokers and non-smokers appears to be 
differentially affected by the experimental manipulation of dopamine levels, 
which is in line with the inverted ‘U’ curve theory of dopamine and cognitive 
control. The current findings suggest that optimal dopamine levels are crucial to 
effectively implement inhibitory control. Altered baseline dopamine levels in 
addicted individuals may contribute to the often observed reduction in inhibitory 
control in these populations. Based on these findings pharmacotherapy should 
be targeted at restoring the dopamine balance in smokers, specifically in 
prefrontal brain regions.
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Supplementary Materials 
Medical screening
All participants were screened by a Psychiatrist. The screening included a check 
for contraindications for haloperidol (lifetime prevalence of epileptic seizure, 
heart disease and first degree relatives with diseases affecting dopaminergic 
transmission such as Parkinson disease, Huntington disease or psychosis. 
Participants were also provided with information on potential side effects such 
as drowsiness and muscle stiffness and were explained that these side effects 
are not expected to occur with a single low dose of 2 mg haloperidol. In addition, 
participants were screened for neurological and psychiatric diseases to make 
sure that participants had no lifetime neurological or psychiatric diagnoses and 
that they did not use any medication that crosses the blood brain barrier. 
Effect of haloperidol on baseline Go activation
To check whether the observed effects of haloperidol on brain activation 
associated with inhibitory control are not due to baseline alterations of non-
cognitive brain activation we performed an additional paired samples t-test to 
compare brain activation after placebo and haloperidol for the Go correct 
condition including both groups. Given the high percentage of Go-stimuli (78%), 
the low cognitive demands for these stimuli and presentation of Go stimuli in a 
continuous stream one could consider brain activation associated with GO 
stimuli as baseline activation in this Go/NoGo paradigm. Note that the current 
task included four fifteen second rest periods such that Go-activation is relative 
to activation in rest periods. Results of this analysis showed that haloperidol 
increased baseline activation in the left occipital gyrus (MNI coordinates, -16 
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-92 22, z = 3.31, 832 mm3) and the right insula (MNI coordinates, 42 -14 -8, z = 
3.81, 1144 mm3). No regions showed a reduction in activation after haloperidol. 
These findings, as well as the absence of effects of haloperidol on reaction times 
and Go accuracy support the idea that the observed reduction in inhibitory 
control after haloperidol is due to a reduction in prefrontal brain activation 
associated with inhibitory control and not due to a reduction in baseline activity, 
a general slowdown in reaction times or a general performance deficit.
 
Supplementary Figure 1
Brain activation associated with Inhibitory control (NoGo minus Go) for both groups and medication 
types combined
Note supplementary figure 1 p < 0.01 corrected, corrected for multiple comparisons using a Monte 
Carlo simulation.
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Introduction
Substance abuse and addiction are commonly associated with enhanced 
reactivity to substance-related cues. Attentional bias is one of the key cognitive 
processes involved in cue reactivity and involves the tendency of substance 
dependent patients to automatically and involuntarily allocate and maintain their 
attention to conditioned drug cues (Field, et al. 2008). Attentional bias for drug 
cues is thought to result from acquired motivational and attention grabbing 
properties of these cues due to sensitization of dopamine systems in the brain 
(Robinson, et al. 2008). For substance-dependent patients, drug cues become 
extremely salient, become the focus of attention and elicit behaviors like drug 
seeking and consumption. Attentional bias has consistently been found in 
various types of addiction (for reviews see Field, et al. 2008; Franken 2003; 
Robbins, et al. 2004) utilizing a wide range of experimental paradigms including 
attentional tasks such as the emotional Stroop and visual probe task. Smokers, 
for example, are slower to name the color of smoking-related words when 
compared to neutral words during the smoking Stroop task (Munafo, et al. 
2003), and they are faster to respond to probes replacing smoking pictures than 
to probes replacing non-smoking pictures (Bradley, et al. 2004; Ehrman, et al. 
2002; Mogg, et al. 2005) during the visual probe task. Eye-tracking and Event-
Related Potential studies (Field, et al. 2004; Littel, et al. 2007; Mogg, et al. 2003) 
have also indicated enhanced attentional processing of drug cues in smokers. 
As predicted by theoretical models, attentional bias is associated with current 
craving, the strong subjective urge to consume a substance of abuse (Field, et 
al. 2009; Franken 2003). Recently, attentional bias has been proven to be a 
clinically relevant construct that is associated with relapse rates or treatment 
outcome in smokers (Waters, et al. 2003), alcohol (Cox, et al. 2002), cocaine 
(Carpenter, et al. 2006) and heroin dependent patients (Marissen, et al. 2006). 
Further, preliminary evidence has been provided that attentional bias extinction 
training reduces conditioned cigarette craving in smoking males (Attwood, et al. 
2008) and drinking behavior in alcohol dependent patients (Attwood, et al. 
2008; Field, et al. 2005; Field, et al. 2007; Schoenmakers, et al. 2007). Despite 
these theoretical and clinical advances, the neurobiological mechanisms of 
attentional bias are largely unknown. 
 Previous studies have shown that conditioned drug cues elicit a 
response in substance dependent patients in a general network of brain regions 
mainly consisting of the anterior cingulate cortex (ACC), dorsolateral prefrontal 
cortex (DLPFC), orbitofrontal cortex (OFC), and ventral striatum, as well as 
superior parietal and temporal brain areas (for review see Wilson, et al. 2004). 
Abstract
Substance dependent patients automatically and involuntarily allocate their 
attention to drug cues in the environment, a process referred to as attentional 
bias. Attentional bias is increased during periods of subjective craving and 
predictive of treatment outcome and relapse in substance dependence. Despite 
recent theoretical and clinical advances with regard to attentional bias, the 
underlying neurobiological mechanisms are largely unknown. The objective of 
the current study was to investigate the neural substrate of attentional bias and 
associated subjective craving in smokers. A group of smokers (n = 20) and a 
group of age and gender matched non-smoking controls (n = 22) were recruited 
from the general population and participated in a single session of fMRI scanning 
while attentional processes were manipulated. Main Outcome Measures were 
Blood oxygen level dependent (BOLD) fMRI activation during an attentional bias 
paradigm and self-reported cigarette craving. Results of the current study show 
that the dorsal anterior cingulate cortex, the superior parietal gyrus and the 
superior temporal gyrus were more strongly activated in smokers, as compared 
to controls, when they had to pay attention to task-relevant information (line 
counting) while smoking cues were present as distracters (attentional bias). 
Subjective craving measures during attentional bias correlated with brain 
activation in the insula and putamen. To our knowledge, this is the first controlled 
study that shows the brain regions involved in attentional bias in smokers. The 
current study demonstrates that brain regions contributing to top-down 
attentional processing are implicated in attentional bias in smokers, suggesting 
that smokers have to employ more attentional resources to focus on a standard 
cognitive task when smoking cues are present. 
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Although these studies have provided important information regarding the 
neurophysiology of addiction, they do not clarify the contribution of brain 
structures within this network to specific processes that occur during exposure 
to drug related stimuli, such as attentional bias and craving. Several brain 
regions activated during cue-exposure are known to be involved in attentional 
processing and may be involved in attentional bias for alcohol, drug, and 
smoking cues as well. Although empirical studies are largely lacking, an 
important role for the ACC in attentional bias has been hypothesized (Franken 
2003). The ACC is a heterogeneous brain region consisting of several 
functionally distinct areas, and regulates attention that serves both cognitive 
and emotional processing (Bush, et al. 2000; Bush, et al. 2001; Vogt, et al. 2005; 
Weissman, et al. 2005). A widely supported view of ACC functioning is that 
cognitive and emotional information is processed separately in two major 
subdivisions (Bush, et al. 2000). The rostral-ventral zone of the ACC (rvACC) is 
involved in emotional processing, more specifically in emotional conflict, 
salience attribution and emotional response (Bishop, et al. 2004; Compton, et 
al. 2003; Etkin, et al. 2006; Fujiwara, et al. 2009). Other brain structures 
supposed to be involved in the bottom-up process of salience attribution are the 
OFC, ventral striatum and amygdala; areas that are anatomically connected to 
the rvACC (Goldstein, et al. 2002; Volkow, et al. 2004). Together, they may 
constitute a ventral attentional system involved in attentional bias that operates 
in a stimulus driven fashion by directing attention to salient stimuli. In contrast, 
the dorsal ACC (dACC) has been implicated in top-down attention (Silton, et al. 
2010). Activity in the dACC contributes to focused attention on relevant stimuli, 
especially when the achievement of behavioral goals is threatened by distracting 
events (i.e., salient stimuli, Weissman, et al. 2005). In addition to the dACC, 
superior parietal and dorsolateral prefrontal brain regions are involved in 
attention and executive control (Cavanna, et al. 2006; Kompus, et al. 2009; Liu, 
et al. 2004; Silton, et al. 2010). The dACC, superior parietal and dorsolateral 
prefrontal regions may thus be involved in attentional bias and constitute a more 
dorsal top-down attentional system. Currently, there is some evidence that 
these regions are hypoactive in substance dependent patients during 
performance of non-affective cognitive paradigms (Forman, et al. 2004; 
Kaufman, et al. 2003; Volkow, et al. 2004). On the other hand, it has been 
suggested that these regions may become overactive during cue exposure as a 
result of increased effort to maintain cognitive control (Lubman, et al. 2004). 
 To the best of our knowledge, there are no controlled studies in the 
literature that are explicitly designed to examine brain regions involved in 
substance-related attentional bias. Although several fMRI studies have been 
published in which substance abusers perform an attention demanding task 
while being exposed to drug cues (Goldstein, et al. 2007; Goldstein, et al. 2009b; 
Goldstein, et al. 2009a; Hester, et al. 2009a; Tapert, et al. 2004) the results of 
these studies are difficult to interpret with regard to brain processes involved in 
attentional bias for several reasons. First, two studies employing the drug Stroop 
task did not report drug cue specific activations, therefore it is unclear if 
differential processing of drug cues relative to neutral cues occurred (Goldstein, 
et al. 2007; Goldstein, et al. 2009b). Second, modifications of the Stroop task 
paradigm (Goldstein, et al. 2009b; Goldstein, et al. 2009a; Tapert, et al. 2004), 
such as the addition of a reward component (participants could earn money as 
a function of task performance in Goldstein, et al. 2009b; Goldstein, et al. 2009a) 
tend to confound interpretation in terms of attentional bias. Besides these 
conceptual issues, some of these studies suffer from methodological problems, 
such as low power (Goldstein, et al. 2007; Tapert, et al. 2004) or the lack of a 
control group (Goldstein, et al. 2007; Hester, et al. 2009a), the latter precluding 
conclusions regarding involvement of specific brain regions in substance abuse 
patients. Although the results of these studies most likely do not reflect the 
neural substrates of attentional bias per se, they suggest that substance 
dependent patients show deviant brain activation in both subregions of the ACC 
(Goldstein, et al. 2007; Goldstein, et al. 2009a; Tapert, et al. 2004), the 
dorsolateral prefrontal (Tapert, et al. 2004) and inferior frontal gyrus (Hester, et 
al. 2009a), the superior parietal lobe (Goldstein, et al. 2009a; Tapert, et al. 2004) 
and the brain stem (Goldstein, et al. 2009b). In addition to the above-reviewed 
methodological issues, there is also an important conceptual issue that is likely 
to be present in standard (non-adapted) attentional bias paradigms like the drug 
word Stroop task. Notably, it cannot be ruled out that differential brain activation 
in these task paradigms is the result of differences in simple cue-reactivity to 
drug cues between substance dependent patients and controls. Therefore, in 
the present study we developed a new pictorial task paradigm to elicit brain 
activations specifically associated with attentional bias in smokers while 
controlling for non-specific activations resulting from other processes involved 
in cue-reactivity (i.e., picture viewing), including arousal and familiarity.
 Based on the previous studies and theoretical accounts, we 
hypothesized that both subregions of the ACC are involved in attentional bias. 
Specifically, we expected that the dACC will be overactive in smokers during the 
attentional bias paradigm. This dACC activity will contribute to focused attention 
on the primary task, as smokers will be highly distracted by the conditioned 
smoking cues. In keeping with the other brain regions involved in salience 
attribution and top-down attention, we expected the OFC, ventral striatum, 
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amygdala, superior parietal and dorsolateral frontal cortex to be similarly 
hyperactive due to their involvement in attentional bias for smoking-related 
stimuli as well.
Materials and Methods
Subjects
A total of 20 smokers and 22 non-smoking controls participated in the study. 
Subjects were recruited via advertisements on the internet and were screened 
by telephone for study eligibility. Exclusion criteria for both groups were (a) drug 
abuse other than nicotine, (b) current physical or psychological illness (c) any 
use of medication and (d) fMRI contraindications. Data from two smokers and 
three non-smoking controls was discarded due to scanner failure. The final 
sample consisted of 18 smokers (mean age = 23.6 years, SD = 4.1, 13 men) and 
19 non-smokers (mean age = 22.8 years, SD = 2.1, 12 men). Smokers smoked 
at least 10 cigarettes per day (mean = 16.7 cigarettes per day, range = 10-25) 
for a duration of at least two years (mean = 7.1 years, range = 2-14). The 
Fagerström test for nicotine dependence (FTND: Heatherton, et al. 1991) 
served as a measure of nicotine dependence in smokers (mean score = 3.72, 
range = 0-7). Non-smokers had smoked less than five cigarettes during lifetime, 
except for one non-smoker who had smoked 20 cigarettes more than 10 years 
ago (mean = 2.1 cigarettes lifetime, range = 0-20). Although a study from 
Jacobsen (Jacobsen, et al. 2002) and colleagues suggests that nicotine does 
not alter the coupling between BOLD signal and neural activity, smokers 
abstained from smoking for three hours before scanning in order to avoid direct 
pharmacological confounds without introducing marked withdrawal effects. 
Both smokers and non-smoking controls abstained from alcohol for at least 24 
hours before scanning. All subjects provided written informed consent. The 
study was approved by the Ethics Committee of Erasmus Medical Center 
Rotterdam. 
 
Paradigm
An experimental paradigm, the attentional bias line counting task, was developed 
to detect brain regions specifically involved in attentional bias. During each trial 
in this task, a picture with either smoking-related stimuli (people engaged in 
smoking behavior or smoking-related objects) or neutral stimuli (people 
engaged in non-smoking behavior or neutral objects) was presented for 900ms 
(figure 1). A fixation cross was shown for an average of 2100ms (jittered from 
1100 to 3100ms, steps of 250ms), prior to the presentation of the next picture 
stimulus. Two to five lines were displayed within each picture, with semi-
randomly distributed spaces between these lines. Instructions for participants 
varied over blocks. In one block (counting lines) participants were asked to 
count the number of lines presented in the picture and to press the corresponding 
button as fast as possible. Note that for this task the content of the picture is 
irrelevant to task performance. In the other block (naming pictures) participants 
had to indicate whether the content of the picture included smoking stimuli or 
neutral stimuli by pressing the corresponding button. This is an easy and 
straightforward task, with low cognitive demands. Before each block, task-
instructions were presented for 4 seconds. Within each block, smoking and 
neutral pictures were semi-randomly presented. In total, 72 trials were presented 
in each of the following conditions: line-counting smoke picture (LCSP), line-
counting neutral picture (LCNP), picture-naming smoke picture (PNSP), and 
picture-naming neutral picture (PNNP). Based on these conditions three 
contrasts were defined for analyses. First, the LCSP and LCNP relative to 
baseline contrast (overall cognitive effort) was computed to assess the overall 
effects of line counting irrespective of picture content. Brain activation related 
to this contrast reflects overall cognitive effort during line counting in smoking 
and neutral pictures. Second, the LCSP minus LCNP contrast (attentional bias) 
represents brain activation associated with attentional bias for smoking stimuli, 
as all brain activation related to line counting is cancelled out. What remains is 
the brain activation reflecting the task irrelevant (automatic) attentional bias for 
the smoking pictures. Third, the LCSP minus PNSP contrast (cue-exposure 
corrected attention) was computed. This contrast reflects attention to the 
smoking pictures during line counting while correcting for cue reactivity to 
these smoking cues, and therefore serves as a check to ensure that group 
Figure 1 
The attentional bias line counting task
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differences in brain activation in the attentional bias contrast (LCSP minus 
LCNP) does not solely reflect cue-reactivity induced by the content of the 
pictures.
Procedures 
After arrival, participants approved participation by signing informed consent. 
Breath carbon monoxide concentration was measured in all subjects using a 
calibrated Micro+ Smokerlyzer (Bedfont Scientific Ltd., Rochester, UK) to 
objectively define smokers and non-smokers. In addition, smokers completed 
the FTND (Heatherton, et al. 1991) to measure nicotine dependence and the 
Questionnaire of Smoking Urges (QSU: Cox, et al. 2001) to indicate their current 
subjective craving for a cigarette. All subjects completed several questionnaires, 
including the positive affect negative affect scale (PANAS: Watson, et al. 1988) 
and the Snaith-Hamilton Pleasure Scale (SHAPS: Snaith, et al. 1995) to measure 
mood state and anhedonia. These questionnaires were administered in order to 
ensure that differences between smokers and non-smoking controls were not 
the result of differences in mood states. Participants performed two tasks 
during fMRI scanning. The attentional bias line counting task was administered 
after a cognitive paradigm (not addressed in this paper). Smokers completed 
the QSU again immediately after the scanning session.
 
Imaging acquisition and data analysis 
Blood oxygen level-dependent (BOLD) fMRI data were acquired on a 3T 
General Electric Healthcare (HDx platform, Milwaukee, WI) scanner. Functional 
T2*-weighted images were acquired in 26 axial slices (thickness = 3.5 mm, 
interslice gap = 0.5 mm) covering the entire supratentorial brain with a repetition 
time (TR) of 2000 ms, echo time (TE) of 30 ms, field of view (FOV) of 220 mm, 
and matrix size 96 x 64. A structural 3 dimensional inversion recovery (IR) fast 
spoiled gradient recalled echo (FSPGR) T1-weighted image was acquired in 
192 axial slices (thickness = 1.6 and 0.8 mm overlap) with TR: 10.6 ms, TE: 2.2 
ms, FOV: 250 mm, and matrix size 416 x 256 mm.
 Imaging data were analyzed using SPM5 (Statistical Parametric 
Mapping; Wellcome Department of Cognitive Neurology, London, United 
Kingdom). Preprocessing of the functional data included realignment and slice 
time correction. Next, the anatomical scan was co-registered to the first T2*-
weighted image. The data was normalized using a SPM T1 template and the 
data was spatially smoothed using a Full Width Half Maximum Gaussian kernel 
of 8 mm. The four conditions; LCSP, LCNP, PNSP, PNNP were modeled in the 
context of the general linear model, using delta functions convolved with a 
canonical hemodynamic response function. The three contrasts for overall 
cognitive effort, attentional bias and cue exposure corrected attention were first 
calculated at single-subject level, and subsequently fed into second-level 
(random effects) analyses for main effects (one-sample t-test) and between-
group comparisons (independent samples t-test). Differences between groups 
for all contrasts are reported at p< 0.001 (uncorrected) masked inclusively with 
the appropriate main effect to reduce the number of comparisons. Finally, the 
increase in craving during task performance was calculated for each smoker 
and whole brain correlations were performed on the attentional bias (LCSP 
minus LCNP) contrast. Craving related brain activation in attentional bias is 
reported at p< 0.001 (uncorrected). 
 Demographics and task performance data were analyzed in SPSS 
(Version 16.0 for Windows; SPSSInc., Chicago, IL). We used repeated measures 
ANOVA to analyze task performance (separately for accuracy and reaction 
times during line counting) with group as the between subject factor and picture 
type (smoking picture or neutral picture) as the within subject factor.
 
Results
Questionnaires and Breath analysis
As expected, smokers showed higher CO breath levels (mean = 8.3, range 3-21) 
than non-smoking controls (mean = 1.5, range 0-5), t(36) = 6.55, p< 0.001. 
Groups did not differ on anhedonia, positive and negative affect scores (all p’s> 
.05). Smokers differed in their changes in craving after the attentional bias line 
counting task. Twelve out of eighteen smokers showed an increase in craving 
after the attentional bias line counting task. However, this increase was not 
significant for those smokers with all fMRI data available t(17) = 1.72, p= 0.1. 
This non-significant result is probably due to low statistical power, because when 
all available smokers were included (n=20) the p-value was found to be 0.04.
 
Behavioral performance
Both groups performed the line counting task accurately: overall accuracy was 
92%. Repeated measures analysis of accuracy performance did not show a 
Neurobiological substrate of smoking related attentional biasChapter Seven   
 
144 145
main effect for group. A main effect of picture content on accuracy was found, 
F(1,35) = 4.82, p< 0.05, with both groups performing less accurately at counting 
lines in smoking pictures than in neutral pictures (91% versus 92%). The picture 
x group interaction was not significant. With regard to reaction times, no main 
effect for group or picture was found. However, a trend for the main effect of 
picture, F(1,35) = 3.98, p< .1, could be observed indicating that reaction times 
to smoking pictures were slightly faster (791ms versus 796). No picture x group 
interaction was found, F(1,35) = 0.82, p< .05,. Although the interaction was 
non-significant, we observed that the difference in reaction times between 
smoking and neutral pictures was significant in controls, t(17) = 2.43, p< 0.05 
but not in smokers. Non-smoking controls were significantly faster on indicating 
the number of lines in smoking pictures than in neutral pictures. 
 
fMRI results
Overall cognitive effort (LCSP and LCNP) was associated with robust brain 
activation in bilateral occipital, parietal, and prefrontal brain regions, as well as in 
motor areas, the ACC and several subcortical regions (table 1). Smokers showed 
less brain activation associated with overall cognitive effort than controls in the 
rvACC, the left caudate nucleus, left intraparietal lobe, left lingual gyrus and the 
left parahippocampal gyrus (table 1). Both groups showed attentional bias 
(LCSP minus LCNP) related brain activation in visual brain regions (table 2). 
Most importantly, smokers showed significantly more attentional bias related 
brain activation as compared to controls in the rostral zone of the dACC, 
extending into supplementary motor area (as functionally defined by 
Ridderinkhof et al., (2004a), the right superior parietal lobe (SPL) and the left 
superior temporal gyrus (STG) (table 2, figure 2). Both groups showed more 
activation in visual, parietal and motor areas (table 2) during cue-exposure 
corrected attention (LCSP minus PNSP). Importantly, smokers, as compared to 
controls, showed more brain activation related to cue-exposure corrected 
attention for smoking cues in the rostral zone of the dACC (x=15 y=30 z= 33, 
Z=3.13; table 2) confirming that attentional bias related brain activation in this 
region does not arise from mere cue-exposure effects. 
 Self-reported craving in smokers during the attentional bias paradigm 
was significantly associated with activation in the right putamen (x=24 y =-6 z 
=24 Z =3.63) and the left insula (x=-36 y=-39 z=18 Z=3.52; figure 3).
 
MNI Coordinates MNI Coordinates
x y z Z-value x y z Z-value
Overall cognitive effort (LCSP and LCNP)
Main effects smokers and controls Main effects smokers and controls continued
l- occipital -42 -75 -6 > 8 l- PCG -27 -12 54 5.07
l- precuneus l- PCG -30 -15 66 4.95
l- SPL r- culmen 9 -54 -9 4.96
r- MOG 27 -93 6 > 8 l- IFG -51 3 33 4.93
r- SOG 30 -84 24 7.79 r- PHG 24 -30 -6 4.89
r- precuneus r- thalamus 18 -36 0 4.71
r- SPL
l- medial frontal gyrus -3 0 57 6.32 Smokers > Controls
l- ACC - - -
r- middle frontal gyrus 27 -12 63 5.95
r- PCG 36 -18 63 5.43 Smokers < Controls
l- PHG -21 -36 -3 5.91
l- caudate -24 -42 6 5.43 r-rvACC 15 36 3 3.81
r- IFG 45 3 30 5.31 l-lingual gyrus -12 -48 -3 3.64
r- IPL 45 -39 51 5.30 l-IPL -63 -27 27 3.60
r- postcentral gyrus 48 -24 54 4.56 l-PHG -18 -54 -9 3.39
Table 1 
Main and group effects for overall cognitive effort (LCSP and LCNP)
Note table 1 Main effects are reported at p<0.05 FWE corrected. Group effects are masked for 
main effects and reported at p<0.001 uncorrected. Abbreviations: PCG, precentral gyrus; SPL, 
superior parietal lobe; MOG, middle occipital gyrus; SOG, superior occipital gyrus; ACC, anterior cin-
gulate cortex; PHG, parahippocampal gyrus; IFG, inferior frontal gyrus; rvACC, rostro-ventral anterior 
cingulate cortex; IPL, inferior parietal lobe. 
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MNI coordinates
x y z Z-value
Attentional bias (LCSP minus LCNP)
Main effects smokers and controls
l-OCC/ITG 45 -66 -3 5.16
l-MOG -45 -81 3 4.54
l-MOG -48 -75 -9 3.72
r-MTG 51 -75 6 4.21
r-MOG 45 -81 6 4.18
Cue exposure corrected attentions (LCSP minus PNSP)
Main effects smokers and controls
r-MFG 27 -9 57 4.89
r- precuneus 27 -75 39 4.76
r-IPL 42 -39 51 4.66
l-MOG -30 -87 15 4.20
r-IFG 51 3 24 4.16
r-STG 54 -21 9 3.86
l-lingual gyrus -9 -87 2 3.81
l-precuneus -18 -72 51 3.42
l-culmen -6 -63 -12 3.41
MNI coordinates
x y z Z-value
Smokers >Controls
l-STG -60 -12 -3 3.71
r-dACC 9 21 48 3.63
r-SPL 27 -75 39 3.18
Smokers< Controls
- - -
Smokers >Controls
r-dACC 15 30 33 3.13
Smokers <Controls
- - -
Table 2 
Main and group effects on attentional bias (LCSP minus LCNP) and cue exposure corrected attention (LCSP 
minus PNSP)
Figure 2 
Group effect in the dACC and the right SPL for the LCSP versus LCNP contrast
Figure 3 
Correlation between craving and attentional bias related brain activation in the left insula and right 
putamen
Note figure 2 all effects and details are listed in table 2. 
Note table 2 Main effects are reported at p<0.05 FDR corrected. Group effects are masked for main effects 
and reported at p< 0.001 uncorrected. Abbreviations: OCC, occipital; ITG, inferior temporal gyrus; MOG, middle 
occipital gyrus; MFG: middle frontal gyrus; STP, superior temporal gyrus; dACC, dorsal anterior cingulate cortex.
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Discussion
To our knowledge, this is the first controlled study showing the neural correlates 
of attentional bias in smokers. In line with our hypothesis, we observed greater 
brain activation in smokers relative to healthy controls in the dACC and right SPL 
during an attentional bias task paradigm. Unexpectedly, a similar effect was also 
observed in the left STG. Importantly, we showed that dACC hyperactivation in 
smokers could not be attributed to processes arising from mere cue-exposure or 
cue-exposure related phenomena, including enhanced familiarity to smoking 
cues and arousal. Additionally, activations in the left insula and the right putamen 
were found to be associated with attentional bias related craving. Further, in line 
with the cocaine study of Goldstein et al. (2009a) we found that smokers showed 
hypoactivation in the rvACC during overall cognitive effort. 
 Current theories of ACC function suggest that the dorsal region of the 
ACC is involved in conflict monitoring (Botvinick, et al. 2004; Egner, et al. 2008; 
Etkin, et al. 2006; Fan, et al. 2008; Haas, et al. 2006) and reducing possible 
interference effects from distracting stimuli, by boosting attention toward task 
relevant stimuli (Fan, et al. 2008; Weissman, et al. 2004; Weissman, et al. 2005). 
Therefore, the current finding that attentional bias in smokers is associated with 
dACC hyperactivation suggests that smokers experience more cognitive conflict 
and need more focused (top-down) attention when performing a simple cognitive 
task (line counting) while smoking stimuli are present in the background. This 
enhanced activation in the dACC is probably needed to compensate the effects 
of the automatic (bottom-up) distraction by the conditioned smoking cues. 
 Attentional bias associated brain activation was also observed in the 
right SPL and the left STG. The SPL has been implicated in top-down attention 
processing (Szczepanski, et al. 2010), more precisely, it has been suggested that 
the SPL is involved in directing attention in space (Cavanna, et al. 2006). 
Therefore, the activation in the SPL is in accordance with our interpretation that 
smokers have to employ more attentional top-down resources to stay involved in 
the primary task. Hyperactivation in the STG is in line with previously observed 
temporal activation in several cue reactivity studies (David, et al. 2007; Due, et al. 
2002; Garavan, et al. 2000; Lee, et al. 2005; McBride, et al. 2006; Park, et al. 
2007; Schneider, et al. 2001). Although speculative, we suggest that this effect is 
related to greater in-depth visual processing, in accordance with a theory of STG 
function proposed by Kartnath (2001). The hypothesis of more elaborate visual 
processing receives some support from the fact that STG hyperactivation in 
smokers was not observed during cue exposure corrected attention. 
 The current finding of hyperactivation in the dACC in smokers is in 
contrast with the observed hypoactivation of this region in Goldstein et al. 
(2009a) during performance of the cocaine word Stroop task. There may be 
several reasons for this discrepancy. First, the observed hypoactivation in the 
Goldstein et al. (2009a) study was not specific to drug cues and may therefore 
reflect a more general cognitive deficit in drug abusers and not a specific 
attentional bias process. Second, the cocaine Stroop task as employed in their 
study also included a monetary reward component, which may have biased 
dACC activation since this region is also involved in reward based decision 
making (Bush, et al. 2002; Fujiwara, et al. 2009). Third, the substance users in 
Goldstein et al. (2009a) consisted of cocaine users, who may not be comparable 
to our smoking group. It is known that cocaine users have more pronounced 
cognitive dysfunctions (Verdejo-Garcia, et al. 2007a; Verdejo-Garcia, et al. 
2007b) as compared to smokers. Finally, we cannot unequivocally state that our 
smoking group is nicotine dependent as FTND scores indicate medium 
dependence levels only. However, smokers in the current study smoked at least 
ten cigarettes per day, and half of our sample smoked at least 20 cigarettes per 
day. Still, it would be important to replicate the current finding of dACC 
hyperactivation in another population diagnosed with substance dependence.
 In the present study, we did not observe attentional bias related brain 
activation in brain regions involved in salience attribution or stimulus driven 
attention including the OFC, ventral striatum and amygdala. Activation in these 
brain regions was expected since environmental drug cues tend to capture the 
attention of drug users, due to the established salience of these cues (Robinson, 
et al. 2008). The absence of activation in these regions is probably due to our fast 
event-related paradigm that was specifically designed to measure attentional 
bias and to keep other constructs such as prolonged cue-exposure and emotional 
involvement to a minimum. In line with Goldstein et al. (2009a) we did find more 
pronounced hypoactivation in smokers in the rvACC during overall cognitive 
effort. This finding supports the notion that hypoactivation in this region is not 
related to specific drug cue processing or attentional bias in substance dependent 
patients. The rvACC facilitates emotional processing, and is involved in emotional 
conflict, most likely by salience attribution and emotional responsiveness. It has 
been suggested that hypoactivation in the rvACC during focused attention 
contributes to the dynamic interplay between continuous cognitive and emotional 
processes (Gusnard, et al. 2001; Raichle, et al. 2001). The hypoactivation in 
smokers during overall cognitive effort in this region may therefore reflect a 
conflict between cognitive performance and emotional involvement as 
experienced by smokers.
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 We also found that subjective craving induced by the attentional bias 
paradigm was related to activation in the insula and putamen. This suggests that 
these regions are involved in the reciprocal relation between attentional bias and 
craving (Field, et al. 2009). The insula has currently attracted attention as an 
important brain region in addiction by representing conscious urges to the drug 
of abuse via connections with the ventromedial prefrontal cortex and the 
amygdala (Naqvi, et al. 2007; Naqvi, et al. 2009). Furthermore, Paulus et al. 
(2005) demonstrated that activation in the insula, amongst other brain regions, 
predicted relapse in abstinent methamphetamine dependent subjects. In 
addition, the putamen is supposed to play a role in addictive behavior through 
modulation of the mesolimbic dopaminergic system via D1 and D2 receptors (Ito, 
et al. 2002; Naha, et al. 2009). 
 A limitation of the current study is that behavioral measures are not fully 
supportive for attentional bias to conditioned smoking cues in smokers. However, 
reaction time data did show that non-smoking controls were faster in counting 
the number of lines in smoking pictures than in neutral pictures, whereas this 
difference was not evident for smokers. These results suggest that non-smoking 
controls are faster in counting lines in smoking pictures by ignoring the content 
of the picture, whereas smokers are less able to ignore the content of the smoking 
related pictures. However, such an interpretation must be viewed with caution 
due to the lack of a significant omnibus interaction effect. 
 To conclude, we demonstrated, for the first time, hyperactivation in 
smokers compared to non-smokers in the dACC, the right SPL and the left STG 
associated with attentional bias. Furthermore, we demonstrated that brain 
activation related to attentional bias in the dACC cannot be attributed to other 
processes as a result of cue-exposure. As converging evidence suggests that 
ACC dysfunction may be a biomarker for addiction (Goldstein, et al. 2009a; 
Hong, et al. 2009; Ma, et al. 2010; Romero, et al. 2010), it would be interesting to 
further investigate the differential contribution of the dorsal and ventral parts of 
the ACC in various specific task paradigms. It has also been hypothesized that 
dopamine plays an important role in attentional bias and craving (Franken, et al. 
2005; Franken, et al. 2004). The most important regions found to be implicated 
in attentional bias and craving in the current study, the dACC, the putamen and 
the insula, all have efferent and afferent dopaminergic projections. It would 
therefore be a future research agenda to examine the role of dopamine in 
attentional bias and craving related brain activation.
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Introduction
Substance abuse and addiction are associated with enhanced processing of 
substance-related cues (e.g., Franken, et al. 2003; Kuhn, et al. 2011). Attentional 
bias is one of the mechanisms underlying enhanced processing of these cues and 
is defined as the tendency of substance dependent people to automatically and 
involuntarily allocate and maintain their attention to conditioned drug cues (for 
reviews see: Field, et al. 2008; Franken 2003; Robbins, et al. 2004). Attentional 
bias has been linked to craving (Field, et al. 2009) as well as to the temptation to 
use substances (Waters, et al. 2012), treatment outcome (Carpenter, et al. 2006; 
Cox, et al. 2002) and relapse rates (Marissen, et al. 2006; Waters, et al. 2003). 
Preliminary evidence has further suggested that attentional bias extinction training 
reduces conditioned cigarette craving in smoking males (Attwood, et al. 2008) 
and drinking behavior in alcohol dependent patients (Fadardi, et al. 2009; 
Schoenmakers, et al. 2010). However, it seems that a single training session is not 
successful to reduce smoking behavior (Attwood, et al. 2008; Field, et al. 2009; 
McHugh, et al. 2010b).
 Theoretical models propose that attentional bias is a consequence of a 
dopamine signal that triggers attention to substance-related cues (Franken 2003; 
Robinson, et al. 2003). After repeated drug intake, substance-related cues 
become conditioned cues and elicit dopaminergic activity (Volkow, et al. 2006; 
Wong, et al. 2006; Zijlstra, et al. 2008) thereby signaling the expectation of a future 
reward (i.e., the intake of the substance of abuse). Gradually, the dopaminergic 
system becomes sensitized for substance-related cues so that they become 
extremely salient, become the focus of attention and elicit behaviors like drug 
seeking and consumption (Phillips, et al. 2003; Robinson, et al. 2008). 
Consequently, it can be predicted that attentional bias will be attenuated when 
dopamine is no longer able to signal the salience of conditioned substance-related 
cues. A few studies tested this hypothesis. Two studies used acute tyrosine/
phenylalanine depletion to reduce dopamine levels in smokers (Hitsman, et al. 
2008; Munafo, et al. 2007). Both studies found that attentional bias in smokers 
was reduced when dopamine levels were decreased. Similar results were found in 
heroin users, in which attentional bias was attenuated after a single dose of the 
dopamine antagonist haloperidol (Franken, et al. 2004). As these studies did not 
measure brain activation, it is not yet known whether a pharmacologically induced 
reduction in dopamine also reduces brain activation in those regions involved in 
salience detection and attentional bias. Only recently progress has been made to 
elucidate the neurobiological substrate of attentional bias. Functional magnetic 
resonance imaging (fMRI) has shown that attentional bias is associated with 
Abstract
Attentional bias in substance dependent individuals is the tendency to 
automatically direct the attention to substance-related cues in the environment. 
Attentional bias is known to be associated with clinical measures such as relapse 
or successful quitting in smokers. It has been suggested that attentional bias 
emerges as a consequence of dopaminergic activity evoked by substance-
related cues. The current fMRI study employed a dopaminergic challenge in 
order to test whether brain activation associated with attentional bias in smokers 
could be modulated by a dopamine antagonist. 25 smokers were compared with 
24 controls. Participants were scanned twice while performing a pictorial 
attentional bias task. Haloperidol (2mg), a selective D2/D3 dopamine antagonist, 
or placebo was orally administered four hours before each scanning session in a 
double-blind randomized cross-over design. Imaging analyses were performed 
in a-priori selected regions of interest. Results showed that smokers had 
enhanced brain activation compared to controls in the dorsal anterior cingulate 
cortex (dACC), right dorsolateral prefrontal cortex (r-DLPFC) and left superior 
parietal lobe (l-SPL) after placebo. Group x Medication interactions were found 
in the dACC and r-DLPFC, with no differences between groups in these regions 
after haloperidol. The current findings suggest that a pharmacologically induced 
reduction in dopamine normalizes brain activation associated with attentional 
bias in the dACC and DLPFC in smokers, probably because salience of these 
cues is no longer detected when dopamine activity is reduced.
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increased activation in brain regions innervated by dopaminergic projection such 
as the ACC and the ventral striatum (Janes, et al. 2010a; Luijten, et al. 2011c; 
Nestor, et al. 2011; Vollstadt-Klein, et al. in press). In addition, dorsolateral and 
inferior frontal regions, as well as the insula, amygdala, superior parietal and 
superior and middle temporal gyri were implicated in attentional bias for 
substance-related cues (Ersche, et al. 2010; Hester, et al. 2009a; Janes, et al. 
2010a; Luijten, et al. 2011c; Vollstadt-Klein, et al. in press). Ersche et al. (2010) 
showed that a dopamine agonist enhanced attentional bias and associated brain 
activation in the left ventral prefrontal cortex and the cerebellum in high-
compulsive stimulant dependent individuals, whereas it reduced activation in 
these regions in low-compulsive stimulant users. The Ersche et al. study could not 
demonstrate a reduction in attentional bias and associated brain activation 
following administration of the dopamine antagonist amilsulpride. Consequently, 
it is still unknown whether a pharmacologically induced reduction in dopamine 
levels could normalize brain activation associated with attentional bias. In the 
current study attentional bias related brain activation was measured twice in 
smokers and non-smokers using an attentional bias task involving pictorial stimuli 
(Luijten, et al. 2011c). The D2/D3 dopamine antagonist haloperidol was used to 
reduce dopamine levels and was compared to placebo in a double-blind 
randomized cross-over design. Based on theoretical accounts and our previous 
study in smokers (Luijten, et al. 2011c), we hypothesized that brain activation 
associated with attentional bias in dopaminergic innervated regions such as the 
ACC and other prefrontal regions will normalize in smokers after haloperidol 
administration. That is, no differences between smokers and non-smokers in 
attentional bias related brain activation were expected after haloperidol. 
 
Materials and methods
Participants
Twenty-five smokers and twenty-five non-smokers participated in this study. 
Data from one non-smoker was discarded due to technical problems during data 
analyses. The final sample consisted of 25 smokers (mean age = 22.56 years, 
SD = 2.84, 18 male) and 24 non-smokers (mean age = 21.75 years, SD = 1.78, 
14 male). Smokers smoked at least 15 cigarettes per day (M = 19.12, SD = 3.37; 
range 15-25) for a duration of at least three years (M = 7.20, SD = 3.01, range= 
3-14). The average score on the Fagerström Test for Nicotine Dependence (Vink, 
et al. 2005) for smokers was 3.80, SD = 3.37, range= 1-8. Non-smokers had 
smoked ten cigarettes or less during their lifetime (M = 1.73, SD = 2.62, range= 
0-10). Participants underwent a medical examination by a psychiatrist to assure 
eligibility for a single dose of 2 mg oral haloperidol (see supplementary materials 
for details). Exclusion criteria for both groups were (a) current substance abuse 
or dependence (other than nicotine for smokers), (b) any physical or psychological 
illness, (c) any use of psychotropic medication or medication that may affect 
blood circulation and/or respiration, (d) fMRI contraindications and (e) left 
handedness. There were no significant differences between the groups in age, 
t(47) = 2.40; ns, or gender, χ2 (1, n= 49) = 0.32; ns. The study was conducted in 
accordance with the Declaration of Helsinki and all procedures were carried out 
after participants signed informed consent. The ethics committee of Erasmus 
MC-University Medical Centre Rotterdam approved this study.
Dopaminergic manipulation
Participants were administered a single oral dose of 2 mg haloperidol and a 
placebo employing a double-blind randomized cross-over design. Haloperidol is 
a selective post-synaptic dopamine D2/D3 receptor antagonist. Using positron 
emission tomography (PET), it has been shown that striatal D2 receptor 
occupancy three hours after administration of 2mg haloperidol is 18% and 52% 
after six hours (Nordstrom, et al. 1992). The present fMRI session took place four 
hours after administration which, according to the Nordstrom study, results in 
about 30% D2 receptor occupancy. The dose and time interval was further based 
on previous studies using haloperidol (Franken, et al. 2008; Franken, et al. 2004; 
Mahler, et al. 2005) that showed attenuated cue-reactivity in smokers (Mahler, et 
al. 2005) and attentional bias in heroin users (Franken, et al. 2004) after 
haloperidol. No side effects were reported by the participants. Participants’ 
guesses on the type of medication they received for each scanning session were 
not above chance (48.97% of the participants correctly indicated in which test 
occasion they received haloperidol, p= 0.56).
Procedures
Two scanning sessions were scheduled that were separated by one week. 
Smokers were not allowed to smoke after taking the medication until scanning 
was finished to ensure that indirect nicotine effects on dopamine levels did not 
interfere with the binding of haloperidol to D2/D3 receptors in the brain. Breath 
carbon monoxide (CO) concentration was measured in all subjects using a 
calibrated Micro+Smokerlyzer (Bedfont Scientific Ltd., Rochester, UK). Smokers 
completed the FTND (Heatherton, et al. 1991; Vink, et al. 2005) to measure 
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nicotine dependence on the first scanning session only and the Questionnaire of 
Smoking Urges (QSU: Cox, et al. 2001) to indicate their current subjective craving 
for a cigarette during both scanning sessions. Participants performed the 
attentional bias line counting task during fMRI scanning. Smokers indicated their 
craving levels on a 100-point visual analogue scale (VAS) immediately before 
and after task performance. 
 
Task paradigm
The attentional bias line counting (ABLC) task was used to measure brain 
activation related to attentional bias, and has previously been described by Luijten 
et al. (2011c). In each trial, a picture with either smoking-related stimuli (people 
engaged in smoking behavior or smoking-related objects) or neutral stimuli 
(people engaged in non-smoking behavior or neutral objects) was presented for 
900ms (figure 1). Two to five lines were displayed within each picture, with semi-
randomly distributed spaces between these lines. Instructions for participants 
varied over blocks. In one block (counting lines) participants were asked to count 
the number of lines presented in the picture and to press the corresponding 
button as fast as possible. In the other block (naming pictures) participants had to 
indicate whether the content of the picture included smoking-related stimuli or 
neutral stimuli by pressing the corresponding button. Within each block, smoking-
related and neutral pictures were semi-randomly presented. Seventy-two trials 
were presented for each condition: line-counting smoke picture (LCSP), line-
counting neutral picture (LCNP), picture-naming smoke picture (PNSP), and 
picture-naming neutral picture (PNNP). Based on these conditions four contrasts 
can be defined for analyses. The main contrast reflecting brain activation 
associated with attentional bias is the LCSP minus LCNP contrast. For the line 
counting condition smoking cues are unrelated to task performance, so that brain 
activation for LCSP relative to LCNP shows the disruption of ongoing behavior 
(line counting) because of the enhanced attentional and motivational properties 
of the smoking pictures. The other three contrasts do not reflect attentional bias 
and accordingly are not associated with the main focus of this paper. See 
supplementary materials for the definition and results of these contrasts.
 
 
Data analyses questionnaires and behavioral 
performance
A Group (Smokers versus Non-smokers) x Medication (Placebo versus 
Haloperidol) Repeated Measures Analyses of Variance (RM-ANOVA) was applied 
to analyze CO levels. A Group x Medication x Picture (Smoking-related pictures 
Figure 1 The attentional bias line counting task
versus Neutral pictures) RM-ANOVA was performed to investigate reaction times 
and accuracy during line counting. QSU craving scores in smokers were analyzed 
with Medication as a single within subject factor. To investigate the effect of task 
performance on craving levels a Medication x Time (before versus after task 
performance) RM-ANOVA was performed for craving VAS scores.
Image acquisition
Imaging data were acquired on a 3T GE Healthcare (The Discovery® MRI 750 
3.0T, Milwaukee, US) scanner. Blood oxygen level-dependent (BOLD) sensitive 
functional T2*-weighted images were acquired in 44 axial slices covering the 
entire supratentorial brain with a repetition time (TR) of 2500 ms, echo time (TE) 
of 30 ms, field of view (FOV) of 240 mm, and isotropic voxel size of 2.5 mm3. A 
structural 3-dimensional (3D) inversion recovery fast spoiled gradient echo T1-
weighted image was acquired in 164 contiguous axial slices with TR of 7.9 ms, TE 
of 3.1 ms, FOV of 240 mm, and isotropic voxel size of 1 mm3 for anatomical 
reference.
Image processing
Imaging data were analyzed using SPM8 (Statistical Parametric Mapping; 
Wellcome Trust Centre for Neuroimaging, London, UK). Preprocessing of the 
functional data included realignment and unwarping of functional images. The 
anatomical scan was coregistered to the mean T2*-weighted image and 
subsequently segmented into grey and white matter. Segmentation parameters 
were used for normalization using the SPM T1 MNI template. Functional scans 
were spatially smoothed using a full-width at half-maximum Gaussian kernel of 8 
mm. Correct trials for the four conditions (LCSP, LCNP, PNSP, PNNP) were 
modeled in the context of the general linear model for both medication conditions, 
using delta functions convolved with a canonical hemodynamic response function. 
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Incorrect trials were modeled separately as regressors of non-interest. The 
contrast reflecting brain activation associated with attentional bias (LCSP minus 
LCNP) was calculated for each individual for both medication conditions. 
Subsequently, a random effects RM-ANOVA with Group as between subject factor 
and Medication as within subject factor was performed to investigate Group x 
Medication interactions. Between Group and between Medication t-tests were 
performed (i.e., differences between groups for placebo and haloperidol separately 
and medication effects in smokers and non-smokers separately), masked 
inclusively by voxels showing a Group x Medication interaction in the RM-ANOVA 
(p< 0.01 uncorrected), thus ensuring that group differences and medication 
effects met the requirement of a Group x Medication interaction. Furthermore, we 
report results for the between group two sample t-test for placebo without 
masking for the interaction effect, with the aim to replicate findings from our 
previous study (Luijten, et al. 2011c). Finally, cue induced craving during task 
performance was calculated for each smoker for placebo and haloperidol 
separately (craving VAS score after task performance minus craving VAS score 
before task performance) and was correlated with brain activation associated with 
attentional bias in each medication condition separately. Given findings of previous 
studies the ACC, superior parietal lobe (SPL), superior temporal gyrus (STG), 
dorsolateral prefrontal gyrus (DLPFC), inferior frontal gyrus (IFG), amygdala, 
insula and nucleus accumbens (NACC) were selected as a-priori regions of 
interest. ROIs were defined using the automatic anatomical labeling (AAL) atlas 
(Tzourio-Mazoyer, et al. 2002). As the NACC is not included in the AAL atlas, a 10 
mm sphere with MNI coordinates ±10 12 -2 was created as a ROI for the NACC 
(Knutson, et al. 2008). Results were thresholded at p< 0.05, Family Wise Error 
(FWE) corrected for multiple comparisons across the search volume (Small 
volume correction: Friston, et al. 1996; Worsley, et al. 1996). In order to do so, 
analyses were first thresholded at p< 0.001 uncorrected with 20 contingently 
activated voxels (160mm3), and then corrected using a small volume correction 
(p< 0.05 FWE corrected) in which the search volume was defined by the AAL 
template corresponding to the a-priori defined ROI. 
 
Results
Breath CO levels and questionnaire data
Smokers had a higher breath CO concentration (Mhaloperidol= 6.20, SD = 3.39, 
Mplacebo= 6.72, SD = 3.50) than non-smokers (Mhaloperidol= 1.42, SD = 0.78, 
Mplacebo= 1.67, SD = 0.64), F(1,47) = 55.15, p< 0.001. CO levels did not differ 
between medication conditions, F(1,47) = 1,91, ns. Haloperidol did not influence 
QSU (Mhaloperidol= 38.03, SD = 11.80, Mplacebo= 39.71, SD = 11.48) and VAS 
craving scores. However, VAS craving scores increased after task performance 
confirming the presence of cue-evoked craving, F(1,24) = 21.36, p<.001, 
(Mhaloperidol/before= 58.96, SD = 21.49, Mhaloperidol/after= 67.00, SD = 17.84, 
Mplacebo/before= 62.60, SD = 23.21, Mplacebo/after= 68.64, SD = 23.38). 
Behavioral performance
Accuracy scores and reaction times are displayed in figure 2. Repeated measures 
analysis for performance accuracy did not show a main effect of group F(1,47) = 
2.96, ns. A main effect of medication showed that haloperidol decreased task 
performance relative to placebo, F(1,47) = 10.36, p< 0.01. Furthermore, a main 
effect of picture was found for accuracy, F(1,47) = 11.10, p< 0.01, with both 
groups performing less accurately for line counting in smoking-related pictures 
than in neutral pictures. Regarding reaction times, no main effect of group or 
medication was found, both F’s< 3.71, ns. A main effect of picture was found, 
F(1,37) = 4.14, p< .05, indicating that reaction times to smoking-related pictures 
were faster. No interaction effects were found, all F’s< 2.87, ns. The combination 
of reduced accuracy and faster reaction times to smoking-related pictures 
suggests that there may be an impulsive response style to smoking-related 
pictures in both groups.
Figure 2 
Behavioral measures for the attentional bias line counting task 
Note figure 2 RM-ANOVA for accuracy rates and reaction times during line counting showed that both smokers 
and non-smoking controls were less accurate for smoking related pictures and showed shorter reaction times 
for smoking related pictures. Both groups were less accurate after haloperidol.
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Imaging results
After placebo, smokers showed attentional bias related brain activation (i.e., 
more activation than controls on the LCSP minus LCNP contrast) in the 
dorsal zone of the ACC (dACC), the left superior parietal lobe (SPL) and the 
right DLPFC. After masking for the Group x Medication interaction, group 
differences remained present in the dACC and the right DLPFC. No differences 
between groups were found in attentional bias related brain activation after 
haloperidol administration. See figure 3 and table 1 for details. These findings 
suggest that the dACC, right DLPFC left SPL are involved in attentional bias 
in smokers. Group x Medication interactions and the lack of group differences 
after haloperidol suggest that brain activation associated with attentional bias 
in smokers is normalized when dopamine levels are reduced by haloperidol. 
Paired t-tests, however, did not reveal significant medication effects in 
either smokers or non-smokers at the FWE corrected level. We therefore 
extracted parameter estimates in those regions showing a whole brain group 
x medication interaction and significant group differences (dACC and right 
DLPFC). Subsequently, paired sample t-tests in SPSS were performed 
for both groups separately. Results showed a significant reduction in brain 
activation in smokers for the right DLPFC, t(24) = 3.07, p< 0.01, and a trend 
for the dACC, t(24) = 1.99, p< 0.058. Brain activation in the right DLPFC was 
significantly increased by haloperidol for non-smokers, t(23) = 2.67, p<0.05. 
 Brain activation associated with attentional bias in smokers was 
neither positively nor negatively correlated with cue evoked craving during task 
performance in any of our a-priori defined regions of interest. See supplementary 
table 7 and 8 for (non-significant) correlation coefficients between craving and 
brain and behavioral indices of attentional bias.
Figure 3
Group differences for brain activation associated with attentional bias  
Note figure 3 * p< 0.05 FWE small volume corrected both with and without masking for the Group x 
Medication interaction, + p < 0.05 FWE small volume corrected only without masking for the Group x 
Medication interaction. The values on the Y-axis represent contrast values for LCSP minus LCNP, con-
sequently positive values on the Y-axis indicate more brain activation for line counting when smoking 
related pictures are presented on the background relative to when neutral pictures are presented on 
the background. l: left; r: right; dACC: dorsal anterior cingulate gyrus; DLPFC: dorsolateral prefrontal 
cortex; SPL: superior parietal lobe; LCSP: line counting smoking picture; LCNP: line counting neutral 
picture.
MNI coordinates
X Y Z Z-valuea mm3
Placebo
Smokers > Controls
left dACC -2 -2 36 4.00 360b
right DLPFC  24  44 46 4.03 456  
left SPLc -34 -46 56 3.85 616
Smokers < Controls - - -
Haloperidol
Smokers > Controls - - -
Smokers < Controls - - -
Table 1
Group differences for brain activation associated with attentional bias
Note table 1 a p < 0.05 FWE small volume corrected, b After masking with the Group x Medication 
interaction the size of this cluster reduced to 176 mm3, c After masking with the Group x Medication 
interaction this cluster no longer met the requirements to correct for multiple comparisons. dACC: 
dorsal anterior cingulate cortex; DLPFC: dorsolateral prefrontal gyrus; SPL: superior parietal lobe.
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Discussion
The main purpose of the current study was to investigate whether brain 
activation associated with attentional bias in smokers could be modulated by 
a dopamine antagonist. The current results provide support for the proposed 
role of dopamine in attentional bias. In line with our hypotheses, smokers 
showed increased activation associated with attentional bias in the dACC, right 
DLPFC, and left SPL after placebo, whereas this activation was normalized 
when dopamine levels were reduced following administration of a dopamine 
antagonist. That is, no differences in brain activation between smokers and non-
smokers were found after haloperidol intake. These results are in line with a 
previous study showing that the dopamine antagonist amisulpride normalized 
cue induced brain activation in alcohol dependent patients (Hermann, et al. 2006). 
 
 The current findings replicate and extend findings of our previous study 
using the same pictorial attentional bias task (Luijten, et al. 2011c). Again, our 
results implicate a role for the dACC in attentional bias in smokers. The dACC 
is known to be involved in multiple cognitive processes (Shackman, et al. 2011) 
such as salience detection (Seeley, et al. 2007), behavioral monitoring and 
top-down control of attention (Bush, et al. 2000; Weissman, et al. 2005). The 
dopaminergic signal in the striatum evoked by conditioned substance cues 
(Volkow, et al. 2006; Wong, et al. 2006; Zijlstra, et al. 2008) may modulate 
dACC activation via connections between the dACC and the ventral striatum 
(Kunishio, et al. 1994) such that the salience of these cues is detected. 
Meanwhile, the dACC may signal conflict of attentional resources, since 
attention is automatically allocated to the substance cues and withdrawn from 
ongoing behavior. Given the multi-functionality of the dACC (Shackman, et al. 
2011), we suggest that the dACC is involved in salience detection of conditioned 
substance cues and subsequent allocation of additional cognitive resources. 
To increase cognitive control for the continuation of ongoing behavior during 
smoking-cue exposure, the ACC may cooperate with the DLPFC, a region that 
was also found to be associated with attentional bias in smokers. For example, 
it has been shown that co-activation of the dACC and DLPFC contributes to 
the implementation of adjustments in activation of future behavior (Kerns, et 
al. 2004). In the present study we showed that when dopamine transmission in 
response to conditioned smoking cues is reduced by a dopamine antagonist the 
activation in the dACC and DLPFC associated with attentional bias in smokers 
is reduced accordingly. For future studies it would be interesting to examine 
whether individual differences in dopaminergic activation in smokers are 
associated with differences in attentional bias related brain activation. Although 
the dopaminergic theory for attentional bias does not involve an inverted 
U-shape aspect as yet, it may be that the association between dopamine and the 
attentional control aspects of attentional bias, follows a similar inverted U-shape 
curve as previously described in the domain of cognitive control (Cools, et al. 
2011). In studies addressing this hypothesis, a group of smokers with a broad 
range of attentional bias scores should be included to sample all parts of the 
U-shaped curve. Also, dopamine levels would preferably be measured with 
positron emission tomography in order to obtain a more direct estimation of 
dopamine levels.
 The findings in the current study provide a proof of principles for the 
role of dopamine in attentional bias related brain activation and may guide the 
development of new pharmacotherapies for smoking addiction. However, some 
findings in the current study suggest that the association between dopamine 
and controlling substance-related behavioral may be rather complex. First, 
it was found that haloperidol reduced overall performance accuracy and 
activation in the medial prefrontal and bilateral DLPFC during line counting 
(see supplementary table 5) suggesting that dopamine antagonists may reduce 
overall cognitive control. Given that reduced cognitive control is also associated 
with problems controlling substance use (Feil, et al. 2010a; Goldstein, et al. 
2011) a reduction in cognitive control may constitute an unfavorable effect. 
Second, the single dose of haloperidol was not able to reduce subjective craving 
in smokers, which is in line with previous studies failing to show reduced craving 
after a short term reduction in dopamine levels (Ersche, et al. 2010; Franken, 
et al. 2004; Hitsman, et al. 2008; Munafo, et al. 2007). Various explanations 
exist for the discrepancy in findings between attentional bias related brain 
activation and subjective craving. First, we could not replicate the association 
between attentional bias related brain activation and subjective craving as 
shown in our previous study (Luijten, et al. 2011c). This inconsistency remains 
currently unresolved, as previous imaging studies investigating attentional bias 
in addicted individuals have not examined this association (Ersche, et al. 2010; 
Hester, et al. 2009a; Janes, et al. 2010a; Janes, et al. 2010b; Nestor, et al. 2011). 
The discrepancy in effects of the dopaminergic manipulation as well as the lack 
of an consistent association between attentional bias related brain activation 
and craving may arise as a consequence of differences between phasic and 
tonic dopamine neurotransmission. Phasic dopamine transmission has been 
suggested to be involved in attentional bias while tonic dopamine levels may 
mediate symptoms associated with withdrawal such as subjective craving 
(Hitsman, et al. 2008). Furthermore, it has been proposed that brain activation 
is a rather sensitive measure to detect abnormalities in addicted individuals 
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regarding cue reactivity compared to other subjective measures such as 
craving (Goldstein, et al. 2011). The latter is also in line with behavioral data in the 
current study that could not differentiate between smokers and non-smokers. 
In fact, behavioral data indicated that smoking-related pictures disrupt ongoing 
behavior in both groups indicating that brain activation differences between 
groups after placebo should be interpreted as increased neural effort in smokers 
to reach similar performance. Enhanced activation in non-smokers for picture 
naming of smoking-related versus neutral pictures (see supplementary table 4) 
further support that non-smokers may react stronger to smoking cues. While 
interference for smoking cues in non-smokers is not typically found, a previous 
study that also showed this interference effect in non-smokers suggested that 
it may be due to non-addiction reasons such as negative valence (Stippekohl, 
et al. 2012). Another unexpected finding in non-smokers is that brain activation 
associated with attentional bias after haloperidol was significantly increased. 
Activation patterns (see figure 3) suggest that non-smokers are characterized 
by reduced activation for line counting in smoking-related pictures relative 
to neutral pictures after placebo, an effect that disappeared after haloperidol 
administration. Although highly speculative, we suggest that the increase in 
brain activation in the DLPFC for smoking-related pictures reflects an attempt 
to prevent a further decrement in performance levels as performance is lowest 
after haloperidol and for smoking-related pictures in general.
 A final important consideration regarding the current study is that 
smokers did not smoke for four hours before testing as this could have interfered 
with medication effects. Given the current study design we cannot completely 
rule out withdrawal effects on our results. We could demonstrate, however, 
that withdrawal was not influenced by medication type and was not associated 
with individual differences in task performance (see supplementary materials). 
In our previous study showing similar attentional bias related brain activation 
(Luijten, et al. 2011c), smokers were abstinent for three hours, while smokers 
smoked did not abstain in other studies investigating attentional bias related 
brain activation in smokers (Janes, et al. 2010a; Janes, et al. 2010b; Nestor, et 
al. 2011; Stippekohl, et al. 2012). Generally, it is assumed that attentional bias is 
augmented after longer periods of abstinence (Waters, et al. 2000), therefore 
the four hours abstinence period is important to consider when interpreting the 
current results.
 To conclude, it was shown that administration of a dopamine antagonist 
normalized activation associated with attentional bias in the dACC and DLPFC 
in smokers. This finding supports theoretical accounts of the role of dopamine 
in attentional bias, and may have implications for the development of new 
pharmacotherapies for smoking addiction. However, our finding that haloperidol 
reduced overall task performance and associated brain activation indicates that 
it should be a future research agenda to investigate whether an optimal balance 
of dopamine in different brain regions in smokers can be achieved. 
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Supplementary Materials
Medical screening
All participants were screened by a Psychiatrist. The screening included a check 
for contraindications for haloperidol (lifetime prevalence of epileptic seizure, 
heart disease and first degree relatives with diseases affecting dopaminergic 
transmission such as Parkinson disease, Huntington disease or psychosis. 
Participants were also provided with information on potential side effects such 
as drowsiness and muscle stiffness and were explained that these side effects 
are not expected to occur with a single low dose of 2 mg haloperidol. In addition, 
participants were screened for neurological and psychiatric diseases to make 
sure that participants had no lifetime neurological or psychiatric diagnoses and 
that they did not use any medication that crosses the blood brain barrier. 
Additional imaging analyses
The four task conditions of the attentional bias line counting task (line-
counting smoke picture: LCSP; line-counting neutral picture: LCNP; picture-
naming smoke picture: PNSP; picture-naming neutral picture: PNNP) are 
associated with four contrasts to be defined for second level analyses (Luijten 
et al., 2011). Results for the main contrast reflecting brain activation associated 
with attentional bias are reported in the main text. The second contrast in the 
ABLC task reflects cue-exposure corrected attention (LCSP minus PNSP). 
This contrast reflects attention to the smoking-related pictures during line 
counting while correcting for differences between smokers and controls in 
smoking cue-reactivity such as arousal and familiarity for smoking cues. The 
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third contrast (PNSP minus PNNP) reflects overall cue-reactivity effects for 
smoking pictures. Finally, the fourth contrast (overall cognitive effort) reflects 
brain activation associated with overall cognitive effort during line counting 
irrespective of picture content (LCSP and LCNP relative to baseline contrast). 
This contrast is defined in order to show whether the task robustly elicits brain 
activation and to investigate main effects of group and medication for overall 
task performance regardless of picture type.
 
Attentional bias (LCSP minus LCNP)
In addition to the analyses described in the main manuscript, we here report 
main effects (i.e., one-sample t-tests) per group per medication condition for 
the attentional bias contrast. Main effects were not limited to regions showing a 
Group x Medication interaction. The same ROIs were used for these analyses as 
in the main text and included the bilateral ACC, SPL, superior temporal gyrus, 
DLPFC, IFG, amygdala, insula and nucleus accumbens. ROIs were defined 
using the automatic anatomical labeling (AAL) atlas (Tzourio-Mazoyer, et al. 
2002). As the nucleus accumbens is not included in the AAL atlas, a 10 mm 
sphere with MNI coordinates ± 10 12 -2 was created as a ROI for the nucleus 
accumbens (Knutson, et al. 2008). Results were thresholded at p< 0.05, 
Family Wise Error (FWE) corrected for multiple comparisons across the search 
volume (Small volume correction: Friston, et al. 1996; Worsley, et al. 1996). In 
order to do so, analyses were first thresholded at p< 0.001 uncorrected with 
20 contingently activated voxels (160mm3), and then corrected using a small 
volume correction (p<0.05 FWE corrected) in which the search volume was 
defined by the AAL template corresponding to the a-priori defined ROI. 
 
Cue-exposure corrected attention (LCSP minus PNSP) 
and cue-reactivity (PNSP minus PNNP)
The same analyses were applied to these contrasts as to the attentional bias 
contrast described in the main text and supplementary materials. Shortly, for 
both contrasts a random effects Group x Medication RM-ANOVA was performed 
to investigate Group x Medication interactions. Planned between group and 
between medication t-tests were performed (i.e., differences between groups 
for placebo and haloperidol separately and medication effects in smokers 
and non-smoking controls separately), masked by voxels showing a Group x 
Medication interaction in the RM-ANOVA (p< 0.01 uncorrected). In order to 
replicate the main findings from our previous study results for the between 
group two sample t-test for placebo will also be reported without masking for 
the interaction effect. Furthermore, main effects (one-sample t-tests) per group 
per medication condition for both contrasts were calculated. Main effects were 
not limited to regions showing a Group x Medication interaction. The same ROIs 
and methods to correct for multiple analyses were used as for the attentional 
bias contrast.
 
Overall cognitive effort (LCSP and LCNP relative to 
baseline)
The first aim of the overall cognitive effort contrast was to show that the ABLT 
task robustly elicited brain activation during the line counting condition. For this 
aim a one sample t-test across groups was performed for the overall cognitive 
effort contrast after placebo (p< 0.05 whole brain FWE corrected). A second 
aim was to investigate whether smokers and non-smoking controls differed 
regarding brain activation associated with overall cognitive effort (i.e., line 
counting regardless of picture type). Therefore, a two-sample t-test (smokers 
versus non-smoking controls) for the overall cognitive effort contrast was 
performed collapsed across medication conditions. Finally, the overall effects 
of haloperidol on brain activation associated with overall cognitive effort was 
investigated using a paired t-test (placebo versus haloperidol) collapsed across 
smokers and non-smoking controls. Between group and between medication 
analyses were performed in the above mentioned a-priori defined ROIs using 
small volume corrections.
Additional imaging results 
Attentional bias
Main effects per group per medication condition show attentional bias related 
brain activation in smokers after placebo in the left SPL and right IFG. No 
attentional bias related brain activation was found in smokers after haloperidol. 
Non-smoking controls activated the left DLPFC after haloperidol. See 
supplementary table 1 for details.
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Cue-exposure corrected attention
After placebo smokers showed reduced activation for cue-exposure corrected 
attention relative to non-smoking controls in the bilateral ventral zone of the 
ACC and the bilateral nucleus accumbens (see supplementary table 2 for 
details). These group differences after placebo were not found after masking 
with the Group x Medication effect. No group differences were observed after 
haloperidol. Main affects show extended activation in prefrontal, insular, parietal 
and temporal regions in both smokers and non-smoking controls after placebo. 
After haloperidol, activation in smokers was largely reduced whereas non-
smoking controls still showed extended activation patterns. See supplementary 
table 3 for a complete overview and details of the main effects for the cue-
exposure corrected attention contrast. No significant effects of medication type 
were found in either smokers or non-smoking controls.
Supplementary Table 2 
Group effects for brain activation associated with cue-exposure corrected attention
Supplementary Table 1 
Brain activation associated with attentional bias for smokers and non-smoking controls during 
placebo and haloperidol 
Note supplementary table 2 Group differences in this table reflect differences in brain activation 
associated with cue-corrected attention (contrast line counting smoking pictures minus picture 
naming smoking picture). a p< 0.05 FWE small volume corrected; (v)ACC: (ventral) anterior cingulate 
cortex; NACC: nucleus accumbens.
Note supplementary table 1 Active regions in this table reflects brain activation associated with 
attentional bias (contrast line counting smoking pictures minus line counting neutral pictures). 
a p< 0.05 FWE small volume corrected SPL: superior parietal lobe; IFG: inferior frontal gyrus; 
DLPFC: dorsolateral prefrontal cortex.
Placebo MNI coordinates Haloperidol MNI coordinates
X Y Z Z-valuea mm3 X Y Z Z-valuea mm3
Smokers Smokers
left SPL -28 -58 54 3.94 1208 ---
right IFG 42 42 -2 3.74 328
Controls Controls
--- left DLPFC -16 56 10 4.10 264
MNI coordinates
X Y Z Z-valuea mm3
Smokers > Controls ---
Smokers < Controls
left vACC -10 44  4 3.95 1256
right ACC  14 32  16 3.66 264
left NACC -10 12  8 3.68 496
right NACC  6 14 -2 4.52 520
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Cue-reactivity
No significant group differences were found regarding cue reactivity related 
brain activation after placebo or haloperidol. Main effects per group per 
medication condition showed that smokers and non-smokers had similar cue-
reactivity responses after placebo in the insula and STG. Only the ventral ACC 
was uniquely activated in smokers after placebo. Cue-reactivity related brain 
activation in the ventral ACC in smokers was not found after haloperidol. See 
supplementary table 4 for main effects of cue-reactivity related brain activation. 
No significant medication effects were found in either smokers or non-smoking 
controls.
Overall cognitive effort
During placebo overall cognitive effort across groups was associated with 
robust brain activation in bilateral occipital, inferior and superior parietal, and 
dorsolateral prefrontal brain regions, as well as in motor areas, the insula, the 
ACC and subcortical regions including the thalamus and caudate (p < 0.05 
FWE corrected; see supplementary figure 1). In addition, haloperidol reduced 
brain activation in the right medial prefrontal cortex and bilateral DLPFC (see 
Placebo MNI coordinates Haloperidol MNI coordinates
X Y Z Z-valuea mm3 X Y Z Z-valuea mm3
Smokers Smokers
left SPL -20 -58 54 4.48 1768 right SPL 16 -66 54 4.48 1320
left SPL -36 -42 56 4.35 192 left DLPFC -22 -8 58 4.12 664
right SPL 20 -62 56 5.06 3624
left STG -48 0 -6 4.72 3544
left DLPFC -24 -8 50 6.75 1984
right DPLFC 28 -2 52 5.96 3784
left insula -38 -16 2 4.51 4608
right insula 34 -14 8 4.07 1016
Controls Controls
left ACC -8 -24 34 3.98 344 left ACC -10 -30 34 3.89 248
right ACC 12 -32 40 3.78 712 left ACC -10 -10 36 3.59 232
left SPL -20 -54 52 5.81 4496 left SPL -24 -52 58 5.99 4736
right SPL 18 -64 58 6.32 5440 right SPL 26 -52 60 6.86 5568
left STG -52 -36 14 3.93 1136 left STG -46 -22 4 4.18 5712
left STG -48 -18 6 3.63 424 right STG 52 0 -6 4.14 1504
left DLPFC -24 -6 52 5.57 3152 left DLPFC -22 -10 60 5.59 4256
right DLPFC 28 -2 52 5.40 4912 right DLPFC 32 -6 66 5.62 5112
right IFG 44 4 22 4.48 712 left IFG -40 0 24 3.79 400
right insula 42 2 10 3.54 208 right IFG 42 4 24 3.71 424
right insula 34 -4 8 3.50 256 left insula -34 -6 12 3.96 952
left NACC -12 10 6 3.53 176 right insula 50 4 -6 4.20 640
right insula 38 -16 14 3.76 736
right insula 38 -2 8 3.56 168
Supplementary Table 3 
Brain activation associated with cue-exposure corrected attention in smokers and non-smoking controls for placebo and 
haloperidol
Supplementary Table 4 
Brain activation associated with cue-reactivity for smokers and non-smoking controls during placebo and haloperidol 
Note supplementary table 3 Active regions in this table reflects brain activation associated with cue-exposure corrected 
attention (contrast line counting smoking pictures minus picture naming smoking pictures).a p< 0.05 FWE small volume 
corrected. SPL: superior parietal lobe; STG: superior temporal gyrus; DLPFC: dorsolateral prefrontal gyrus; ACC: anterior 
cingulate cortex; IFG: inferior frontal gyrus; NACC: nucleus accumbens.
Note supplementary table 4 Active regions in this table reflects brain activation associated with cue reactivity (contrast 
picture naming smoking pictures minus picture naming neutral pictures).a p< 0.05 FWE small volume corrected. vACC: 
ventral anterior cingulate cortex; STG: superior temporal gyrus.
Placebo MNI coordinates Haloperidol MNI coordinates
X Y Z Z-valuea mm3 X Y Z Z-valuea mm3
Smokers Smokers
left vACC 0 38 -2 3.66 264 left insula -38 -20 14 4.22 392
right vACC 6 40 -2 3.71 456
left insula -36 -18 14 4.84 760
left STG -52 -20 12 4.59 536
Controls Controls
left insula -34 -18 8 5.79 1720 left insula -36 -20 18 4.17 616
left STG -62 -26 16 4.37 1128
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supplementary table 5 for details). None of the brain regions showed increased 
activation after haloperidol. Brain activation associated with overall cognitive 
effort did not differ between smokers and non-smoking controls.
 
Withdrawal
Smokers were not allowed to smoke after taking the medication, which was four 
hours before scanning and could have introduced withdrawal. Withdrawal was 
assessed using the withdrawal subscale of the Questionnaire of Smoking Urges 
(Cox, et al. 2001). Withdrawal scores in smokers were analyzed with Medication 
as a single within subject factor. Results showed that medication type did not 
influence withdrawal scores F(1,23) = 0.65, p= 0.8. As individual differences 
in withdrawal may influence cognitive performance we correlated withdrawal 
scores with line counting accuracy and reaction times per medication condition. 
No significant correlations were found, all p’s> 0.14 suggesting that individual 
differences in withdrawal in smokers were not associated with cognitive 
performance. However, given the current study design it cannot be completely 
ruled out that withdrawal may have influenced cognitive performance.
Supplementary Table 5 
Medication effects for brain activation associated with overall cognitive effort
Supplementary Figure 1 
Brain activation associated with overall cognitive effort after placebo across smokers and  
non-smoking controls 
Note supplementary figure 1 p<0.05 FWE corrected (whole brain).
Note supplementary table 5 Medication effects in this table reflect differences in brain activation 
associated with overall cognitive effort (contrast line counting smoking pictures and line counting 
neutral pictures versus baseline). a p< 0.05 FWE small volume corrected. PFC: prefrontal cortex; 
DLPFC: dorsolateral prefrontal cortex.
MNI coordinates
X Y Z Z-valuea mm3
Haloperidol < Placebo
right medial PFC  8 38 34 3.74 160
left DLPFC -20 34 30 4.25 3632
right DLPFC 20 52 34 3.81 848
Haloperidol > Placebo     - - -
Lifetime substance use 
Supplementary table 6 shows lifetime substance use for smokers and non-smoking 
controls. Although groups do not differ significantly on any of the substances of 
abuse, it seems that smokers have used cannabis more often than non-smoking 
controls. More specifically, two smokers were identified as outliers as they have 
used cannabis more than 150 times lifetime. Although it is theoretically unlikely 
that cannabis use would have an impact on nicotine-related attentional bias (i.e., 
attentional biases are known to be substance-specific), we conducted an additional 
analyses excluding the two smokers who have used cannabis more than 150 
times lifetime for brain and behavioral indices of attentional bias. These analyses 
were exactly similar to the analyses described in the paper. Removing these two 
subjects did not change results substantially. Two minor differences were noticed. 
First, the p-value for the main effect of Picture for reaction times increased from 
p= 0.048 to p= 0.06. Second, although activation levels were still significant at the 
p< 0.05 FWE corrected level, the volume of increased brain activation in smokers 
after placebo in the dACC decreased from 176 mm3 to 40 mm3 when masked for 
the Group x Medication interaction. These minor differences are most likely the 
result of reduced statistical power.
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Substance Smokers Controls
Mean SD Mean SD
Cannabis 205.67 717.74 1.54 1.69
Cocaine 1.32 5.99 0.04 0.20
Amphetamines 1.12 3.53 0.04 0.20
Ecstasy 3.28 8.36 0.21 1.02
Opiates - - - -
Alcohol ab 17.63 3.47 12.84 3.34
Supplementary Table 6 
Lifetime occasions of drug use for smokers and non-smoking controls
Supplementary Table 7 
Correlations between cue induced craving in smokers and behavioral and brain indices of attentional 
bias
Supplementary Table 8
Correlations between behavioral measures and brain activation 
Note supplementary table 6 aSum scores representing quantity and frequency of alcohol 
consumption measured utilizing the Quantity-Frequency-Variability Index (QFV-index: Lemmens, et 
al. 1992). In this questionnaire three items are employed in order to determine the drinking quantity 
(number of glasses), frequency (drinking days), and variability (binge drinking) during the last six 
months. b Significant group difference p< 0.001, SD: Standard deviation.
Cue induced craving Placebo (ρ) Haloperidol (ρ)
Reaction times -.03 .01
Accuracy -.16 .07
dACC -.11 .16
Right DLPFC -.01 .20
Left SPL -.26 .05
Note supplementary table 7 ρ = spearman rank correlation coefficients for cue induced craving 
during performance of the attentional bias line counting task and behavioral and brain indices. None 
of the correlations are significant. Behavioral and brain indices are based on the contrast line counting 
smoking pictures minus line counting neutral pictures. Brain indices reflect those regions in which 
group differences were found. dACC: dorsal anterior cingulate gyrus; DLPFC: dorsolateral prefrontal 
cortex; SPL: superior parietal lobe.
Note supplementary table 8 ρ = spearman rank correlation coefficients for behavioral 
measures and brain activation. None of the correlations are significant. Behavioral and 
brain indices are based on the contrast line counting smoking pictures minus line counting 
neutral pictures. Brain indices reflect those regions in which group differences were found. 
dACC: dorsal anterior cingulate gyrus; DLPFC: dorsolateral prefrontal cortex; SPL: superior parietal 
lobe.
Placebo (ρ) Haloperidol (ρ)
Reaction times Accuracy Reaction times Accuracy
dACC -.12 .04 .24 .06
Right DLPFC -.28 -.27 .21 .19
Left SPL -.22 -.10 .07 .03
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Chapter Nine
Summary, discussion and 
concluding remarks
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The main objective of this thesis was to gain more knowledge concerning 
neurocognitive processes involved in smoking behavior. For this purpose, brain 
functions associated with cognitive control and attentional bias were investigated 
in smokers and healthy controls. First, we focused on inhibitory control and 
error-processing as two core processes of cognitive control. We investigated 
whether these functions are dysfunctional in smokers due to alterations in the 
cognitive control brain circuit. The second major objective of this thesis was to 
identify the neural substrate of attentional bias in smokers. We aimed to provide 
empirical evidence for the idea that attentional bias is associated with enhanced 
brain activation in the mesocorticolimbic system when smokers are confronted 
with smoking-related cues. In addition, the dopaminergic basis of attentional 
bias was investigated by measuring brain activation associated with attentional 
bias while manipulating dopamine levels in the brain.
 Greater insight into the malfunction of neural networks associated with 
cognitive control and attentional bias in smokers could provide valuable 
information to understand the maintenance of smoking behavior. Eventually, 
neurocognitive insights in smoking behavior may contribute to the development 
of new treatments supporting attempts to quit smoking. The current chapter 
provides a summary and discussion of the main results described in this thesis.
 
Cognitive control in addicted individuals
The role of cognitive control in substance dependence is emphasized in several 
contemporary theoretical models of substance dependence (Dawe, et al. 
2004a; Goldstein, et al. 2011; Jentsch, et al. 1999; Lubman, et al. 2004; Verdejo-
Garcia, et al. 2008). Substance dependent individuals are characterized by the 
inability to adequately control behavior related to substance use such as 
abstaining from substances of abuse. In addition, the reduced ability to perform 
goal directed behavior in substance dependent individuals is often accompanied 
by an apparent failure to adaptively learn from previous harmful behavior 
(Franken, et al. 2007). The ability to guide our behavior in accordance with our 
long-term goals requires the inhibition of automatic behavior and the monitoring 
of ongoing behavior, with both these functions being implemented by cognitive 
control circuits in our brain. More specifically, inhibitory control and error-
processing are two core components of cognitive control that are associated 
with specific neural networks; the former to implement the inhibition of 
inappropriate behavior and the latter to monitor performance errors in order to 
prevent future mistakes (Ridderinkhof, et al. 2004a). Given the important role of 
cognitive control in substance dependence, greater insight into the malfunction 
of neural networks in substance dependent individuals could provide valuable 
information for understanding the problems associated with controlling 
substance use. A rapidly increasing number of studies have examined inhibitory 
control and error-processing in substance dependent individuals by using 
neuroimaging techniques such as event-related potentials (ERPs) and functional 
magnetic resonance imaging (fMRI). Therefore, the main goal of chapter 2 was 
to evaluate fMRI and ERP studies in the domains of inhibitory control and error-
processing in order to evaluate the consistency of the findings across 
neuroimaging studies in the most common substance dependent populations. 
In light of the new update of the DSM-V that will include a section ‘Addictive 
behaviors’, studies in pathological gamblers and excessive internet users are 
also included in the review described in chapter 2. Thirty-two ERP and fMRI 
studies were evaluated. Reduced N2 amplitudes were found in addicted 
individuals in the domain of inhibitory control. Reduced N2 amplitudes suggest 
that deficits in inhibitory control in addiction may be due to problems with early 
cognitive processes such as conflict detection that are necessary to execute 
inhibitory control. Complementary to reduced N2 amplitudes, fMRI studies 
showed deviant activation in addicted individuals mainly in the anterior cingulate 
cortex (ACC), inferior frontal gyrus (IFG) and dorsolateral prefrontal cortex 
(DLPFC) but also in inferior and superior parietal gyri. From these findings, it 
can be concluded that substantial parts of the network that forms the basis of 
inhibitory control are dysfunctional in addicted individuals including smokers 
and cannabis-, alcohol-, opiate-, and stimulant-dependent individuals.
 With regard to error-processing, several studies showed that addicted 
individuals are characterized by reduced activation in the ACC; the most critical 
area for error-processing. Additionally, reduced activity in other regions such as 
superior and inferior frontal gyri and the insula was reported. ERP findings both 
confirm and complement fMRI findings. Reduced error-related negativity (ERN) 
amplitudes were found in substance dependent individuals confirming reduced 
initial error detection in addicted individuals. Given that the ACC is the neural 
generator of the ERN (Herrmann, et al. 2004; Ridderinkhof, et al. 2004a; Van 
Veen, et al. 2002), both ERN and fMRI findings suggest that ACC dysfunction 
(i.e., hypoactivation) associated with error-processing could be a marker for 
addiction. Pe findings complement fMRI findings by providing information on 
the timeframe of error-processing deficits. Reduced Pe amplitudes in substance 
dependent individuals suggest that, besides the initial error detection, more 
conscious processing of errors is reduced in addicted individuals. ERP and fMRI 
findings regarding error-processing in alcohol dependence constitutes an 
exception on the generally observed hypoactivation in addicted individuals. In 
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contrast to other addicted individuals, alcohol dependent individuals show 
enhanced processing of errors as reflected by enlarged ERN amplitudes and 
increased error related activation in the ACC. Findings in the study by Schellekens 
et al. (2010) provide a plausible explanation for these findings as ERN amplitudes 
in high anxious alcohol dependent individuals were larger than in low anxious 
alcohol dependent individuals. These findings of increased ERN amplitudes in 
high anxious alcohol dependent individuals suggest that the often observed 
comorbid internalizing psychopathology (i.e., anxiety-related disorders) in 
alcohol dependent individuals (Bacon, et al. 2010; Baillie, et al. 2010) may be 
responsible for the increase in error-processing. An overview of ERN findings in 
both internalizing and externalizing psychopathology confirms that internalizing 
psychopathology is associated with enhanced ERN amplitudes while 
externalizing psychopathology is associated with reduced ERN amplitudes 
(Olvet, et al. 2008). The effects of anxiety in alcohol dependent individuals on 
error related brain activation suggest that comorbidity with internalizing 
psychopathology may be a confounding factor in studies in substance dependent 
individuals. It would be interesting if future studies report comorbidity and 
investigate individual differences within substance dependent individuals. 
 Finally, the evaluation of studies in individuals showing excessive 
addiction-like behaviors, as described in chapter 2, provided preliminary 
evidence for similar neural deficits associated with inhibitory control and error-
processing in behavioral addictions and substance dependence. 
 
Error-processing in smokers
The main goal of the study described in chapter 3 was to evaluate the ability to 
monitor ongoing behavior during exposure to salient smoking cues in smokers. 
For this aim, an Eriksen-Flanker task (Eriksen, et al. 1974) including smoking 
cues was developed and behavioral and brain responses to performance errors 
were recorded in smokers and non-smoking controls. It was expected that 
during smoking cue exposure limited capacity may be available to monitor 
ongoing performance. As a consequence, smokers will show reduced error-
processing compared to non-smoking controls. Additionally, the nature of error-
processing deficits was examined in more detail by investigating their 
associations with trait impulsivity, severity of nicotine dependence and cigarette 
craving. Results indeed showed behavioral and physiological evidence of 
reduced error-processing in smokers during a task in which participants were 
exposed to smoking cues. On the behavioral level, smokers showed less post-
error slowing than non-smoking controls suggesting that behavioral adaptation 
after an error (e.g., slowing down in order to prevent another error) is reduced in 
smokers. Furthermore, smokers showed reduced ERN and Pe amplitudes 
following incorrect responses as compared to non-smoking controls. Reduced 
ERN and Pe amplitudes suggest that both initial error detection as well as the 
more conscious evaluation of errors is reduced in smokers. In addition, self-
reported levels of impulsivity, which were higher in smokers, were associated 
with a reduced ERN across smokers and non-smokers. Moreover, higher 
nicotine dependence levels among smokers were also associated with smaller 
ERN responses. Together, these results suggest that both personality traits and 
specific nicotine dependent characteristics are associated with diminished 
error-processing. Since adequate error-processing is required to adapt behavior 
properly, reduced error-processing may contribute to the development and 
maintenance of addictive behaviors.
 
Inhibitory Control in Smokers 
In chapter 4, inhibitory control in smokers is investigated using ERPs. The aim 
of this study was twofold. First, it was investigated whether inhibitory control is 
reduced in smokers, as behavioral findings this far have been inconsistent and 
neuroimaging studies in smokers were largely lacking. Second, it was 
investigated whether deficits in inhibitory control in smokers are more evident 
when smokers are confronted with highly salient smoking-related cues. Both 
behavioral accuracy as well as N2 and P3 event-related potentials were 
evaluated in smokers and non-smoking controls in the context of an adapted 
Go/NoGo task that included both neutral and smoking-related stimuli. 
Differences between smokers and non-smokers were found on both behavioral 
and electrophysiological indices of inhibitory control. That is, performance on 
the Go/NoGo task was generally less accurate in smokers than in non-smokers, 
i.e., smokers showed significantly more difficulties inhibiting their responses for 
NoGo trials. This deficit in inhibitory control was reflected in reduced N2 
amplitudes for NoGo trials in smokers as compared to non-smokers. The 
findings in the current study did not show more distinct deficits in inhibitory 
control in smokers in the presence of smoking cues. In fact, the findings 
described in chapter 4 suggest that deficits in inhibitory control in smokers are 
of a more general nature and are present both during neutral and smoking cue 
exposure conditions. 
 The study described in chapter 5 investigated the neural basis to 
inhibit an immediately rewarding stimulus in order to obtain a larger delayed 
reward in smokers. It was also investigated whether punishment insensitivity 
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could be another factor contributing to inefficient inhibitory control over 
rewarding stimuli. For this purpose a modified version of the Go/NoGo paradigm 
was designed that included specific reward and punishment contingencies. In 
line with contemporary theories on addiction, it was hypothesized that smokers 
would have significantly greater difficulty inhibiting their response to a rewarding 
stimulus when compared to matched control participants. With regard to 
punishment sensitivity, it was expected that smokers are less sensitive to the 
effects of punishment to guide control over rewarding stimuli. More specifically, 
we expected that non-smoking controls would adopt a more cautious responding 
style when failed inhibition resulted in an immediate punishment, while this was 
not expected to influence behavior to the same extent in smokers. Results 
showed that task performance was equal for smokers and non-smoking 
controls. At the neural level, however, it was found that smokers needed 
additional activation in the pre-supplementary motor area, right anterior insula, 
right inferior/middle frontal gyrus and right DLPFC both during inhibition of an 
immediate rewarding stimulus in order to obtain a larger delayed reward as well 
as during inhibition of neutral non-rewarding stimuli. Tentative evidence was 
found for the idea that smokers are insensitive to the inhibitory effect of 
punishment to guide control over rewarding stimuli. 
 When combining results of chapter 4 and chapter 5, it is interesting to 
note that group differences between smokers and non-smoking controls were 
neither influenced by smoking cue exposure nor by the availability of immediate 
monetary reward. These results could imply that inefficient inhibitory control in 
smokers may not be specific for smoking-related or rewarding cues but may 
reflect a general problem with inhibitory control across a broad range of 
situations. Therefore, inefficient inhibitory control in smokers may not only be 
associated with addictive behaviors but could also be associated with other 
impulsive and possibly maladaptive behaviors. This idea is supported by the 
high proportion of smokers in, for example, conduct disorder (Bagot, et al. 2007) 
and problem gambling (Verdejo-Garcia, et al. 2008). However, the implications 
of inefficient inhibitory control on tasks such as the Go/NoGo task for daily 
behaviors should be further investigated in future studies.
 
The pharmacology of inhibitory control
The pharmacology of inhibitory control is an ongoing scientific endeavor. 
Theorists assume that the relation between dopamine and cognitive control 
follows an inverted U-shaped curve such that either too low or too high levels of 
prefrontal dopamine are disadvantageous for cognitive functioning (Cools, et al. 
2011). It is important to gain more knowledge on how dopamine affects neural 
networks that form the basis of inhibitory control, especially to better understand 
disorders such as substance dependence that are characterized by dysfunctional 
dopamine systems (Balfour 2009; Berkman, et al. 2011; Diekhof, et al. 2008; 
Franken, et al. 2005; Koob, et al. 1997; Volkow, et al. 2009). Given the 
dysfunctional dopamine system in smokers and the inverted U-shaped curve 
theory, it is likely that deficiencies in dopaminergic functioning may contribute to 
problems in inhibitory control. Therefore, the study described in chapter 6 
employed a dopaminergic challenge in order to test the hypothesis that brain 
activation associated with inhibitory control is modulated by dopamine. To 
manipulate dopamine levels, Haloperidol (2mg), a selective D2/D3 dopamine 
antagonist, or placebo was orally administered in a double-blind randomized 
cross-over design in smokers and non-smoking controls. A Go/NoGo task was 
used to measure inhibitory control. It was hypothesized that a reduction in 
dopamine levels after haloperidol reduced inhibitory control and associated 
brain activation in both smokers and non-smoking controls. In addition, based 
on baseline differences in dopaminergic functioning between smokers and 
non-smoking controls it was expected that haloperidol would have differential 
effects on brain activation associated with inhibitory control in smokers and non 
smokers. At the behavioral level, results showed that smokers generally had 
longer reaction times and reduced NoGo accuracy rates for the first test 
occasion. Longer reaction times on Go trials suggest less efficient task 
performance or the use of different strategies. Besides behavioral performance 
deficits, group differences between smokers and non-smoking controls in brain 
activation associated with inhibitory control were found after the administration 
of placebo. Activation in prefrontal brain regions including the ACC, left IFG and 
right middle frontal gyrus (MFG) was found to be reduced in smokers compared 
to non-smoking controls. This study further confirmed the hypothesis that 
reduced dopamine levels after haloperidol intake are associated with 
impairments in inhibitory control. Haloperidol reduced NoGo accuracy rates in 
both groups, while Go accuracy and reaction times were unaffected, indicating 
a specific effect of dopamine on inhibitory control. Impaired inhibitory control 
after haloperidol was accompanied by reduced activation in prefrontal regions 
associated with inhibitory control including the ACC, IFG and MFG. Haloperidol 
intake, however, was associated with reduced activity relative to placebo in 
prefrontal regions in non-smoking controls, but not in smokers. This implies that 
dopamine D2/D3 receptor blockade by haloperidol renders non-smoking 
controls more similar to smokers regarding reduced inhibitory control and 
hence presumably regarding dopamine levels. The differential effects of 
haloperidol in both groups may be due to the previously observed differences in 
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baseline dopamine levels between smokers and non-smoking controls (Fehr, et 
al. 2008). Findings in this study suggest that the effects of reduced dopamine 
receptor densities in smokers (Fehr, et al. 2008), or in substance dependence in 
general, may not be limited to motivational processes linked to dopamine such 
as reward sensitivity, but could also be the underlying neurobiological 
mechanism for reduced inhibitory control. It would be interesting for future 
studies to administer both a dopamine agonist and antagonist in order to 
examine the full range of the inverted U-curve theory on dopamine levels and 
cognitive control and their consequences for nicotine dependence.
 When comparing findings of the three studies investigating inhibitory 
control in smokers, it is striking that smokers have reduced N2 amplitudes and 
reduced prefrontal activation relative to non-smoking controls in the studies 
described in chapters 4 and 6, whereas chapter 5 describes increased prefrontal 
activation in smokers. Differences between studies in terms of hypo- versus 
hyperactivation in addicted individuals were also noticed in the review of 
neuroimaging studies in chapter 2. Generally, the interpretation of hypo- versus 
hyperactivation in ERP and fMRI studies in clinical populations compared to 
healthy controls remains difficult. Behavioral findings as well as task difficulty 
may be key factors to guide the interpretation of hypo- or hyperactivation, at 
least in our findings in smokers. Hypoactivation in combination with reduced 
accuracy (chapters 4 and 6) is relatively straightforward and most likely signals 
reduced neural capacities leading to behavioral deficits. Hyperactivation 
coupled with intact behavioral performance (chapter 5) is often interpreted as 
an increased neural effort or the use of alternative cognitive strategies to reach 
normal levels of behavioral performance. Task difficulty may have determined 
whether the smokers in the current studies were able to compensate in order to 
reach similar accuracy as non-smoking controls, or whether smokers could no 
longer compensate and reduced behavioral performance was found in 
combination with hypoactivation in the cognitive control circuit. This idea is 
supported by the fact that NoGo accuracy rates were lower in the two studies 
reporting hypoactivation in smokers combined with behavioral deficits (69.63% 
and 57.66%) than in the study in which smokers showed hyperactivation without 
behavioral deficits (80.12%). In line with this notion, literature in the field of aging 
shows that initial cognitive decline is characterized by a combination of increased 
frontal engagement and intact behavioral performance (for review see: Goh, et 
al. 2009).
 
Neurobiological correlates of attentional bias
Smokers are characterized by enhanced attentional processing of smoking-
related cues, a process referred to as attentional bias. Theoretical models 
suggest that attentional bias is a consequence of a dopamine signal that triggers 
attention to substance-related cues whenever they are encountered by 
substance dependent individuals (Franken 2003; Robinson, et al. 2003). After 
repeated drug intake, substance-related cues become conditioned cues and 
elicit dopaminergic activity (Volkow, et al. 2006; Wong, et al. 2006; Zijlstra, et al. 
2008) thereby signaling the expectation of a future reward (i.e., the intake of the 
substance of abuse). Gradually, the dopaminergic system becomes sensitized 
to substance-related cues so that they become extremely salient, become the 
focus of attention and elicit behaviors like drug seeking and consumption 
(Phillips, et al. 2003; Robinson, et al. 2008). Despite these theoretical advances, 
the neurobiological mechanisms of attentional bias are largely unknown. Brain 
activation associated with attentional bias provides a direct measure of the 
enhanced processing of smoking-related cues and contributes to an increased 
understanding of the underlying mechanisms of attentional bias. Therefore, the 
neuroanatomical substrate of attentional bias and associated subjective craving 
in smokers was investigated in chapter 7. For this aim a new pictorial attentional 
bias task was developed (the attentional bias line counting task, i.e., ABLCT). 
Smokers and non smoking controls performed this task while brain activation 
was measured using fMRI. The ABLCT was developed for two major reasons. 
First, we expected that pictures capture the attention more easily than smoking-
related words (Hester, et al. 2006) that are often used to measure attentional 
bias in the smoking-word Stroop task. In addition, the ABLCT addressed another 
important conceptual issue that may confound results in non-adapted attentional 
bias paradigms. That is, if non-adapted attentional bias paradigms were used for 
an fMRI study it cannot be ruled out that differential brain activation in these task 
paradigms is the result of differences in simple cue-reactivity to smoking cues 
between smokers and non-smoking controls. Therefore, the ABLCT involved 
extra task conditions to be able to measure brain activation associated with 
attentional bias while controlling for non-specific activations resulting from 
other processes involved in cue-reactivity (i.e., picture viewing), including 
arousal and familiarity. Results of the study described in chapter 7 indicated 
more brain activation in smokers versus healthy controls in the dorsal ACC 
(dACC) and right superior parietal lobe (SPL) during the ABLCT. Unexpectedly, 
a similar effect was also observed in the left superior temporal gyrus (STG). 
Because of the design of the ABLCT we could demonstrate that dACC 
hyperactivation in smokers cannot be attributed to processes arising from mere 
cue-exposure or cue-exposure related phenomena, including enhanced 
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familiarity to smoking cues and arousal. Additionally, activations in the left insula 
and the right putamen were found to be associated with attentional bias related 
craving. In the study described in chapter 8 we investigated whether brain 
activation associated with attentional bias could be modulated by dopamine. 
Based on the theory that explains attentional bias as a consequence of 
dopaminergic firing elicited by conditioned substance cues, it can be expected 
that attentional bias related brain activation would be attenuated when dopamine 
is no longer able to signal the salience of conditioned substance-related cues. 
The pharmacological fMRI study described in chapter 8 employed a 
dopaminergic challenge in order to test this hypothesis. To manipulate dopamine 
levels, Haloperidol (2mg), a selective D2/D3 dopamine antagonist, or placebo 
was orally administered in a double-blind randomized cross-over design in 
smokers and non-smoking controls. The same pictorial attentional bias task 
(the ABLCT) was used in this study to be able to compare findings of this study 
with the findings in chapter 7. In line with findings in chapter 7, smokers showed 
enhanced brain activation associated with attentional bias after administration 
of placebo in the dACC and the SPL. Additionally, smokers showed increased 
activation in the DLPFC. Studies performed in other labs also suggest that the 
ACC may be associated with attentional bias in smokers (Janes, et al. 2010a) 
and alcohol dependent individuals (Vollstadt-Klein, et al. in press). The dACC is 
known to be involved in multiple cognitive processes (Shackman, et al. 2011) 
such as salience detection (Seeley, et al. 2007), behavioral monitoring and 
cognitive control including guidance of attention (Bush, et al. 2000; Weissman, 
et al. 2005). The dopaminergic signal in the striatum evoked by conditioned 
substance cues (Volkow, et al. 2006; Wong, et al. 2006; Zijlstra, et al. 2008) may 
trigger dACC activation via connections between these regions (Kunishio, et al. 
1994). As a consequence, salience of these cues is detected. Meanwhile, the 
dACC may signal a conflict of attentional resources, since attention is 
automatically allocated to the substance cues and withdrawn from ongoing 
behavior. Therefore we suggest that the consistent finding of enhanced 
activation in smokers during the ABLCT in the dACC is both associated with 
salience detection of smoking cues and is used to increase cognitive control in 
order to continue ongoing behavior when smoking cues are presented. In order 
to increase cognitive control the dACC may cooperate with the SPL and DLPFC. 
Most importantly, results in chapter 8 show that the enhanced activation in 
smokers in the dACC and DLPFC on the ABLCT was normalized when dopamine 
levels were reduced following administration of a dopamine antagonist. That is, 
no differences in brain activation between smokers and non-smokers were 
found after a single dose of haloperidol. Attentional bias has recently been 
shown to be associated with clinical measures of substance use such as 
successful quitting and relapse (Marissen, et al. 2006; Waters, et al. 2003). This 
association between attentional bias and treatment outcome suggests that 
normalizing attentional bias related brain activation following administration of a 
dopamine antagonist may eventually contribute to the development of new 
therapies. However, some other findings in the study described in chapter 8, as 
well as findings described in chapter 6, suggest that the association between 
dopamine and controlling substance-related behavioral may be rather complex. 
Both in the ATBLC task and in the Go/NoGo task described in chapter 6, 
haloperidol was found to reduce performance accuracy and brain activation 
associated with inhibitory control and overall cognitive effort (i.e., line counting 
across neutral and smoking picture conditions in the ABLCT). These findings 
suggest that dopamine antagonists, besides normalizing brain activation 
associated with attentional bias, may also reduce general cognitive functioning 
which may constitute an unfavorable effect. This may be one of the causes why 
dopamine antagonists do not seem to be successful in treatment of cocaine 
dependence (Amato, et al. 2007). The current results of normalization of brain 
activation associated with attentional bias should therefore rather be interpreted 
as a proof of principle for the role of dopamine in attentional bias instead of a 
direct clinical relevant finding. 
 Several other findings in chapter 7 and 8 deserve more discussion. 
First, both studies using the ABLCT did not show group differences in brain 
regions involved in emotion processing or stimulus driven attention such as the 
orbitofrontal cortex (OFC), ventral striatum and amygdala. Activation in these 
brain regions was expected since environmental drug cues tend to capture the 
attention of drug users, due to the established salience of these cues (Robinson, 
et al. 2008). The absence of activation in these regions in smokers is probably 
due to our fast event-related paradigm that was specifically designed to measure 
attentional bias and to keep other processes such as prolonged cue-exposure 
and emotional involvement to a minimum. The requirement to count lines as the 
main instruction for the participants may have caused a shift in brain activation 
to the cognitive control brain regions.
 Second, while both studies consistently found attentional bias related 
brain activation in smokers in the dACC, we could not consistently show that the 
activation in the dACC is still present when controlling for differences between 
smokers and non-smoking controls in familiarity and arousal evoked by the 
smoking cues. Also, the association between craving and attentional bias 
related brain activation in the insula and the putamen could not be replicated in 
the study described in chapter 8. This discrepancy between the two studies may 
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be due to order-effects, as participants performed the ABLCT twice in the study 
described in chapter 8 and participants received placebo either on the first or 
second scan session. Differences between the two studies in methodology to 
control for multiple comparisons may also contribute to discrepancies between 
the two studies. 
 Finally, we were not able to demonstrate group differences between 
smokers and non-smoking controls for accuracy rates and reaction times on the 
ABLCT in neither study employing this paradigm. In fact, behavioral findings 
suggest that both smokers and non-smoking controls have decreased accuracy 
rates in combination with faster reaction times for line counting in smoking-
related pictures. The combination of reduced accuracy and faster reaction times 
for smoking-related pictures may indicate that ongoing behavior is interrupted 
due to an impulsive response style evoked by the smoking-related content of 
the pictures. This may probably happen in non-smoking controls for non-
addiction reasons such as negative valence (Stippekohl, et al. 2010). Although 
the behavioral measures could not discriminate between smokers and non-
smoking control, fMRI findings detected differences between smokers and 
non-smoking controls in both studies. Several explanations exist for this 
discrepancy. It may be that brain activation is a more direct or sensitive measure 
to detect group differences compared to reaction times and accuracy rates. 
Goldstein and Volkow (2011), for example, argued that neuroimaging measures 
are more sensitive in detecting group differences in conditioned responses to 
drug-related cues compared to subjective valence or arousal measures, or even 
autonomic reactions such as skin conductance responses. In addition, in a 
meta-analysis it was shown that the association between craving and brain 
activation measured with ERPs was stronger than the association between 
craving and behavioral measures such as reaction times (r = .37 and .15 
respectively: Field, et al. 2009). The probably limited sensitivity of behavioral 
findings on the ABLCT may be due to the recent finding that the internal reliability 
of event-related behavioral measures in attentional bias paradigms is 
disappointing (Ataya, et al. 2012; Field, et al. 2012). However, the reliability of 
attentional bias related brain activation measured with neuroimaging techniques 
remains to be investigated.
 
Limitations of the described studies
In the current thesis, cross-sectional study designs we used to investigate 
neurocognitive functions in smokers. Although differences between smokers 
and non-smoking controls were found in neurocognitive functioning, no causal 
inferences can be drawn from these studies. That is, based on the current thesis 
it is unknown whether differences in neurocognitive functioning between 
smokers and non-smoking controls predispose individuals to start smoking or 
whether these differences are a consequence of the effects of smoking on the 
brain. Two types of research should be performed in order to find out whether 
neurocognitive deficits in smokers, or in substance dependent individuals in 
general, are causes for or consequences of addictive behaviors. First, 
neurocognitive performance should be investigated in high-risk groups, such as 
children of substance dependent parents. Second, and most importantly, 
longitudinal population based neuroimaging studies should be performed to 
examine whether neurocognitive functioning could be used to differentiate 
individuals who will develop addiction later in life from those who will not. 
Currently, these kinds of studies are mainly lacking, with the exception of one 
large population study in adolescents in the domain of inhibitory control (N = 
1896, Whelan, et al. 2012). Findings of this study suggest that hypoactivity 
associated with inhibitory control in the OFC may be a risk factor for the initiation 
of substance use, including smoking and alcohol use, whereas hyperactivity in 
right prefrontal cortex may result as a consequence of illicit substance use. 
 A second limitation of the studies in the current thesis is that they were 
all performed in young, healthy and highly educated smokers, thereby reducing 
the generalizability of results to the complete population of smokers. 
Differentiating types of smokers based on education levels, age, gender and 
smoking motives may be useful to see whether subgroups exist within the 
smoking population that show different neurocognitive profiles. Stress relief 
and perception of enjoyment of smoking have been reported as the most 
common motives for smoking (Fidler, et al. 2009). It is plausible that cognitive 
control and attentional bias differs between those who mainly smoke for stress 
relief and those who smoke for enjoyment of smoking. For example, a study in 
current and former opiate users showed an association between stress and 
attentional bias. Former opiate users, in contrast to current users, showed a bias 
away from substance-related stimuli after a stress induction and this correlated 
positively with their length of abstinence (Constantinou, et al. 2010). With regard 
to gender effects, it has recently been proposed that nicotine interacts with 
estrogen and the dopamine reward system (Van Voorhees, et al. 2012) 
suggesting that differences between female and male smokers may exist in 
terms of attentional bias or cognitive control. Larger participant numbers are 
needed to increase statistical power when one aims to investigate individual 
differences in neurocognitive functioning, especially when exploring multiple 
sources of variance in a single study.
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 Finally, although measuring brain activation in smokers using ERPs and 
fMRI provides valuable information regarding the functionality of the brain 
during cognitive performance, it does not provide a complete picture of brain 
functioning. Various other imaging techniques and methods to analyze imaging 
data could provide complementary insights in addictive behaviors. For example, 
recent structural magnetic resonance imaging and diffusion tensor imaging 
studies start to demonstrate that smokers could also be characterized by 
alterations in respectively gray and white matter integrity (Almeida, et al. 2008; 
Almeida, et al. 2011; Froeliger, et al. 2010; Zhang, et al. 2011a; Zhang, et al. 
2011b). In addition, functional connectivity patterns in addicted individuals, both 
during task performance and during rest, could provide new insights regarding 
the cooperation of brain regions within in a neural network supporting 
neurocognitive functioning (Janes, et al. 2012; Yu, et al. 2011).
Treatment implications and future research suggestions
Contemporary effective treatments for smoking involve nicotine replacement 
therapy, pharmacotherapy, face-to-face counseling and internet guided 
interventions (Eisenberg, et al. 2008; Hays, et al. 2009; Shahab, et al. 2009). 
Nevertheless, relapse rates in smokers as well as in other addictions are still 
high so there is ample room for improvement. Several treatment targets for 
addiction can be suggested based on the findings described in the current thesis 
and merit further investigations. First, cognitive control capacities and underlying 
neural networks could be trained to increase cognitive control. A recent study 
indicates that explicit training of inhibition of drinking cues via pairing with NoGo 
trials results in a reduction in drinking behavior in social drinking (Houben, et al. 
2011). It is still an unanswered question whether training of inhibitory control can 
also impact substance use in clinical populations. Another more implicit 
possibility to increase inhibitory control could be the direct training of brain 
regions such as the ACC, IFG and DLPFC via neurofeedback techniques 
(deCharms 2008). Previous research has shown that participants can regulate 
their ACC activation by providing them with real-time feedback on ACC 
activation (deCharms, et al. 2005). Another potential treatment method for 
addiction with the brain as a direct target is transcranial magnetic stimulation 
(TMS, Barr, et al. 2008; Feil, et al. 2010b). Repetitive stimulation of the DLPFC in 
depressive individuals reduced Hamilton Depression Rating Scale scores 
(Wassermann, et al. 2012). It would be interesting to see whether repetitive TMS 
can also be effective in addictive individuals by improving cognitive control via 
TMS stimulation of the prefrontal cortex. The dACC may be a good target region 
for both neurofeedback techniques and transcranial magnetic stimulation as 
dysfunctions in this region are among the most consistent findings in this thesis 
and in the addiction literature in general (for reviews see Goldstein, et al. 2011; 
Kuhn, et al. 2011).
 As shown in this thesis, investigations into the role of neurotransmitters 
such as dopamine in inhibitory control could provide valuable insights concerning 
the biochemistry underlying deficits in inhibitory control. Besides dopamine, 
other neurotransmitters such as norepinephrine and acetylcholine could be 
related to cognitive control (Nieuwenhuis, et al. 2011; Sarter, et al. 2009). 
Currently, it is investigated whether the use of cognitive enhancer medication 
such as modafinil may enhance cognitive control via its effects on both 
norepinephrine and dopamine (Brady, et al. 2011). For example, it has been 
shown that modafinil in methamphetamine dependent individuals was able to 
improve task performance on a Go/NoGo task (Dean, et al. 2011).
 Individual differences in cognitive control capacities can also be used 
in clinical practice to guide and personalize treatment plans. It has been shown 
for example that deficits in cognitive control are associated with reduced 
capacities to recognize problems with substance abuse and lower motivation to 
enter treatment (Severtson, et al. 2010). Furthermore, an increasing number of 
studies indicated that substance dependent individuals with reduced cognitive 
control tend to drop out in treatment programs more often (Ersche, et al. 2007). 
A study by Berkman et al. (2011) showed that individual differences in activation 
in the inhibitory control network are linked to the ability to inhibit craving in daily 
life in order to prevent smoking. This study is a good illustration on how 
neuroimaging research could develop to become more clinically relevant. A 
related line of future research is the prediction of relapse based on neuroimaging 
data. Most studies in the domain of cognitive control are cross-sectional and 
cannot link brain activation with the ability of substance dependent individuals 
to remain abstinent. Studies investigating the link between relapse and brain 
activation associated with cognitive control are crucial to understand how 
deficits in cognitive control contribute to the maintenance of addiction. 
 Studies in the domain of attentional bias already showed that behavioral 
measures of attentional bias could be predictive for relapse rates and treatment 
outcome in addicted individuals including smokers (Carpenter, et al. 2006; Cox, 
et al. 2002; Marissen, et al. 2006; Waters, et al. 2003; Waters, et al. 2012). It 
should be noted, however, that the association between attentional bias and 
successful treatment was not found in smokers in a study by Spiegelhalder and 
colleagues (2011). In order to become a valuable treatment marker, a causal 
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relationship between attentional bias and addictive behaviors should be 
demonstrated in experimental studies. A few studies in alcohol dependent 
individuals and smokers have tried to manipulate attentional bias by means of 
an attentional bias modification (ABM) training (Attwood, et al. 2008; Fadardi, et 
al. 2009; Field, et al. 2009; McHugh, et al. 2010b; Schoenmakers, et al. 2007; 
Schoenmakers, et al. 2010). Some of these studies showed that attentional bias 
can be either increased or decreased using a single ABM training (Attwood, et 
al. 2008; Fadardi, et al. 2009; Field, et al. 2009; Schoenmakers, et al. 2007). 
Unfortunately, the effect of a single training on attentional bias was not 
associated with addictive behaviors or treatment success in most of these 
studies (Attwood, et al. 2008; Field, et al. 2009; Schoenmakers, et al. 2007). 
Several methodological issues in this research domain are worth discussing as 
they may clarify the current difficulties to improve treatment outcome using 
ABM training. First, the optimal dose and generalizability of ABM training may 
be a crucial aspect of training success. In alcohol dependent individuals, it has 
been shown that a single ABM training does not influence drinking behaviors 
(Schoenmakers, et al. 2007), while a training consisting of five ABM sessions 
did improve treatment success (Schoenmakers, et al. 2010). This study 
(Schoenmakers, et al. 2010) further showed that after completion of the five 
sessions of ABM training, attentional bias was also reduced for a new set of 
alcohol-related stimuli. This generalizability could not be demonstrated in 
studies using a single session training (Field, et al. 2009; McHugh, et al. 2010b; 
Schoenmakers, et al. 2007) and may be a requisite for the link between ABM 
training and a reduction in addictive behaviors. For future studies it would be 
interesting to investigate whether brain activation related to attentional bias 
could be a valuable additional marker for relapse rates in addicted individuals. 
 Another more explicit way to reduce attentional processing of 
substance-related cues is the use of cognitive reappraisal techniques. The idea 
of reappraisal techniques is that they can be applied by substance dependent 
individuals as a strategy to reduce cue-exposure effects such as enhanced 
attentional processing and craving. Examples of reappraisal strategies are to 
think about long-term consequences associated with smoking, to view the cue 
from an uninvolved perspective or to distract yourself by focusing on visual 
aspects of the scene. Brain activation measures could be particularly useful to 
investigate the effectiveness of reappraisal techniques as they provide objective 
indices of cue-reactivity that are less likely to be influenced by subjective 
expectations and social desirability. Recently, in a study employing event-related 
potentials as indices for attentional processing of smoking-related cues, it was 
shown that different reappraisal strategies were successful to reduce processing 
of smoking-related cues in smokers to the level of neutral cues (Littel, et al. 
2011). Furthermore, Kober et al. (2010) showed that regulation of craving by 
reappraisal techniques associated with increased activation in cognitive control 
regions, such as the DLPFC and dorsomedial cortices, is supported by 
decreased activation in regions previously shown to be associated with craving, 
such as the ventral striatum and the amygdala. It remains to be investigated 
whether substance dependent individuals are able to implement cognitive 
reappraisal strategies in their daily lives and if so, whether this is associated with 
reduced relapse rates.
 
Main conclusions 
Several conclusions can be formulated based on the studies described in this 
thesis. First, it can be concluded that smokers are characterized by a dysfunction 
in substantial parts of the neural circuits underlying cognitive control. More 
specifically it seems that: 1) dysfunctions in neural circuits associated with 
cognitive control in smokers partly overlap with patients dependent on illicit 
substances of abuse as well as with individuals characterized by excessive 
addiction-like behaviors; 2) smokers are characterized by reduced processing 
of errors in ongoing behavior; 3) inhibitory control is decreased in smokers both 
under neutral and smoking cue-exposure conditions; 4) or smokers need more 
neural effort to reach similar performance levels as non-smoking controls, both 
when they inhibit immediate rewarding and neutral stimuli and 5) reduced 
dopamine levels may contribute to problems associated with inhibitory control. 
With regard to attentional bias, the studies described in this thesis showed that: 
1) smokers have increased activation during performance of an attentional bias 
task in brain regions involved in salience detection and top down attentional 
control suggesting that these regions have to compensate to continue ongoing 
behavior when smokers are exposed to smoking-related cues; 2) increased 
brain activation in smokers on the attentional bias task paradigm can be 
normalized by administration of a dopamine antagonist.
 Overall, the findings of the current thesis provide neurocognitive 
insights that increase the understanding of the continuation of smoking despite 
knowledge of long-term negative consequences.
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Achtergrond 
Zevenentwintig procent van de huidige Nederlandse bevolking rookt. Van 
degenen die ooit gerookt hebben ontwikkelt 32% binnen tien jaar een verslaving. 
Dit percentage voor nicotine is hoger dan voor andere verslavende middelen 
(bijvoorbeeld 23 procent voor heroïne: Anthony, et al. 1994). Deze cijfers laten 
zien dat roken zeer verslavend is. Van alle rokers heeft 80% de intentie in de 
toekomst te stoppen. Echter, het overgrote deel van de rokers heeft hier grote 
moeite mee. Dit blijkt uit onderzoek dat aantoont dat 80-95% van de 
stoppogingen na een jaar mislukt is (International Tobacco Control Policy 
Evaluation Project 2011). Nicotine afhankelijkheid is momenteel opgenomen in 
het Diagnostisch en Statistisch Handboek (DSM-IV-TR) als officiële stoornis in 
middelengebruik. Voorbeelden van diagnostische criteria zijn (a) tolerantie; het 
steeds meer moeten roken voor hetzelfde subjectieve effect, (b) 
ontwenningsverschijnselen wanneer men niet kan roken; (c) meer roken dan 
men van plan is en (d) blijven roken ondanks de kennis van de negatieve lange 
termijn gevolgen zoals de serieuze gezondheidsrisico’s die gepaard gaan met 
roken (Schmitz, et al. 2003). De hierboven omschreven kenmerken tonen aan 
dat roken een serieus en chronisch probleem is dat in een groot deel van de 
samenleving voorkomt.
 In de afgelopen decennia heeft dierexperimenteel en humaan 
onderzoek geleid tot neurobiologische modellen die verslaving verklaren als het 
gevolg van een verstoorde balans in de hersenen (Everitt, et al. 2005; Field, et 
al. 2008; Franken 2003; Goldstein, et al. 2011; Volkow, et al. 2004; Wiers, et al. 
2007). Aan de ene kant lijkt het systeem in de hersenen dat controle uitoefent 
over ons gedrag minder goed te werken bij middelen afhankelijke patiënten, 
terwijl aan de andere kant het systeem dat waarde en motivatie toekent aan 
prikkels uit de omgeving overactief is voor prikkels die gekoppeld zijn aan de 
verslaving (ook wel verslavings-gerelateerde cues genoemd).
 Het hierboven genoemde controlesysteem is voornamelijk 
gelokaliseerd in het voorste deel van onze hersenen, ook wel de prefrontale 
cortex genoemd (Chambers, et al. 2009; Garavan, et al. 2006; Simmonds, et al. 
2008). Als men wil stoppen met middelengebruik of roken is een goed 
functionerend controlesysteem van cruciaal belang. Het is hiervoor belangrijk 
dat het verslavingsgedrag onderdrukt kan worden en dat eventuele misstappen 
goed verwerkt worden om fouten in de toekomst te kunnen voorkomen. Het 
onderdrukken van ons gedrag wordt ook wel impulscontrole genoemd en wordt 
gedefinieerd als de mogelijkheid automatisch, onveilig of ongepast gedrag te 
onderdrukken (Chambers, et al. 2007). Het evalueren van onze alledaagse 
fouten wordt ook wel foutverwerking genoemd dat meer specifiek de continue 
evaluatie en verwerking van ons gedrag weerspiegelt met als doel toekomstig 
gedrag optimaal uit te kunnen voeren (Overbeek, et al. 2005; Ridderinkhof, et al. 
2004a). Deze functies worden beide aangestuurd door het controlesysteem in 
onze hersenen (Ridderinkhof, et al. 2004a).
 Tegenover het verminderde controlesysteem staat het overactieve 
motivationele systeem, dat ook wel het mesocorticolimbisch systeem genoemd 
wordt. Een van de processen die voortkomt uit het overactieve motivationele 
systeem is aandachtsbias. Aandachtsbias is de automatische neiging van 
middelenafhankelijke patiënten en rokers om de aandacht te richten op alles 
wat met de verslaving te maken heeft (Field, et al. 2008; Franken 2003). Een 
voorbeeld hiervan is een roker die in zijn ooghoeken ziet dat er een pakje 
sigaretten op tafel ligt. De betreffende roker zal dit pakje sigaretten snel 
opmerken (de initiële aandacht wordt automatisch getrokken) en de aandacht 
van de roker zal langer blijven hangen op het pakje sigaretten (dit wordt ook wel 
volgehouden aandacht genoemd). De verhoogde initiële en volgehouden 
aandacht voor verschillende aan roken gerelateerde cues zorgt ervoor dat de 
roker minder aandacht heeft voor datgene waar hij /zij oorspronkelijk mee bezig 
was. Ook krijgt de roker door de verhoogde aandacht voor roken-gerelateerde 
cues gevoelens van craving, ofwel een sterke drang om te gaan roken (Field, et 
al. 2009). Neurobiologische modellen suggereren dat aandachtsbias ontstaat 
door herhaalde koppeling van middelen-gerelateerde cues en het vuren van 
dopamine na het gebruik van het verslavende middel (Robinson, et al. 1993). 
Dopamine is een neurotransmitter die onder andere de communicatie tussen 
de neuronen verzorgt in het motivationele systeem. Het wordt verondersteld 
dat leereffecten optreden na veelvuldige koppeling van de middelen-
gerelateerde cues en het middelengebruik. Een gevolg hiervan is dat op den 
duur het dopamine systeem al gaat vuren bij het zien van de middelen-
gerelateerde cues nog voordat het middel tot zich genomen wordt. De middelen-
gerelateerde cues krijgen hierdoor een hoge motivationele waarde (ook wel 
salience genoemd) en zullen daardoor de aandacht trekken en vasthouden 
(Franken 2003). Het overactieve motivationele systeem met betrekking tot 
middelen-gerelateerde cues in combinatie met een verminderd functionerend 
controlesysteem zou kunnen verklaren waarom verslaving gekenmerkt wordt 
door het onvermogen het middelengebruik te beheersen.
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Doel en relevantie van het proefschrift
Het belangrijkste doel van dit proefschrift was meer inzicht te krijgen in de 
neurocognitieve processen, zoals impulscontrole, foutverwerking en 
aandachtsbias, die ten grondslag liggen de verslaving van rokers. Aan het begin 
van dit promotieproject (februari 2008) was nog weinig bekend over het 
functioneren van het controlesysteem in de hersenen van rokers. Het was dan 
ook onduidelijk of rokers, net als middelenafhankelijke patiënten voor illegale 
drugs en alcohol, gekenmerkt worden door een verminderd functionerend 
controlesysteem in de hersenen. Daarom is in dit proefschrift met behulp van 
neuroimaging technieken onderzocht of rokers inderdaad gekenmerkt worden 
door verminderde impulscontrole en foutwerking als gevolg van eventuele 
afwijkingen in het onderliggende controlesysteem in de hersenen.
 Het onderzoeken van de neurobiologische achtergrond van 
aandachtsbias bij rokers was het tweede belangrijke doel van dit proefschrift. 
Dit omdat de huidige neurobiologische modellen met betrekking tot 
aandachtsbias voornamelijk gebaseerd zijn op dierexperimenteel onderzoek en 
omdat deze modellen niet uitvoerig getoetst zijn met behulp van humaan 
neuroimaging onderzoek. Bij het onderzoeken van de neurobiologische 
achtergrond van aandachtsbias bij rokers hebben we met name bekeken welke 
hersengebieden hierbij betrokken zijn. Ook is de rol van dopamine in 
hersenactiviteit gerelateerd aan aandachtsbias nader onderzocht.
 Meer inzicht in de neurocognitieve achtergrond van de verslaving van 
rokers kan belangrijke informatie opleveren waardoor een beter begrip ontstaat 
van het verslavingsgedrag. Uiteindelijk kunnen deze neurocognitieve inzichten 
bijdragen aan de ontwikkeling van nieuwe interventies zodat stoppogingen in 
de toekomst beter ondersteund kunnen worden. Hieronder volgt een 
beschrijving van de gebruikte neuroimaging technieken in dit proefschrift en 
een samenvatting van de opzet en resultaten van de uitgevoerde studies. Deze 
samenvatting wordt afgesloten met suggesties voor toekomstig onderzoek en 
de belangrijkste conclusies die voortkomen uit dit proefschrift.
Neuroimaging technieken
Om de neurale achtergrond van de verschillende cognitieve processen van 
rokers te kunnen onderzoeken zijn neuroimaging technieken nodig die de 
hersenactiviteit registreren. Deze neuroimaging technieken worden gebruikt in 
combinatie met cognitieve taken. De cognitieve taken worden aangeboden via 
een computer en brengen hersenactiviteit teweeg gerelateerd aan de cognitieve 
processen die men wil onderzoeken (zoals impulscontrole, foutverwerking of 
aandachtsbias). In het huidige proefschrift hebben we gebruik gemaakt van 
twee verschillende neuroimaging technieken. Voor de studies omschreven in 
hoofdstuk 3 en hoofdstuk 4 hebben we gebruikt gemaakt van event-related 
potentials (ERPs; ofwel gebeurtenis gerelateerde golven) die gemeten kunnen 
worden door middel van elektro-encefalografie (EEG). ERPs representeren 
activiteit in de hersenen die met grote temporele precisie te relateren zijn aan 
een specifieke gebeurtenis tijdens de cognitieve taak (Fabiani, et al. 2000). Voor 
foutverwerking zijn bijvoorbeeld twee ERPs aan te wijzen in het EEG die de 
hersenactiviteit reflecteren na het maken van een fout (Overbeek, et al. 2005). 
De error-related negativity (ERN; ofwel fout gerelateerde negativiteit) is de 
eerste golf die optreed in de hersenactiviteit na het maken van een fout 
(gemiddeld na 50-100 ms) en staat voor de snelle detectie van de gemaakte 
fout. De error-positiviteit (Pe) volgt na de ERN en staat voor een meer diepere, 
bewustere verwerking van de fout (Overbeek, et al. 2005). Op deze manier zijn 
aan iedere cognitieve functie een aantal ERPs verbonden. Het voordeel van 
ERPs is dat ze veel informatie verschaffen over de timing van de cognitieve 
functies in de hersenen. Helaas is het met ERPs lastiger de anatomische locatie 
van de activiteit vast te stellen.
 Functionele magnetic resonance imaging (fMRI) is de andere 
neuroimaging techniek die toegepast is voor de studies omschreven in de 
hoofdstukken 5,6,7 en 8 in dit proefschrift. fMRI is in staat de anatomische 
locatie van hersenactiviteit activiteit vast te stellen met een hoge spatiale 
resolutie. Het signaal gemeten met fMRI is een indirecte maar betrouwbare 
schatting van de neuronale activiteit in een bepaald gebied (Logothetis, et al. 
2001) en komt tot stand op basis van verschillen in de zuurstof via bloedtoevoer 
in een actief gebied ten opzichte van datzelfde gebied in rust. De verhouding 
tussen zuurstofarm en zuurstofrijk bloed gemeten met fMRI wordt ook wel de 
Blood Oxygenation Level-Dependent (BOLD) response genoemd. Ook voor 
fMRI wordt gebruik gemaakt van cognitieve taken die de activiteit in de hersenen 
oproept gerelateerd aan het cognitieve proces dat men wilt meten. Daarnaast 
kan fMRI in combinatie met een farmacologische manipulatie toegepast 
worden, dit wordt dan ook wel farmacologische fMRI genoemd. Farmacologische 
fMRI wordt gebruikt om de rol van bepaalde neurotransmitters, zoals dopamine, 
te onderzoeken voor het cognitieve proces van interesse en de daaraan 
gerelateerde hersenactiviteit. In farmacologische fMRI studies wordt veelal een 
medicijn toegediend dat de niveaus van een bepaalde neurotransmitter in de 
hersenen beïnvloedt. De hersenactiviteit na inname van dit middel wordt dan 
vergeleken met de hersenactiviteit na inname van een neppil (ofwel placebo) 
Nederlandse samenvatting 
228 229
zodat de rol van de neurotransmitter in de hersenactiviteit duidelijk wordt. In de 
studies omschreven in hoofdstuk 6 en hoofdstuk 8 hebben we farmacologische 
fMRI toegepast om de rol van dopamine in impulscontrole en aandachtsbias te 
onderzoeken.
 De hierboven beschreven kenmerken van ERPs en fMRI maken deze 
technieken zeer geschikt voor het onderzoeken van neurocognitieve functies 
van rokers. Door onderzoeksresultaten van zowel ERP als fMRI studies te 
evalueren kan aanvullende informatie verkregen worden met betrekking tot de 
timing en de anatomische locatie van de neurocognitieve aspecten van 
verslaving bij rokers.
 
Samenvatting
onderzoeksbevindingen
In hoofdstuk 2 worden impulscontrole en foutverwerking in meer detail 
besproken. Zowel de ERPs die verbonden zijn aan deze processen als de neuro-
anatomische basis van impulscontrole en foutverwerking wordt uiteengezet. Ook 
worden de cognitieve paradigma’s die gebruikt worden om impulscontrole en 
error-processing te meten besproken. Het hoofddoel van hoofdstuk 2 is een 
overzicht te geven van de gepubliceerde ERP en fMRI studies op het gebied van 
impulscontrole en foutverwerking in de verschillende groepen van 
middelenafhankelijke patiënten en rokers. Op deze manier kunnen consistente 
bevindingen tussen de verschillende studies opgespoord worden en kan er een 
beter beeld gecreëerd worden van de afwijkende neurocognitieve processen in 
de hersenen die ten grondslag liggen aan de verminderde controle over het 
verslavingsgedrag. Op deze manier kan er ook onderzocht worden of er 
verschillen zijn tussen de verschillende groepen middelenafhankelijke patiënten 
met betrekking tot mogelijke afwijkingen in de hersenen. Daarnaast zijn in 
hoofdstuk 2 ook studies besproken die uitgevoerd zijn in de zogenoemde 
‘gedragsverslavingen’ zoals gokken en excessief internetgebruik. Het doel 
hiervan is te onderzoeken of mogelijke neurale afwijkingen met betrekking tot 
impulscontrole en foutverwerking in deze excessieve gedragingen overeenkomen 
met die van middelenafhankelijkheid. Hierdoor kan een bijdrage geleverd worden 
aan de discussie of deze excessieve gedragingen op dezelfde manier 
gediagnostiseerd en behandeld zouden kunnen worden als die van 
middelenafhankelijkheid. De studies die besproken zijn in hoofdstuk 2 werden 
geselecteerd op basis van zoektermen in Pubmed en Embase. De bevindingen in 
hoofdstuk 2 komen overeen met de huidige verslavingsmodellen en ondersteunen 
het idee dat verslaving gekenmerkt wordt door afwijkingen in het neurale 
systeem dat ten grondslag ligt aan impulscontrole en foutverwerking. Met 
betrekking tot de ERPs waren de meest consistente bevindingen verlaagde N2 
en ERN amplituden in middelenafhankelijke patiënten en rokers. Omdat zowel 
de N2 als de ERN golven zijn die vroeg in het cognitieve proces optreden 
suggereren deze bevindingen dat de neurale processen die ten grondslag liggen 
aan impulscontrole en foutverwerking al in een vroeg, mogelijk onbewust, 
stadium afwijkend zijn. Wat betreft de neuro-anatomische achtergrond van 
verminderde cognitieve controle was de meest voorkomende bevinding 
verlaagde activiteit in de anterieure cingulate cortex (ACC), inferieure frontale 
gyrus (IFG) en de dorsolaterale prefrontale cortex (DLPFC). Ondanks de 
gevonden overeenkomsten tussen de beschreven studies waren er ook grote 
verschillen tussen de studies. Sommige studies lieten afwijkingen zien in het 
controlesysteem terwijl de middelenafhankelijke patiënten of rokers even goed 
als gezonde controles presteerden op het cognitieve paradigma dat gebruikt 
werd om impulscontrole of foutverwerking te meten. Dit maakt de interpretatie 
van verschillen in hersenactiviteit tussen middelenafhankelijke patiënten of 
rokers en gezonde controle deelnemers lastig. Een van de verklaringen voor de 
verschillen in bevindingen tussen de studies is de grote variatie in methodologie 
tussen de studies. Daarom is het voor toekomstig onderzoek aan te raden dat er 
meer overeenstemming wordt bereikt met betrekking tot het gebruik van de 
cognitieve taken. De resultaten beschreven in hoofdstuk 2 toonden ook 
verschillen aan tussen de verschillende groepen middelenafhankelijke patiënten. 
Zo werden alcoholisten bijvoorbeeld gekenmerkt door verhoogde foutverwerking 
in plaats van de verlaagde foutverwerking die bij rokers en andere groepen 
middelenafhankelijke patiënten te zien was. Tenslotte werd in hoofdstuk 2 ook 
voorzichtig bewijs gevonden voor het idee dat ook gokkers en excessieve 
internetgebruikers gekenmerkt worden door afwijkingen in het neurale systeem 
dat ten grondslag ligt aan cognitieve controle. Dit is een eerste voorzichtige 
aanwijzing dat de mechanismen achter dit excessieve niet-middelen gebonden 
gedrag overeenkomsten vertoond met middelenafhankelijkheid.
 
Foutverwerking bij rokers
Foutverwerking is een cruciaal onderdeel om ons gedrag op de lange termijn te 
kunnen sturen en controleren (Ridderinkhof, et al. 2004a). In de studie beschreven 
in hoofdstuk 3 hebben we onderzocht of rokers gekenmerkt worden door een 
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verminderde verwerking van fouten in de hersenen. Om dit te kunnen onderzoeken 
hebben zowel rokers als niet-rokers een Eriksen-Flanker taak (Eriksen, et al. 
1974) uitgevoerd terwijl ERPs gerelateerd aan foutverwerking gemeten werden. 
De Eriksen-Flanker taak is speciaal ontwikkeld om deelnemers fouten te laten 
maken zodat onderzocht kan worden hoe deze fouten verwerkt worden in de 
hersenen. Om het extra uitdagend te maken voor rokers bevatte de gebruikte 
Eriksen-Flanker taak ook foto’s met roken-gerelateerde cues. De verwachting 
was dat rokers hun fouten minder goed zouden verwerken tijdens de blootstelling 
aan de roken-gerelateerde cues omdat deze cues ook hersencapaciteit in beslag 
nemen. De bevindingen beschreven in hoofdstuk 3 laten zien dat rokers inderdaad 
gekenmerkt worden door verminderde foutverwerking ten opzichte van niet-
rokers. De resultaten laten zien dat rokers hun gedrag minder goed aanpassen na 
het maken van een fout (niet-rokers werden langzamer na het maken van een 
fout, terwijl rokers op hetzelfde tempo doorgingen). Beide ERPs die gelinkt zijn 
aan foutverwerking (de ERN en Pe) waren verlaagd in rokers. Dit geeft aan dat de 
hersenen van rokers de fout zowel minder goed detecteren en de fout vervolgens 
minder diep verwerken. Op basis van deze resultaten kan men concluderen dat 
rokers gekenmerkt worden door een verminderde verwerking van fouten in de 
hersenen tijdens blootstelling aan roken-gerelateerde cues.
 
Impulscontrole in rokers
In hoofdstuk 4 wordt een studie beschreven waarin de impulscontrole van rokers 
is onderzocht door middel van ERPs. Het doel van deze studie was tweeledig. In 
de eerste plaats werd onderzocht of er inderdaad sprake is van verminderde 
impulscontrole bij rokers en daarbij behorende mogelijke neurale afwijkingen. In 
de tweede plaats werd onderzocht of mogelijke problemen met impulscontrole in 
rokers sterker aanwezig zijn wanneer rokers blootgesteld worden aan roken-
gerelateerde cues met een hoge motivationele waarde. Om dit te onderzoeken 
werd een Go/NoGo taak gebruikt. Tijdens het uitvoeren van een Go/NoGo taak 
moeten deelnemers plotseling en infrequent het gedrag onderdrukken. Om de 
onderzoeksvraag te beantwoorden werd zowel de accuratesse van rokers en niet-
rokers vergeleken tijdens het uitvoeren van de Go/NoGo taak, als de ERPs die 
geassocieerd zijn aan impulscontrole (N2 en P3 golven). De resultaten beschreven 
in hoofdstuk 4 laten zien dat rokers, in vergelijking met niet-rokers, minder goed 
waren in impulscontrole. Dit wil zeggen dat rokers tijdens het uitvoeren van de 
Go/NoGo taak vaker niet in staat waren hun gedrag te onderdrukken. Deze 
verminderde prestatie ging gepaard met verlaagde N2 golven. Deze verlaagde 
N2 golven tonen aan dat de hersenen van rokers al in een vroeg stadium 
afwijkingen laten zien waardoor problemen op kunnen treden met het 
onderdrukken van gedrag. De beschreven resultaten in hoofdstuk 4 tonen aan dat 
de problemen met impulscontrole in rokers aanwezig zijn tijdens blootstelling aan 
roken-gerelateerde cues. Echter, omdat verminderde impulscontrole zowel 
aanwezig was tijdens neutrale condities als tijdens blootstelling aan roken-
gerelateerd cues zijn de beschreven resultaten in overeenstemming met het idee 
dat rokers in het algemeen gekenmerkt worden door een verminderde 
impulscontrole en niet alleen wanneer er roken-gerelateerde cues in de omgeving 
aanwezig zijn.
 Het doel van de studie beschreven in hoofdstuk 5 was te onderzoeken 
of beloning en straf een rol spelen in de hersenactiviteit die gepaard gaat met 
impulscontrole in rokers. Verslavingsmodellen veronderstellen dat middelen-
afhankelijke patiënten en rokers vooral problemen ervaren met het onderdrukken 
van stimuli die voorheen gepaard gingen met een beloning zoals een sigaret 
wanneer men wilt stoppen (Jentsch, et al. 1999; Volkow, et al. 2010). Ook zijn er 
voorzichtige aanwijzingen in de literatuur dat middelenafhankelijke patiënten en 
rokers minder gevoelig zijn voor het gebruik van straf om het gedrag te sturen 
(Vanderschuren, et al. 2004). Om de rol van beloning en straf in de hersenactiviteit 
gerelateerd aan impulscontrole te kunnen onderzoeken werd gebruik gemaakt 
van een cognitieve taak die gebaseerd is op de Go/NoGo taak. In deze taak werd 
gebruik gemaakt van verschillende typen beloning en straf voor het al dan niet 
succesvol onderdrukken van gedrag door middel van het winnen of verliezen van 
geld. Hersenactiviteit in deze studie werd gemeten door middel van fMRI. De 
resultaten van deze studie laten zien dat rokers meer hersenactiviteit nodig 
hebben in het controlesysteem om tot een gelijke prestatie te komen als niet-
rokers. Meer specifiek lieten de resultaten zien dat rokers zowel tijdens het 
onderdrukken van stimuli, die een belonende waarde hebben, als tijdens het 
onderdrukken van neutrale stimuli, verhoogde activiteit hebben in de ACC, de 
insula, IFG en DLPFC. Deze resultaten tonen aan dat rokers meer moeite moeten 
doen om belonende stimuli te onderdrukken. Echter, net als in hoofdstuk 4, werd 
dit ook gevonden voor neutrale stimuli. Met betrekking tot gevoeligheid voor straf 
zijn er in deze studie voorzichtige aanwijzingen gevonden dat niet-rokers meer 
moeite doen hun gedrag te onderdrukken wanneer er mogelijk een straf volgt dan 
rokers. Dit blijkt onder andere uit verhoogde visuele verwerking bij niet-rokers van 
de stimuli die onderdrukt moeten worden wanneer er de mogelijkheid op 
straf was.
 Over de farmacologische basis van impulscontrole is in de 
wetenschappelijke literatuur nog weinig bekend. Er zijn aanwijzingen dat de 
neurotransmitter dopamine een sturende rol heeft in het controlesysteem in de 
hersenen (Cools, et al. 2011). Meer informatie over de rol van dopamine in 
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impulscontrole kan belangrijke informatie opleveren voor stoornissen die gepaard 
gaan met afwijkingen in het dopaminerge systeem zoals verslaving (Volkow, et al. 
2009). Het kan bijvoorbeeld aanknopingspunten opleveren over de manier 
waarop impulscontrole verbeterd zou kunnen worden met behulp van 
farmacologische behandeling. Daarom onderzochten we in de studie beschreven 
in hoofdstuk 6 de rol van dopamine in de impulscontrole van rokers en niet-
rokers. We hebben hiervoor gebruikt gemaakt van farmacologische fMRI. Alle 
deelnemers voerden twee keer de Go/NoGo taak uit terwijl de hersenactiviteit 
gemeten werd met fMRI. De ene keer kregen rokers en niet-rokers een eenmalige 
dosis-haloperidol die het dopamine niveau in de hersenen verlaagt. De andere 
keer kregen de deelnemers een placebo. De toediening van de medicatie werd 
gerandomiseerd en dubbel blind uitgevoerd. Dit betekent dat er geen systeem zat 
in de volgorde waarin de deelnemers haloperidol of placebo kregen en dat zowel 
de deelnemers als de onderzoekers niet wisten wanneer welk type medicatie 
toegediend werd. De resultaten van deze studie tonen aan dat dopamine 
inderdaad een belangrijke rol heeft in impulscontrole. Het verlagen van het 
dopamineniveau in de hersenen had tot gevolg dat zowel rokers als niet-rokers 
minder goed werden in het onderdrukken van gedrag. Dit ging gepaard met 
verminderde activiteit in het controlesysteem in de hersenen. Rokers waren 
minder goed dan niet-rokers in het onderdrukken van gedrag tijdens de eerste 
keer dat ze de Go/NoGo taak uitvoerden. In overeenkomst met verslavingsmodellen 
hadden rokers ook verminderde activiteit in het controlesysteem (ACC, linker IFG 
rechter middel frontale gyrus, MFG) na placebo. Nadat dopamine niveaus verlaagd 
werden door middel van haloperidol waren er geen verschillen meer in de 
hersenactiviteit tussen rokers en niet-rokers in sommige delen van het 
controlesysteem zoals de ACC, IFG en MFG. Dit kwam met name omdat 
haloperidol de activiteit in de niet-rokers verlaagde tot het niveau van de rokers. 
Het verschillende effect van haloperidol voor rokers en niet-rokers zou verklaard 
kunnen worden door verschillen in algemene dopamine niveaus tussen rokers en 
niet-rokers (Fehr, et al. 2008). Op basis van de resultaten beschreven in hoofdstuk 
6 kunnen we concluderen dat dopamine inderdaad een belangrijke rol speelt in 
impulscontrole en het controlesysteem in de hersenen dat hieraan ten grondslag 
ligt. Deze bevindingen laten zien dat problemen met impulscontrole in verslaving 
mogelijk het gevolg zijn van verstoringen in het dopaminesysteem en bieden 
aanknopingspunten voor toekomstig onderzoek met als doel impulscontrole te 
verbeteren op basis van farmacologische behandelingen.
De neurobiologische achtergrond van aandachtsbias 
in rokers
In de studies beschreven in hoofdstuk 7 en 8 is de neurobiologische achtergrond 
van aandachtsbias in rokers onderzocht. In hoofdstuk 7 beschrijven we een 
fMRI studie waarin bekeken werd welke hersengebieden betrokken zijn bij de 
aandachtsbias van rokers. We hebben hiervoor een cognitieve taak ontwikkeld 
(de aandachtsbias lijnen-tellen taak) waarbij deelnemers lijnen tellen die door 
roken-gerelateerde foto’s en neutrale foto’s heen stonden. Op deze manier 
waren we in staat de hersenactiviteit te bekijken die rokers extra nodig hebben 
voor het tellen van lijnen in roken-gerelateerde foto’s ten opzichte van neutrale 
foto’s en ten opzichte van niet-rokers. Deze extra hersenactiviteit reflecteert de 
automatische aandacht (de aandachtsbias) voor roken-gerelateerde cues 
omdat deze cues niet relevant zijn voor de opdracht die deelnemers uit moeten 
voeren, namelijk het tellen van lijnen. De resultaten van deze studie lieten zien 
dat hersenactiviteit geassocieerd aan aandachtsbias voortkomt uit activiteit in 
de ACC, de superieure pariëtale gyrus (SPG) en de superieure temporale gyrus 
(STG). De ACC en SPG zijn beide betrokken bij het sturen en controleren van de 
aandacht. Deze bevindingen suggereren dan ook dat rokers meer hersenactiviteit 
nodig hebben in gebieden die de aandacht sturen en controleren om een 
simpele taak zoals lijnen tellen uit te voeren wanneer roken-gerelateerde cues 
op de achtergrond aanwezig zijn. In de studie beschreven in hoofdstuk 8 
hebben we dezelfde cognitieve taak gebruikt om aandachtsbias gerelateerde 
hersenactiviteit te meten als in hoofdstuk 7. In deze studie onderzochten we de 
rol van dopamine in hersenactiviteit gerelateerd aan aandachtsbias. Dezelfde 
gerandomiseerde dubbel blinde methode werd gebruikt voor het toedienen van 
haloperidol en placebo zoals omschreven bij de samenvatting van hoofdstuk 6. 
De verwachting was dat lagere dopamine niveaus in rokers door toediening van 
haloperidol er voor zou zorgen dat de overmatige hersenactiviteit gerelateerd 
aan aandachtsbias in rokers genormaliseerd zou worden. De bevindingen 
waren in overeenstemming met de verwachtingen. We toonden opnieuw aan 
dat de ACC en de SPG betrokken zijn bij aandachtsbias in rokers na placebo. In 
deze studie vonden we daarnaast dat ook de DLPFC betrokken is bij 
aandachtsbias in rokers. De belangrijkste bevinding van deze studie was dat de 
overmatige activiteit van rokers in de ACC en de DLPFC verminderde tot 
hetzelfde niveau als in niet-rokers na inname van haloperidol. Deze resultaten 
bevestigen hiermee het idee dat aandachtsbias gerelateerde hersenactiviteit 
afhankelijk is van dopamine niveaus en geeft nieuwe aanknopingspunten voor 
toekomstig onderzoek met als doel de aandachtsbias te verminderen.
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Beperkingen van de besproken studies
Bij het interpreteren van de resultaten van de hierboven genoemde studies is 
het belangrijk een aantal beperkingen van de studies aan te geven. Op de eerste 
plaats zijn de studies cross-sectioneel van aard. Dit betekent dat rokers op één 
specifiek moment in de tijd vergeleken zijn met niet-rokers en dat deelnemers 
niet voor langere tijd gevolgd en getest werden op meerdere momenten. 
Vanwege dit cross-sectionele karakter van het onderzoek kunnen we geen 
uitspraken doen met betrekking tot oorzaak en gevolg. We kunnen hierdoor niet 
concluderen dat verminderde impulscontrole het gevolg is van de effecten van 
nicotine in de hersenen of dat de verminderde impulscontrole de oorzaak is 
voor het ontstaan van verslaving in rokers. Grootschalig onderzoek waarin 
deelnemers op meerdere momenten getest worden over een langere 
tijdsperiode is noodzakelijk om uitspraken te kunnen doen over oorzaak en 
gevolg.
 Een tweede beperking van het huidige onderzoek is dat de meeste 
rokers in de uitgevoerde studies jong, gezond en veelal hoogopgeleid zijn. Dit 
vermindert de toepasbaarheid van de resultaten voor alle rokers in de algemene 
bevolking. Ook hebben we niet gekeken naar individuele verschillen tussen 
rokers. Het kan zijn dat verschillen in leeftijd, geslacht, opleidingsniveau of 
motieven om te roken kunnen leiden tot verschillen in onderliggende 
neurocognitieve functies (Constantinou, et al. 2010; Van Voorhees, et al. 2012). 
 Ondanks dat ERP en fMRI studies belangrijke informatie opleveren 
met betrekking tot de neurocognitieve processen betrokken bij verslaving in 
rokers geven zij geen compleet beeld van het functioneren van de hersenen. Er 
zijn verschillende andere neuroimaging technieken beschikbaar die aanvullende 
informatie op kunnen leveren. Zo kan diffusie tensor imaging en structurele MRI 
meer inzicht geven in mogelijke structurele afwijkingen in de hersenen van 
middelenafhankelijke patiënten en rokers (Almeida, et al. 2008; Almeida, et al. 
2011; Froeliger, et al. 2010; Zhang, et al. 2011a; Zhang, et al. 2011b). Analyses 
gericht op de samenwerking tussen de verschillende gebieden tijdens een 
cognitieve taak of tijdens rust kunnen ook aanvullende waardevolle inzichten 
opleveren (Janes, et al. 2012; Yu, et al. 2011). 
Klinische toepassing en suggesties voor  
vervolgonderzoek
Gebaseerd op bevindingen in dit proefschrift kunnen een aantal aanbevelingen 
gedaan worden voor toekomstig onderzoek. Gezien behandelingen voor 
middelenafhankelijkheid en roken nog steeds beperkt succesvol zijn zal 
toekomstig onderzoek zich met name moeten richten op de klinische toepassing 
van de opgedane neurocognitieve inzichten. Zo zou het bijvoorbeeld interessant 
zijn te onderzoeken of de verschillende neurocognitieve processen zoals 
impulscontrole, foutverwerking en aandachtsbias verbeterd kunnen worden bij 
rokers. Door het verbeteren van deze functies is het mogelijk dat ook de kans op 
een succesvolle stoppoging toeneemt. Trainen van neurocognitieve functies 
kan op verschillende manieren bereikt worden. Men kan bijvoorbeeld gebruik 
maken van cognitieve taken die frequent uitgevoerd moeten worden zodat men 
de impulscontrole, foutverwerking of aandachtsbias traint. Het verminderen 
van aandachtsbias door middel van training met behulp van cognitieve taken is 
in eerdere studies gedaan, echter met wisselende resultaten (Attwood, et al. 
2008; Field, et al. 2009; McHugh, et al. 2010b; Schoenmakers, et al. 2010). Meer 
onderzoek zal nodig zijn om de juiste training te ontwikkelen zodat aandachtsbias 
kan verminderen. Neurocognitieve functies kunnen ook getraind worden door 
middel van directe verandering van de activiteit in de onderliggende systemen 
in de hersenen. Neurofeedback is een methode waarbij de deelnemer directe 
feedback krijgt over de activiteit in een bepaald hersengebied (deCharms 
2008). Op basis van deze directe feedback kan men de eigen hersenactiviteit 
beïnvloeden. Eerder onderzoek heeft bijvoorbeeld aangetoond dat men de 
activiteit in de ACC kan aanpassen op basis van onmiddellijke feedback over de 
activiteit in dat gebied (deCharms, et al. 2005). Een andere manier om 
hersenactiviteit te kunnen beïnvloeden is door gebruik te maken van 
Transcraniële Magnetische Stimulatie (TMS: Feil, et al. 2010b). TMS is een 
techniek waarbij van buitenaf de hersenactiviteit in een bepaald gebied 
gestimuleerd of onderdrukt kan worden. Toekomstige studies zullen uit moeten 
wijzen of het manipuleren van hersenactiviteit door middel van neurofeedback 
of TMS bij kan dragen aan betere behandelingen voor verslaving.
 Een andere klinische toepassing is het afstemmen van behandel-
strategieën op basis van de individuele verschillen in middelenafhankelijke 
patiënten met betrekking tot de verschillende neurocognitieve functies. Het is 
bijvoorbeeld bekend uit eerder onderzoek dat middelenafhankelijke patiënten 
met verminderde cognitieve controle gekenmerkt worden door verminderde 
herkenning van problemen gerelateerd aan het middelengebruik, een lagere 
motivatie om een behandeling te starten en een grote kans de behandeling niet 
af te maken (Ersche, et al. 2007; Severtson, et al. 2010). Een hieraan gerelateerde 
onderzoekslijn heeft betrekking op de vraag of neurocognitieve functies 
gebruikt kunnen worden voor het voorspellen van behandelsucces of stopsucces 
bij rokers. Onderzoek op het gebied van aandachtsbias heeft al aangetoond dat 
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aandachtsbias gemeten met gedragsexperimentele taken van voorspellende 
waarde kan zijn voor terugval (e.g., Waters, et al. 2012). Toekomstig onderzoek 
zal uit moeten wijzen of de hersenactiviteit geassocieerd aan de verschillende 
neurocognitieve processen een betrouwbare voorspelling op kan leveren voor 
terugval in middelengebruik of roken.
 Met betrekking tot farmacologisch onderzoek zou het interessant zijn 
als toekomstige studies zich niet alleen richten op de rol van dopamine in 
verslaving, maar ook op de rol van andere neurotransmitters zoals noradrenaline 
en acetylcholine onderzoeken (Nieuwenhuis, et al. 2011; Sarter, et al. 2009). 
Recent onderzoek suggereert dat cognitieve controle mogelijkerwijs verbeterd 
kan worden door middel van psychoactieve medicatie (Brady, et al. 2011). Dit 
type medicatie wordt ‘cognitieve versterker’ genoemd en dankt het mogelijke 
positieve effect aan het stimuleren van het noradrenerge en dopaminerge 
systeem
 
Conclusies
Dit proefschrift leverde een aantal waardevolle conclusies op. Ten eerste kan 
geconcludeerd worden dat rokers gekenmerkt worden door een verminderd 
functioneren van een substantieel deel van het cognitieve controlesysteem in 
de hersenen. Meer specifiek lijkt het erop dat: 1) de afwijkingen in het 
controlesysteem in de hersenen van rokers deels overeenkomen met de 
gevonden afwijkingen in andere middelen gebonden verslavingen en excessief 
niet-middelen gebonden gedrag; 2) rokers worden gekenmerkt door een 
verminderde verwerking van fouten in het gedrag; 3) rokers gekenmerkt worden 
door een verminderde impulscontrole zowel tijdens blootstelling aan roken-
gerelateerde als neutrale cues; 4) dat rokers meer neurale activiteit nodig 
hebben in het controlesysteem om tot hetzelfde niveau van impulscontrole te 
komen als niet-rokers tijdens het onderdrukken van belonende en neutrale 
stimuli en 5) verlaagde dopamineniveaus in de hersenen kunnen bijdragen aan 
een verlaagde impulscontrole.
 De studies in dit proefschrift met betrekking tot aandachtsbias laten 
zien dat: 1) rokers meer activiteit nodig hebben tijdens het uitvoeren van een 
cognitieve taak die aandachtsbias meet in hersengebieden die de aandacht 
sturen en controleren. De verhoogde activiteit in deze gebieden suggereert dat 
rokers meer moeite moeten doen om een simpele taak uit te voeren als roken-
gerelateerde cues aanwezig zijn; 2) deze toegenomen activiteit van rokers 
genormaliseerd kan worden door toediening van een dopamine remmend 
middel.
 Over het geheel genomen geven de bevindingen in dit proefschrift 
belangrijke neurocognitieve inzichten met betrekking tot verslaving bij rokers. 
Deze neurocognitieve inzichten dragen eraan bij dat we beter begrijpen waarom 
rokers doorgaan met roken ondanks de kennis over de negatieve lange termijn 
gevolgen.
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Het is zover, mijn proefschrift is af en ik mag mijn dankwoord schrijven. Ik heb er 
vaak naar uitgekeken mijn dank uit te spreken aan iedereen om mij heen. Jullie 
hebben het verdiend!
Om te beginnen mijn promotor, professor Franken, beste Ingmar. We kenden 
elkaar nauwelijks toen ik aan dit promotietraject begon, maar wat heeft het toch 
goed uitgepakt. Bedankt voor je vertrouwen in mij als onderzoeker. Bedankt 
voor je fantastische begeleiding. Altijd heb ik het gevoel gehad dat je achter me 
staat en dat mijn persoonlijke ontwikkeling belangrijk voor je is. Je bescheidenheid 
en de respectvolle manier waarop je over andere onderzoekers spreekt zijn erg 
bijzonder. Ik kijk er naar uit samen te blijven werken en nog vele mooie 
onderzoeken op te zetten en te publiceren. Bedankt dat je me deze mogelijkheid 
hebt geboden. Ik was gezegend met twee promotoren en ben dus ook professor 
Veltman veel dank verschuldigd. Beste Dick, het was heel prettig terug te kunnen 
vallen op jouw expertise op het gebied van fMRI. Ook heb ik veel geleerd van je 
waardevolle en gedegen feedback op mijn papers. Daarnaast ben ik erg 
dankbaar dat je me geïntroduceerd hebt bij verschillende fMRI onderzoekers in 
Amsterdam. 
Graag wil ik alle overige leden van de promotiecommissie bedanken voor het 
lezen van mijn proefschrift en de bereidheid met mij van gedachten te wisselen 
tijdens de verdediging van mijn proefschrift. Ik waardeer jullie aanwezigheid en 
kritische blik enorm.
Mijn collega’s bij het Instituut voor Psychologie hebben ervoor gezorgd dat ik 
me meteen welkom voelde op de afdeling. Op mijn eerste dag een C3-uitje was 
een goed begin, dat representatief bleek voor de gezelligheid in de afgelopen 
jaren. C3-ers en ex-C3’ers, Ali, An, Angela, Anita, Anja, Arjan, Birgit, Colin, 
Danielle, Elke, Eric, Freddy, Guus, Hans, Ilse, Ivo, Jorg, Katrien, Leonie, Marien, 
Marjolein, Marlies, Peter, Renske, Reshmi, Sabine, Susan, Suzanne en Tim, 
bedankt voor de prettige samenwerking, jullie enthousiasme, feedback en steun 
voor mijn onderzoek. In het bijzonder wil ik mijn kamergenoten Anita, Marianne 
en Mario bedanken. Het was ontzettend leuk om niet alleen het hele 
promotietraject, maar ook onze privé-belevenissen met elkaar te delen. 
Terugkijkend op de afgelopen jaren hebben we ontzettend veel meegemaakt, 
onze eerste publicaties, presentaties en congressen, maar ook het kopen van 
onze eerste huizen, nieuwe liefdes of zelfs vader worden op de dag van het 
kerstfeest. Marianne, bedankt dat je mijn paranimf wilt zijn. Het is fijn zo’n lieve 
en slimme onderzoeker naast me te hebben staan. Bedankt ook voor het 
brainstormen over ons onderzoek. Naarmate we verder kwamen hebben we 
steeds meer aan elkaar gehad. Dat geldt ook voor Anja en Reshmi. Samen 
kunnen we ontzettend enthousiast worden over ons onderzoek. Als je straks al 
onze proefschriften naast elkaar ziet hebben we toch een flinke bijdrage aan het 
verslavingsonderzoek geleverd. Het was fijn dit alles met elkaar te delen en van 
elkaar te leren, vooral wanneer dit gepaard ging met wijntjes en lekker eten 
(want ook daar leveren we een flinke bijdrage aan). Ook met de andere aio’s van 
het instituut die rond 2008 begonnen aan hun promotietraject heb ik wijntjes 
gedronken, gezellige etentjes gehad, filmpjes bekeken, gestapt, congressen en 
symposia bezocht en gezongen met Singstar. Allemaal bedankt voor deze 
onvergetelijke tijd. Ik wil Angela en Leonie in het bijzonder bedanken voor de 
vele kletspraatjes en wederzijdse peptalks. De onderzoekers van het EAN-lab 
wil ik bedanken voor hun bijdrage aan mijn EEG-studies. Het is fijn en leerzaam 
om werkzaam te zijn in een groep met zoveel ervaring op het gebied van ERP 
onderzoek. De ‘mannen van het EBL’ wil ik bedanken voor de professionele 
manier waarop zij het EBL leiden en ons onderzoek ondersteunen. Als je bij 
jullie aanklopt met een probleem kan je ervan uitgaan dat het opgelost wordt. 
Mirella, Hanny en Angelique, bedankt voor jullie administratieve ondersteuning. 
Voor de opzet en het uitvoeren van de fMRI studies in dit proefschrift wil ik mijn 
grote dank uitspreken aan de afdeling Radiologie van het Erasmus MC. De 
afdeling Radiologie is zeer gastvrij (de memorabele kerstfeesten mogen hierbij 
niet onvermeld blijven). In het bijzonder wil ik professor Van der Lugt en Marion 
Smits bedanken. Aad, bedankt voor het faciliteren van ons onderzoek op jullie 
afdeling. Marion, bedankt dat je me opgenomen hebt in jouw fMRI-groep. De 
manier waarop je mij en andere onderzoekers bijstaat is inspirerend. Jouw 
betrokkenheid bij ieders onderzoek wekt enthousiasme en energie op bij 
anderen. Ik vind het een eer dat je plaatsneemt in mijn promotiecommissie. De 
wekelijkse bijeenkomsten die we samen met Rebecca organiseren hebben me 
geholpen me verder te ontwikkelen in het fMRI onderzoek. Carolina, Freddy, 
Gabry, Gerbrich, Ilse, Ivo, Janne, Jos, Karen, Marcus, Marion, Melissa, Rebecca, 
Reshmi, Rozanna, Ryan, Sandra en Tonya, bedankt voor jullie bijdrage aan deze 
bijeenkomsten. Bedankt ook voor de gezelligheid en het lekkers dat gepaard 
ging met de bijeenkomsten (chocolade, cupcakes en ijsjes helpen zeker om 
lastige materie beter te begrijpen ;-)). Sjel en Rebecca, ook jullie zijn zeer 
waardevolle kamergenoten. Sjel, je verdient alle lof voor je geduld met de fMRI 
meiden en ook je handigheidjes op de PC worden zeer gewaardeerd. Rebecca, 
samen bedenken we wat we gaan bespreken in de wekelijkse fMRI 
bijeenkomsten. Het is heerlijk met je samen te werken door je oneindige 
betrokkenheid bij alles en iedereen om je heen en je grote 
verantwoordelijkheidsgevoel. Ik ben er trots op dat je als paranimf naast me 
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staat bij mijn verdediging. Ten slotte wil ik Bob, Fania, Gavin, Jolanda, Mart, Piotr, 
en Ronald bedanken voor het ondersteunen van ons onderzoek op de afdeling 
Radiologie. 
Dear Rob Hester, all the way from Australia you were a great support for me 
during my PhD studies. It was a blessing that Ingmar introduced me to you a few 
months after I started as a PhD student. You answered all my emails full with 
questions very kindly, and you gave me the great opportunity to perform a study 
together in Melbourne. Thank you for your hospitality, the opportunity to write a 
paper from the data acquired in Melbourne, and being such a helpful person. 
David, Sarah and Maria, thank you for all the work you did for our study in 
smokers and for making me feel welcome in Melbourne. 
Marise Machielsen wil ik bedanken voor de samenwerking tijdens het schrijven 
van het review paper in hoofdstuk 2. Het was en is een lange weg. Maar ik weet 
zeker dat er een goed einde aan komt. Ook mijn andere co-auteurs wil ik 
bedanken voor alle hulp bij het onderzoek en jullie feedback op de manuscripten 
voor de diverse hoofdstukken in dit proefschrift. Lolke Pepplinkhuizen wil ik in het 
bijzonder bedanken voor de screening van alle deelnemers voor de studie met 
de haloperiol.
Graag wil ik Liza Heusdens en Esther Tönder-Spittel bedanken die in het kader 
van hun master scriptie een grote bijdrage hebben geleverd aan de onderzoeken 
beschreven in dit proefschrift. Ook de deelnemers aan alle studies wil ik bedanken 
voor hun inzet. Zonder jullie geen onderzoek. 
Mijn vrienden en familie wil ik bedanken voor hun interesse in mijn werk. Nog 
belangrijker is dat ik bij jullie de nodige afleiding en ontspanning vind om het 
werk even te vergeten. Lieve Femmes, soms doen we net alsof we weer even 
student zijn en maken we mooie nachtelijke avonturen mee, maar nog blijer 
word ik van de vriendschappen die ik overgehouden heb aan mijn studententijd. 
Bedankt hiervoor. Lieve Mencia-meiden, ik ben ontzettend trots op onze 
vriendschap. We waren even bang dat we oud en saai zouden worden, maar het 
tegendeel is waar. Iedere keer als we elkaar zien hebben we weer mooie en 
bijzondere dingen meegemaakt. Laten we doorgaan met onze kletsmomentjes, 
etentjes, weekendjes, surprises, BBQ’s etc. totdat we achter de geraniums zitten. 
Ik weet zeker dat we dan nog steeds niet uitgepraat zijn. Jullie betekenen heel 
veel voor mij. 
Lieve ‘schoonfamilie’, ik ben ontzettend blij met jullie als tweede familie. Omdat 
ik jullie al zo jong heb leren kennen heb ik soms het gevoel een extra setje 
ouders, broers en zussen te hebben. Bedankt ook voor jullie grote interesse in 
mijn onderzoek. Ik hoop dat ik een leuke tante zal zijn voor lieve Eva en .....? 
Nelleke, wil ik in het bijzonder bedanken voor het controleren van de spelling 
van sommige hoofdstukken in dit proefschrift. Hiervoor wil ik ook Carla 
bedanken. Het was leerzaam om met jou mijn Engelse schrijfstijl te bespreken. 
Jos, grote broer Bart, mijn verslagje is af. Lees je het even door? Ik heb grote 
bewondering voor de manier waarop jij en Martine in het leven staan. Hard 
werken op de boerderij in het prachtige Nieuw-Zeeland. Jullie maken je dromen 
waar. Het is heerlijk bij jullie te zijn en een heel andere manier van leven te zien. 
Lieve Sam en Britt, jullie zijn geweldig! Leef je leven zoals je ouders, ga je 
dromen achterna. Lieve Pap en Mam, ik heb alles aan jullie te danken. Door jullie 
heb ik vertrouwen in mezelf en voel ik me vrij te doen wat ik wil. Ik ben gezegend 
met fantastische ouders die mij het gevoel geven vol trots achter me te staan. Ik 
vind het een grote eer dat de voorkant van mijn proefschrift tot stand is gekomen 
door jullie creativiteit. De quilt van het brein gemaakt door mama, de foto 
genomen in Nieuw-Zeeland door papa. Op deze manier is de hele familie 
vertegenwoordigd. Bedankt hiervoor en voor alles wat jullie me gegeven en 
bijgebracht hebben. 
Ten slotte, de allerbelangrijkste, Marc. Mijn leven met jou te mogen delen is een 
groot voorrecht. We hebben samen veel lol, raken niet uitgeknuffeld, vullen 
elkaar feilloos aan en blijven van elkaar leren. Onze discussies, ook over mijn 
onderzoek, houden me scherp. Jouw betrokkenheid bij mijn werk is bijzonder 
groot, daarvoor ben ik erg dankbaar. Je hield me gezelschap tijdens het scannen, 
je zocht me op in Arizona en in Melbourne, je denkt mee over het maken van 
figuren en je luistert iedere avond tijdens het koken naar mijn verhalen. Mijn 
liefde en bewondering voor jou zijn groot! 
Iedereen die ik hier niet genoemd heb, maar die de afgelopen jaren direct of 
indirect aan mijn onderzoek heeft bijgedragen: Hartelijk Dank!
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